NCT05494853
Novel Biomarker Assay for Biomarker Assay for HCC Detection No drug interventions Not Available Not Available not_yet_recruiting NCT01642446
Optimal Treatment on Hepatocellular Carcinoma (HCC) With Cirrhotic Portal Hypertension No drug interventions treatment Not Available completed NCT02921139
Comparing Re-TACE Versus SABR for Post-prior-TACE Incompletely Regressed HCC: a Randomized Controlled Trial (TASABR) No drug interventions treatment Not Available recruiting NCT03775863
AFP Model and Liver Transplantation. No drug interventions Not Available Not Available completed NCT01744639
Analysis of Body Composition in Patients With Hepatocellular Carcinoma in Radioablation No drug interventions diagnostic Not Available withdrawn NCT01272557
Sorafenib Plus Doxorubicin Versus Sorafenib Alone for the Treatment of Advanced Hepatocellular Carcinoma: a Randomized Phase II Trial treatment 2 unknown_status NCT01717729
Hepatocellular Carcinoma Treated With Iodine-125 Implantation No drug interventions treatment 3 completed NCT01380392
The Illness of Uncertainty, Personality and Coping Strategies in Patients With Hepatocellular Carcinoma No drug interventions Not Available Not Available unknown_status NCT00791544
Dose Finding Study of AVE1642 in Patients With Advanced or Metastatic Liver Carcinoma treatment 1 / 2 terminated NCT01020812
Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma No drug interventions treatment 1 / 2 terminated NCT02424955
Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation diagnostic Not Available completed NCT04955808
Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery No drug interventions Not Available Not Available suspended NCT02465060
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) screening 2 active_not_recruiting NCT04288323
Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis screening 4 recruiting NCT04682847
Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic Cancers Not Available Not Available active_not_recruiting NCT06144385
A Phase 1, Single-arm, Open-label, Dose-escalation Study of JWATM204 as T Cell-targeted Immunotherapy in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma No drug interventions treatment 1 recruiting NCT05681234
Clinical Application of 18F-labeled RD2 PET/CT Imaging in the Diagnosis and Treatment of Small Liver Carcinoma No drug interventions diagnostic Not Available completed NCT04825470
Liver Transplantation for Unresectable GIST Liver Metastases No drug interventions treatment Not Available not_yet_recruiting NCT04443322
Durvalumab and Lenvatinib in Participants With Locally Advanced and Metastatic Hepatocellular Carcinoma ( Dulect2020-1 ) treatment Not Available recruiting NCT03178409
Combined HCC-MFCCC No drug interventions Not Available Not Available completed NCT02305459
CIRSE Registry for SIR-Spheres Therapy No drug interventions Not Available Not Available completed NCT01482442
SorAfenib Versus RADIOEMBOLIZATION in Advanced Hepatocellular Carcinoma treatment 3 completed NCT00767234
Permission to Collect Blood Over Time for Research No drug interventions Not Available Not Available terminated NCT00328770
De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma treatment 2 / 3 completed NCT05596630
Stereotactic Body Radiation Therapy for the Safety and Prognosis of Small Intrahepatic Recurrent HCC No drug interventions treatment Not Available recruiting NCT03397342
MRI Only Radiation Therapy With CPAP No drug interventions supportive_care Not Available terminated NCT05665348
Study Evaluating the Benefit of Adding Ipilimumab to the Combination of Atezolizumab and Bevacizumab in Patients With Hepatocellular Carcinoma Receiving First-line Systemic Therapy treatment 2 / 3 recruiting NCT06437457
Comparison of Gd-EOB-DTPA-enhanced MRI and Contrast-enhanced Ultrasound for Measuring Tumor Size of Solitary Hepatocellular Carcinoma ≤ 5cm:A Retrospective Study No drug interventions Not Available Not Available completed NCT06375317
HAIC Combined With PD-L1 Plus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma After Immunotherapy Failure treatment 2 not_yet_recruiting NCT04371042
PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies No drug interventions Not Available Not Available recruiting NCT01911000
Effectiveness and Safety of the Simultaneous Radiotherapy and Hyperthermia After Transarterial Chemoembolization in Hepatocellular Carcinoma Patients Combined With Portal Vein Tumor Thrombosis No drug interventions treatment 2 completed NCT05366829
Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma treatment 2 recruiting NCT04546802
HepATocellular Cancer Hcv Therapy Study treatment 3 withdrawn NCT04567615
A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors treatment 2 active_not_recruiting NCT05103631
Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors No drug interventions treatment 1 recruiting NCT05195294
Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC treatment 1 / 2 not_yet_recruiting NCT02704130
TAE and MWA Combination Therapy in Early-stage Hepatocellular Carcinoma No drug interventions treatment Not Available terminated NCT02460991
A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma treatment 3 terminated NCT00669136
Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma treatment 1 terminated NCT03349957
TACE for HCC by TANDEM and Idarubicin Not Available Not Available completed NCT04634357
ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma treatment 1 / 2 recruiting NCT04044326
The Safety and Efficacy of Spherical Microwave Ablation for the Treatment of Malignant Liver Tumors No drug interventions treatment Not Available withdrawn NCT01761266
A Multicenter, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-line Treatment of Participants With Unresectable Hepatocellular Carcinoma treatment 3 completed NCT05770882
Chidamide + Regorafenib in Hepatocellular Carcinoma (HCC) treatment 1 / 2 recruiting NCT03412773
Phase 3 Study of Tislelizumab Versus Sorafenib in Participants With Unresectable HCC treatment 3 completed NCT05022927
A Phase I Study of ERY974 in Patients With Hepatocellular Carcinoma treatment 1 active_not_recruiting NCT04235660
Y90 Radiation Segmentectomy vs SBRT for HCC No drug interventions treatment Not Available terminated NCT04639180
A Study to Evaluate Camrelizumab Plus Rivoceranib (Apatinib) as Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablation treatment 3 active_not_recruiting NCT04510740
Liver Cancer Registry Platform No drug interventions Not Available Not Available recruiting NCT02508467
A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular Carcinoma treatment 1 completed NCT02188901
Contrast (Sonazoid)-Enhanced US as a Screening Tool for Hepatocellular Carcinoma in Cirrhosis: An Exploratory Cross-sectional Study No drug interventions screening Not Available completed NCT04687969
Multimodal Machine Learning Characterization of Solid Tumors No drug interventions Not Available Not Available recruiting NCT02834546
Correlation Between Sorafenib Plasma Concentrations, Toxicity and Disease Control Rate in Patients Treated by Sorafenib for Hepatocellular Carcinoma Not Available Not Available completed NCT03007212
Outcome of Transarterial Chemo-embolization (TACE) in Hepatocellular Carcinoma Patients With Partial Portal Vein Thrombosis No drug interventions treatment 4 completed NCT05909995
Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors treatment 1 active_not_recruiting NCT02562755
Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone treatment 3 completed NCT04241523
Efficacy and Safety of Lenvatinib as a Conversion Therapy for HCC treatment 2 unknown_status NCT02406508
Sequential Melphalan for Use With Hepatic Delivery System Treatment Followed by Sorafenib in Patients With Unresectable HCC treatment 2 withdrawn NCT03267290
Comparing Diagnostic Accuracy for Liver Tumours Between the Combination of CEUS and CEMRI Versus CECT and CEMRI No drug interventions other Not Available completed NCT06040099
A US Study to Evaluate Transarterial Radioembolization (TARE) in Combination With Durvalumab and Bevacizumab Therapy in People With Unresectable Hepatocellular Carcinoma Amenable to TARE treatment 2 recruiting NCT06345001
A First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer or Other Select Solid Cancers No drug interventions other 1 not_yet_recruiting NCT04539717
FAST (Focused Abbreviated Screening Technique)-MRI Study No drug interventions Not Available Not Available enrolling_by_invitation NCT03753659
IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC) treatment 2 completed NCT06487559
A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves Through the Bodies of Adult Chinese Participants With Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) treatment 1 not_yet_recruiting NCT04601428
Hepatic IA Therapy in Stage B or Limited Stage C Hepatoma (HCC) No drug interventions treatment 0 recruiting NCT04522908
Dose Escalation Study of Cabozantinib for Advanced HCC Patients With Preserved Liver Function treatment 2 active_not_recruiting NCT00355238
A Phase II Open Label Study of BMS-582664 in Locally Advanced or Metastatic Hepatocellular Cancer treatment 2 completed NCT03735628
An Study to Evaluate the Safety and Efficacy of Copanlisib in Combination With Nivolumab in Patients With Advanced Solid Tumors treatment 1 completed NCT03419897
Study of BGB-A317 in Participants With Previously Treated Unresectable HCC treatment 2 completed NCT05889949
Microvascular Invasion for Guiding Treatment of Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma Not Available Not Available active_not_recruiting NCT05057013
HMBD-001 in Advanced HER3 Positive Solid Tumours No drug interventions treatment 1 / 2 recruiting NCT03236649
The Phase III Study of Icaritin Versus Sorafenib in PD-L1 Positive Advanced Hepatocellular Carcinoma Subjects treatment 3 terminated NCT05213637
Expanded Activated Lymphocytes (EAL) as Adjuvant Therapy in Patients With HCC at High Risk of Recurrence After Radical Resection No drug interventions treatment 2 recruiting NCT04465734
A Clinical Study to Compare the Efficacy and Safety of HLX10 in Combination With HLX04 Versus Sorafenib as the First-line Treatment in Patients With Locally Advanced or Metastatic HCC treatment 3 withdrawn NCT04227808
Efficacy and Safety of Lenvatinib as an Adjuvant Therapy for Hepatocellular Carcinoma treatment 2 unknown_status NCT03516071
A Phase 2 Study of Brivanib in Chinese Patients With Previously Treated Advanced HCC treatment 2 completed NCT03510871
Nivolumab Plus Ipilimumab as Neoadjuvant Therapy for Hepatocellular Carcinoma (HCC) treatment 2 recruiting NCT03452553
Study in the Treatment of HCC With a Radiopaque (RO) Bead (LC Bead LUMI™) Loaded With Doxorubicin No drug interventions treatment Not Available withdrawn NCT03144661
An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies No drug interventions treatment 1 terminated NCT03138239
The Potential Role of Ga-68-PSMA in Staging, Restaging and Monitoring Response in Primary Liver Cancer: Comparison With F-18-FDG No drug interventions diagnostic Not Available unknown_status NCT03071094
A Trial to Evaluate the Safety and Efficacy of the Combination of the Oncolytic Immunotherapy Pexa-Vec With the PD-1 Receptor Blocking Antibody Nivolumab in the First-line Treatment of Advanced Hepatocellular Carcinoma (HCC) treatment 1 / 2 terminated NCT02990351
Efficacy of Loco-regional Treatment for Hepatocellular Carcinoma Prior to Living Donor Liver Transplantation in Egypt No drug interventions Not Available Not Available completed NCT02794805
Determination of HCC With Octanoate Breath Test vs. MRI Diagnosis No drug interventions diagnostic 2 completed NCT02541149
Annexin A2 as a Novel Diagnostic Marker in Hepatocellular Carcinoma No drug interventions Not Available Not Available completed NCT02325739
FGF401 in HCC and Solid Tumors Characterized by Positive FGFR4 and KLB Expression treatment 1 / 2 completed NCT02178722
Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers treatment 1 / 2 completed NCT02173119
Can Quantitative MRI After cTACE Help Predict Survival ? No drug interventions Not Available Not Available completed NCT01972672
The Phase II Study of Icaritin in Patients With Advanced Hepatocellular Carcinoma treatment 2 completed NCT01821482
A Study of DC-CIK to Treat Hepatocellular Carcinoma No drug interventions treatment 2 unknown_status NCT01433016
Detection of Hepatocellular Carcinoma (HCC) With Octanoate Breath ID Test Compared to MRI No drug interventions diagnostic 2 terminated NCT01247298
A Pilot Study of Trans Arterial Chemoembolization (TACE), Followed by Stereotactic Radiation Therapy (SBRT) for Patients With Hepatocellular Carcinoma No drug interventions treatment 0 completed NCT03706157
Kinectics of Distribution of Doxorubicin-Lipiodol Emulsion in c-TACE other 4 completed NCT05904886
A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (IMbrave152) treatment 3 recruiting NCT04777851
Regorafenib-pembrolizumab vs. TACE/TARE in Intermediate Stage HCC Beyond Up-to-7 treatment 3 recruiting NCT06571396
Perioperative Risk of Immunotherapy Based Neoadjuvant and Conversion Therapy for Hepatocellular Carcinoma No drug interventions Not Available Not Available recruiting NCT04976634
Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Solid Tumors (MK-6482-016) treatment 2 recruiting NCT05908786
A Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular Carcinoma treatment 1 / 2 recruiting NCT06454578
Adjuvant Adebrelimab Plus Apatinib for Participants With HCC at High-risk of Recurrence After Curative Resection treatment 2 recruiting NCT05091346
A Study of E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid Tumors treatment 1 / 2 active_not_recruiting NCT06084234
National Liver Cancer Screening Trial No drug interventions screening 4 recruiting NCT06422403
A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers No drug interventions treatment 2 not_yet_recruiting NCT04008797
A Study of E7386 in Combination With Other Anticancer Drug in Participants With Solid Tumor treatment 1 recruiting NCT03418922
A Study of Lenvatinib Plus Nivolumab in Participants With Hepatocellular Carcinoma treatment 1 completed NCT05389527
Pembrolizumab and Lenvatinib for Resectable Hepatocellular Carcinoma treatment 2 active_not_recruiting NCT04102098
A Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation treatment 3 active_not_recruiting NCT00857805
Transarterial Chemoembolization Versus Proton Beam Radiotherapy for the Treatment of Hepatocellular Carcinoma No drug interventions treatment Not Available completed NCT03017326
Paediatric Hepatic International Tumour Trial treatment 3 active_not_recruiting NCT05337137
A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer treatment 1 / 2 recruiting NCT06365034
Study on the Efficacy and Safety of Conversion Therapy in Patients With Initially Unresectable Hepatocellular Carcinoma No drug interventions Not Available Not Available recruiting NCT04660929
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors treatment 1 active_not_recruiting NCT04618367
HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With PVTT treatment Not Available completed NCT06302400
Individualized Dosimetry for Holmium-166 Radioembolization in Patients With Unresectable Hepatocellular Carcinoma No drug interventions treatment Not Available recruiting NCT02081755
Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer treatment 4 active_not_recruiting NCT02329860
Study of Apatinib After Systemic Therapy in Patients With Hepatocellular Carcinoma(AHELP) treatment 3 completed NCT03727633
Hepatocellular Carcinoma on Cirrhosis With Child A/B7 and Hepatic Intra Arterial Injection of Idarubicin/Lipiodol Emulsion treatment 2 recruiting NCT06205732
A Retrospective Study on the Treatment of Intermediate and Advanced Liver Cancer. No drug interventions Not Available Not Available recruiting NCT03713593
Safety and Efficacy of Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) Versus Lenvatinib as First-line Therapy in Participants With Advanced Hepatocellular Carcinoma (MK-7902-002/E7080-G000-311/LEAP-002) treatment 3 active_not_recruiting NCT03894917
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma No drug interventions Not Available Not Available recruiting NCT05461430
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) No drug interventions Not Available Not Available recruiting NCT06060847
Liver Resection and Simultaneous Sleeve Gastrectomy for MS-HCC (LIRESS) No drug interventions treatment Not Available not_yet_recruiting NCT02221778
SBRT for Hepatocellular Carcinoma Patients With Partial Response to TACE No drug interventions treatment 2 active_not_recruiting NCT04338685
A Study Evaluating Safety, Pharmacokinetics, Pharmacodynamics, And Clinical Activity Of RO7119929 (TLR7 Agonist) In Participants With Unresectable Advanced Or Metastatic Hepatocellular Carcinoma, Biliary Tract Cancer, Or Solid Tumors With Hepatic Metastases treatment 1 completed NCT04985357
Defining the Clinical Potential of Mass Response as a Biomarker for Patient Tumor Sensitivity to Drugs No drug interventions Not Available Not Available not_yet_recruiting NCT05486572
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI No drug interventions prevention Not Available recruiting NCT04297254
A Study to Assess the Safety and Efficacy of Lenvatinib as First-line Treatment in Participants With Unresectable HCC treatment 4 completed NCT05953961
90Y Transarterial Radioembolization Versus Microwave Ablation in Small Hepatocellular Carcinoma With Hypoalbuminemia No drug interventions treatment Not Available recruiting NCT03756051
Harms of Hepatocellular Carcinoma Surveillance No drug interventions Not Available Not Available active_not_recruiting NCT04246177
Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012) treatment 3 active_not_recruiting NCT05848947
SIR-Spheres Study to Calculate the Radiation-Absorbed Dose of 99mTc-MAA other 4 completed NCT03062358
Study of Pembrolizumab (MK-3475) or Placebo Given With Best Supportive Care in Asian Participants With Previously Treated Advanced Hepatocellular Carcinoma (MK-3475-394/KEYNOTE-394) treatment 3 active_not_recruiting NCT03812874
A Study of PTX-9908 Injection for Non-resectable HCC With TACE treatment 1 / 2 recruiting NCT02856815
Safety and Efficacy of "Immuncell-LC" in TACE Therapy No drug interventions treatment 2 completed NCT04962958
Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery prevention 2 not_yet_recruiting NCT05870969
Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH) No drug interventions Not Available Not Available recruiting NCT03662841
Ablative Chemoembolization for Unresectable and Large Hepatocellular Carcinoma No drug interventions treatment Not Available terminated NCT03808766
A Study on the Angioarchitecture of Hepatocellular Carcinoma No drug interventions other Not Available terminated NCT04180072
Atezolizumab Plus Bevacizumab With HCC and HBV Infection treatment Not Available recruiting NCT05352204
Effect of Tumor Micronecrosis on Postoperative Transcatheter Arterial Chemoembolization in Patients With Hepatocellular Carcinomas No drug interventions Not Available Not Available completed NCT05225207
A Study of Lenvima (Lenvatinib) in Korean Unresectable Hepatocellular Carcinoma (uHCC) Participants No drug interventions Not Available Not Available completed NCT05540925
Vascular Invasion Signatures in cfDNA Support Re-staging of Liver Cancer No drug interventions Not Available Not Available completed NCT05383066
Anti-angiogenesis Combined With PD-1/PD-L1 Therapy in Patients With Advanced Liver Cancer No drug interventions Not Available Not Available not_yet_recruiting NCT05376943
Possible Differences in HCC Course Depending on DAA Treatment No drug interventions Not Available Not Available recruiting NCT05038397
A Study to Evaluate Efficacy and Safety of TheraSphere and Resection Combination Therapy in Patients With Single Large ((> 5cm, Long Diameter ) Hepatocellular Carcinoma : Exploratory Trial No drug interventions treatment Not Available completed NCT04903340
Assessment of the Impact of Acquisition Time, Respiratory Gating and New Qclear Reconstruction Modalities on the Quantification of Dosimetry in Selective Internal Radiotherapy No drug interventions Not Available Not Available completed NCT04803019
Transarterial Embolization Alone Versus Drug-Eluting Beads Chemoembolization for Hepatocellular Carcinoma No drug interventions treatment 3 recruiting NCT04560751
TACE Combined With Lenvatinib for Unresectable Hepatocellular Carcinoma (Prolong) Not Available Not Available unknown_status NCT04331184
RFA Using Combined Bipolar and Monopolar Energy Deliver With Twin Cooled-Wet Electrodes No drug interventions treatment Not Available recruiting NCT04310709
Combination of Regorafenib and Nivolumab in Unresectable Hepatocellular Carcinoma treatment 2 completed NCT04127396
Lenvatinib Plus TACE Versus Sorafenib Plus TACE for HCC With PVTT treatment 4 enrolling_by_invitation NCT04027556
Low-contrast Dose Liver CT Using Lean Body Weight Low Monoenergetic Images and Deep Learning-based Reconstruction No drug interventions diagnostic Not Available completed NCT04008082
A Study of Overall Survival in Participants With Unresectable Hepatocellular Carcinoma Not Available Not Available completed NCT03939845
A Prospective, Randomized, Multicenter Study of Comparison of TACE Combination With and Without EBRT for Hepatocellular Carcinoma With Portal Vein Tumor Thrombi No drug interventions treatment 3 unknown_status NCT03939975
Anti-PD-1therapy Combined With Thermal Ablation for Advanced HCC treatment 2 completed NCT03897543
ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma treatment 1 / 2 recruiting NCT03741088
Study to Evaluate VORTX Rx (Theresa) No drug interventions device_feasibility Not Available completed NCT03732547
Study of PolyIC and PD-1 mAb in Subjects With Unresectable Hepatocellular Carcinoma treatment 2 recruiting NCT03636607
Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions of Primary Hepatocellular Carcinoma No drug interventions diagnostic Not Available recruiting NCT03588442
Prospective Surveillance for Very Early Hepatocellular Carcinoma No drug interventions Not Available Not Available recruiting NCT03433703
Trial to Evaluate Safety and Efficacy of Treatment of Physician Choice (TPC) Following First-Line Treatment of Lenvatinib in Subjects With Unresectable Hepatocellular Carcinoma (uHCC) treatment 2 terminated NCT03289533
A Study Of Avelumab In Combination With Axitinib In Advanced HCC (VEGF Liver 100) treatment 1 completed NCT03291379
Vandetanib-eluting Radiopaque Embolic Beads in Patients With Resectable Liver Malignancies treatment 0 completed NCT03261791
Adjuvant Therapy With Apatinib for HCC Patients With PVTT Who Underwent Radical Resection treatment 2 unknown_status NCT03200171
Effect of DAAs on Behavior of HCC in HCV Patients No drug interventions Not Available Not Available completed NCT03168152
Randomized Trial Comparing Stereotactic Body Radiation Therapy to Microwave Ablation for the Treatment of Localized Hepatocellular Carcinoma No drug interventions treatment Not Available withdrawn NCT03145558
TATE Versus TACE in Intermediate Stage HCC treatment 2 suspended NCT03130712
A Study of GPC3-targeted T Cells by Intratumor Injection for Advanced HCC (GPC3-CART) No drug interventions treatment 1 / 2 unknown_status NCT03020342
HBV-host cfDNA as Minimal Residual Tumor Marker for HBV-related HCC No drug interventions Not Available Not Available unknown_status NCT03005756
Needle Guiding Robot for Radiofrequency Ablation: Safety and Efficacy Study on Hepatocellular Carcinoma Patients No drug interventions treatment Not Available unknown_status NCT02959151
A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy No drug interventions treatment 1 / 2 unknown_status NCT02939807
A Phase II Study of ABC294640 as Monotherapy in Patients With Advanced Hepatocellular Carcinoma treatment 2 withdrawn NCT02878109
DCE-MRI for Assessment of Response to TACE of HCC No drug interventions Not Available Not Available completed NCT02880306
Hepatocellular Carcinoma and Rheumatoid Arthritis No drug interventions Not Available Not Available completed NCT02859324
A Safety and Efficacy Study of CC-122 in Combination With Nivolumab in Subjects With Unresectable Hepatocellular Carcinoma (HCC) treatment 1 / 2 completed NCT02832882
RFA for Small HCC With No-touch Technique Using Octopus Electrode No drug interventions treatment Not Available completed NCT02813096
Study of Folfox4 Chemotherapy Regimen to Prevent Early Postoperative Recurrence for HCC-PVTT Patients No drug interventions prevention Not Available unknown_status NCT02794337
TACE vs TACE+SBRT for Unresectable Hepatocellular Cancer treatment 2 / 3 recruiting NCT02738697
Adjuvant Chemotherapy With FOLFOX in HCC Patients After Resection No drug interventions treatment 3 unknown_status NCT02715362
A Study of GPC3 Redirected Autologous T Cells for Advanced HCC No drug interventions treatment 1 / 2 unknown_status NCT02640924
Proton Radiotherapy Versus Radiofrequency Ablation for Patients With Medium or Large Hepatocellular Carcinoma No drug interventions treatment 3 unknown_status NCT02631499
Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation treatment 4 unknown_status NCT02635347
Remote Ischemic Conditioning (RIC) in Recipients of Brain Death Donor Livers - A Feasibility and Safety Study No drug interventions treatment Not Available completed NCT02582918
Texas Hepatocellular Carcinoma Consortium (THCCC) Project 5 No drug interventions screening Not Available completed NCT02564614
A Study of Hypoxia-inducible Factor 1a (HIF1A) Messenger Ribonucleic Acid (mRNA) Antagonist (RO7070179), to Demonstrate Proof-of-mechanism in Adult Participants With Hepatocellular Carcinoma (HCC) treatment 1 completed NCT02556619
Randomized Control Trial (RCT) of Early Palliative Care for HCC No drug interventions supportive_care Not Available recruiting NCT02482909
A Study Comparing Radiofrequency Ablation and Hepatic Resection for Hepatocellular Carcinoma No drug interventions treatment Not Available terminated NCT02448056
MiRNA as a Diagnostic and Prognostic Biomarker of Hepatocellular Carcinoma No drug interventions Not Available Not Available not_yet_recruiting NCT02439008
Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response No drug interventions basic_science Not Available terminated NCT02421185
Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 (Erdafitinib) in Participants With Advanced Hepatocellular Carcinoma treatment 1 / 2 completed NCT02387307
A Study of rSIFN-co in Subjects With Advanced Solid Tumors treatment 1 completed NCT02372162
Fingerprint Characterization of Advanced HCC No drug interventions Not Available Not Available completed NCT02338297
Therapeutic Effect of Ethanol-gelfoam Mixture for the Treatment of Arterioportal Shunts (APS) in Patients With HCC No drug interventions treatment 3 unknown_status NCT02323906
Safety and Efficacy Study of CC-122 Combined With Sorafenib for Primary Liver Cancer treatment 1 terminated NCT02308319
Prompt Or Watchful Monitoring for Hepatitis B Virus Related Hepatocellular Carcinoma Without Elevated viRal Load prevention 4 unknown_status NCT02312817
RCT of Screening Strategies Among Patients at High Risk for Developing HCC in a Safety-net Health System No drug interventions health_services_research Not Available completed NCT02304445
Chemoembolization With or Without Stereotactic Body Radiosurgery for Liver Cancer No drug interventions treatment Not Available withdrawn NCT02293850
Phase I Study to Evaluate the Safety and Efficacy of Telomelysin (OBP-301) in Patients With Hepatocellular Carcinoma treatment 1 unknown_status NCT02192671
HR Versus RFA for HCC in Patients With PHT No drug interventions treatment 3 recruiting NCT02069041
A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer treatment 1 completed NCT01988493
Efficacy, Safety, and Pharmacokinetic of MSC2156119J in Asian Participants With Hepatocellular Carcinoma treatment 1 / 2 completed NCT01930383
Circulating Tumor Cells for Hepatocellular Carcinoma No drug interventions Not Available Not Available unknown_status NCT01933945
Outcomes of HCC (Hepatocellular Carcinoma) Patients Treated With TACE (Transarterial Chemoembolization) and Early, Not Early or Not at All Followed by Sorafenib Not Available Not Available completed NCT01915602
Refametinib in Combination With Sorafenib in RAS Mutant Hepatocellular Carcinoma (HCC) treatment 2 completed NCT01861912
Arsenic Trioxide TACE and Intravenous Administration in Unresectable Hepatocellular Carcinoma treatment 2 / 3 unknown_status NCT01790633
Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests No drug interventions screening Not Available completed NCT01767597
Application of HBV Rapid Tests as a Tool for Wide-Use Screening No drug interventions screening Not Available completed NCT01751763
Sorafenib for Residue Disease After Resection With Curative Intent Not Available Not Available completed NCT01749865
CIK Treatment for HCC Patient Underwent Radical Resection No drug interventions treatment 3 completed NCT01715532
Role of Huachansu in Treating Hepatocellular Carcinoma and the Correlation With Na+/K+-ATPase No drug interventions treatment 2 unknown_status NCT01722175
Associating Liver Partition With Portal Vein Ligation For Staged Hepatectomy (ALPPS) or Portal Vein Occlusion in Treating Patients With Liver Cancer No drug interventions treatment 2 withdrawn NCT01666145
Advanced Image Guidance Utilized in Liver Surgery No drug interventions treatment Not Available completed NCT01668134
Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma No drug interventions treatment 1 completed NCT01655693
Efficacy and Safety Doxorubicin Transdrug Study in Patients Suffering From Advanced Hepatocellular Carcinoma treatment 3 completed NCT01605734
TACE Combinated With Sorafenib in Treating Patients With Unresectable Hepatocellular Carcinoma treatment 2 unknown_status NCT01594125
Dose Escalation Study of Nintedanib (BIBF 1120) in Japanese Patients With Hepatocellular Carcinoma treatment 1 completed NCT01556815
Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma No drug interventions treatment 2 unknown_status NCT01501240
Gadoxetic Acid-enhanced MR Evaluation of Hepatocellular Carcinoma and Dysplastic Nodules in the Cirrhotic Liver No drug interventions Not Available Not Available withdrawn NCT01490203
Evaluation of Remnant Liver Function Using Primovist-enhanced MRI Before Resection/Ablation of Hepatocellular Carcinoma Not Available Not Available completed NCT01441388
A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors. treatment 1 withdrawn NCT01425996
A Dose-escalation Study of Lipotecan® Plus Radiotherapy in Locally Advanced Hepatocellular Carcinoma treatment 1 / 2 terminated NCT01411436
Nexavar Post-marketing Surveillance for Hepatocellular Carcinoma in Japan Not Available Not Available completed NCT01393093
Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular Carinomas No drug interventions treatment Not Available unknown_status NCT01394497
Use of N-Acetylcysteine During Liver Procurement prevention 2 completed NCT01393197
Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular Carinomas (TACE-KMG) No drug interventions treatment Not Available unknown_status NCT01355107
Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of Disease No drug interventions Not Available Not Available completed NCT01337492
Pilot Study Sorafenib as Bridge to Orthotopic Liver Transplantation (OLT) treatment 0 terminated NCT01327521
Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma treatment 3 withdrawn NCT01306058
Sorafenib and TRC105 in Hepatocellular Cancer treatment 1 / 2 completed NCT01246986
A Study of LY2157299 in Participants With Hepatocellular Carcinoma treatment 2 completed NCT01237132
East-West Hepatocellular Carcinoma Study Group No drug interventions Not Available Not Available completed NCT01217034
Transcatheter Arterial Chemoembolization Therapy In Combination With Sorafenib treatment 2 unknown_status NCT01204177
Assessing BAY86-9766 Plus Sorafenib for the Treatment of Liver Cancer. treatment 2 completed NCT01191385
GIDEON Non-Nexavar Arm - HCC Patients Who Are Treated With Any Therapy Other Than Nexavar at Individual Study Start No drug interventions Not Available Not Available withdrawn NCT01171651
A Study of Recombinant Vaccinia Virus Prior to Sorafenib to Treat Unresectable Primary Hepatocellular Carcinoma treatment 2 completed NCT01141478
Proton Radiotherapy Plus Sorafenib Versus Sorafenib for Patients With HCC Exceeding San Francisco Criteria treatment Not Available terminated NCT01108705
Comparison of Brivanib and Best Supportive Care (BSC) With Placebo and BSC for Treatment of Liver Cancer in Asian Patients Who Have Failed Sorafenib Treatment treatment 3 terminated NCT01096914
Radiofrequency Versus Laser Ablation for Hepatocellular Carcinoma No drug interventions treatment Not Available completed NCT01078415
Pilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC) No drug interventions treatment Not Available completed NCT01040559
Chemoembolisation of Non Resectable, Non Metastatic Hepatocellular Carcinomas treatment 1 completed NCT01034865
Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular Cancer No drug interventions Not Available Not Available completed NCT01009593
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) treatment 3 terminated NCT01012011
Regulatory Post Marketing Surveillance Study on Nexavar® Not Available Not Available completed NCT01004003
Phase I/II Comparison of Efficacy and Safety of BIBF 1120 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma treatment 2 completed NCT01003015
Safety Study of BAY73-4506 in Patients With Hepatocellular Carcinoma treatment 2 completed NCT00987935
A Phase I / II Trial of Nintedanib in Asian Hepatocellular Carcinoma Patients treatment 2 completed NCT00926536
Impact of C-arm CT in Patients With HCC Undergoing TACE: Optimal Imaging Guidance No drug interventions diagnostic Not Available completed NCT00919009
Combination of Transcatheter Arterial Chemoembolization (TACE) and Sorafenib for Patients With Unresectable Hepatocellular Carcinoma (HCC) No drug interventions Not Available 2 completed NCT00901901
Nexavar-Tarceva Combination Therapy for First Line Treatment of Patients Diagnosed With Hepatocellular Carcinoma treatment 3 completed NCT00855218
A Phase II Randomized, Double-blind, Placebo-controlled Study of Sorafenib or Placebo in Combination With Transarterial Chemoembolization (TACE) Performed With DC Bead and Doxorubicin for Intermediate Stage Hepatocellular Carcinoma (HCC). treatment 2 completed NCT00843934
Trial of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma treatment 2 / 3 unknown_status NCT00827723
Indocyanine Green and Portal Pressure in Viral and Alcoholic Cirrhotic Patients With Hepatocarcinoma No drug interventions Not Available Not Available completed NCT00812175
Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With Sorafenib Not Available Not Available completed NCT00763776
Parenchyma Resection of Cirrhotic Liver by the Clamp Crushing Technique and the Ultrasonic Dissector No drug interventions treatment Not Available terminated NCT00759109
Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085) prevention 3 completed NCT00703365
Efficacy and Safety of Sorafenib (Nexavar) in Combination With Gemcitabine in Advanced Hepatocellular Carcinoma (HCC) treatment 2 completed NCT00692770
Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM) treatment 3 completed NCT00687778
11C-Acetate PET/CT Non-FDG-Avid Tumors No drug interventions Not Available Not Available unknown_status NCT00582400
A Phase II Protocol of Arsenic Trioxide (Trisenox) in Subjects With Advanced Primary Carcinoma of the Liver treatment 2 terminated NCT00576056
Effectiveness and Safety Study of TACE Plus Oral Sorafenib for Unresectable HCC treatment 2 terminated NCT00559455
Phase II Study of Eloxatin+5-FU/LV in Patients With Unresectable Hepatocellular Carcinoma treatment 2 completed NCT00554372
A Study of Recombinant Vaccinia Virus to Treat Unresectable Primary Hepatocellular Carcinoma No drug interventions treatment 2 completed NCT00490685
Dose Escalation of Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) treatment 2 completed NCT00492752
A Randomized, Double-Blinded, Placebo-Controlled Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma treatment 3 completed NCT00494299
Phase III Study of BAY43-9006 in Patients With Advanced Hepatocellular Carcinoma (HCC) Treated After Transcatheter Arterial Chemoembolization (TACE) treatment 3 completed NCT00493883
Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors No drug interventions treatment 1 / 2 completed NCT00470340
Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic Patients prevention 3 terminated NCT00464295
Phase II Trial of Capecitabine for the Treatment of Unresectable/ Metastatic or Advanced Hepatocellular Carcinoma(HCC) treatment 2 completed NCT00471965
Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) Versus Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma Patients treatment 3 completed NCT00444782
A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular Carcinoma. treatment 2 completed NCT00437424
A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver Dysfunction treatment 1 completed NCT00440934
A Study of Electromagnetic Waves in the Treatment of the Advanced Hepatocarcinoma No drug interventions treatment 2 terminated NCT00392366
Laser Interstitial Thermal Therapy Under "Real Time" MRI Guidance for "Minimal Invasive" Treatment of Liver Metastasis No drug interventions treatment Not Available completed NCT00384800
A Phase II Study of Tegafur/Uracil (UFUR®)Plus Thalidomide for the Treatment of Advanced or Metastatic Hepatocellular Carcinoma (HCC) treatment 2 unknown_status NCT00370513
A Phase I Study of Pazopanib in Adult Patients With Liver Cancer treatment 1 completed NCT00327496
Cytotoxicity Induced by Tumor Lysate Pulsed Dendritic Cells Against Autologous Hepatocellular Carcinoma Cells No drug interventions treatment Not Available unknown_status NCT00280618
Oxaliplatin in Unresectable Hepatocellular Carcinoma treatment 2 completed NCT00247728
PI-88 in Hepatocellular Carcinoma After Hepatectomy treatment 2 completed NCT00243841
Dose Escalation Study for Primary Hepatocellular Carcinoma No drug interventions treatment Not Available completed NCT00155103
Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular Carcinoma No drug interventions Not Available Not Available unknown_status NCT00121914
Treatment of Hepatocellular Carcinoma: Long-Acting Somatostatin Plus Percutaneous Ethanol Instillation (PEI) Versus Long-Acting Somatostatin Alone No drug interventions treatment 3 unknown_status NCT00116454
Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis treatment 3 completed NCT00122876
Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC) treatment 1 / 2 completed NCT00108953
A Research Study to Treat Patients With Advanced Hepatocellular Carcinoma treatment 2 completed NCT00081900
A Safety and Efficacy Study of DENSPM in Patients With Liver Cancer Who Are Not Eligible for Surgical Care treatment 1 / 2 terminated NCT00080236
Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation treatment 2 completed NCT00056992
Testing of ADI-PEG in Hepatocellular Carcinoma treatment 2 completed NCT00044512
A Study to Estimate Safety and Efficacy of Sorafenib (BAY43-9006) in the Treatment of Hepatocellular Carcinoma treatment 2 completed NCT00034333
Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads Vs. IV Doxorubicin in Treating Liver Cancer treatment 2 / 3 terminated NCT00006332
Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate treatment 2 completed NCT01310062
The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer No drug interventions Not Available Not Available unknown_status NCT06230328
Brazilian Reality of Hepatocellular Carcinoma No drug interventions Not Available Not Available recruiting NCT04170556
Regorafenib Followed by Nivolumab in Patients With Hepatocellular Carcinoma (GOING) treatment 1 / 2 completed NCT04145141
National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer No drug interventions Not Available Not Available recruiting NCT02702414
Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Advanced Hepatocellular Carcinoma (MK-3475-224/KEYNOTE-224) treatment 2 completed NCT03778957
A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma treatment 3 active_not_recruiting NCT03534141
Mild Hypothermia and Acute Kidney Injury in Liver Transplantation No drug interventions prevention Not Available terminated NCT06582017
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma treatment 1 recruiting NCT05003895
GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Hepatocellular Carcinoma (HCC) treatment 1 recruiting NCT05301842
Evaluate Durvalumab and Tremelimumab +/- Lenvatinib in Combination With TACE in Patients With Locoregional HCC treatment 3 recruiting NCT06581315
Postoperative Adjuvant Therapy of Donafenib for Hepatocellular Carcinoma treatment Not Available recruiting NCT01752933
SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC) treatment 2 completed NCT01906216
Sorafenib Chemoembolization Evaluation Controlled Trial treatment 3 completed NCT03298451
Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma treatment 3 active_not_recruiting NCT03960008
Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant treatment 3 terminated NCT03847428
Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment treatment 3 active_not_recruiting NCT05101629
Pembrolizumab and Lenvatinib in Patients With Advanced HCC Who Are Refractory to Atezolizumab and Bevacizumab/ IO-based Therapy treatment 2 active_not_recruiting NCT06084481
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400 No drug interventions treatment 1 recruiting NCT06041477
Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC treatment 3 recruiting NCT06218511
A Phase I Trial of IMA970A Plus Montanide in Combination With Durvalumab (Anti-PD-L1) treatment 1 recruiting NCT06345508
Early Detection of Liver Cancer by QUS No drug interventions Not Available Not Available recruiting NCT06577272
Title of Manuscript: Development and Internal-external Validation of a Comprehensive Model for Predicting Risk of Post-RFA Recurrence in HCC Patients No drug interventions Not Available Not Available recruiting NCT00687596
Study of TAC-101 as Second Line Treatment in Patients With Advanced Hepatocellular Carcinoma Who Received Sorafenib as First Line Therapy No drug interventions treatment 2 terminated NCT02112656
Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC) treatment 3 completed NCT03228667
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors treatment 2 active_not_recruiting NCT05024214
Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors treatment 1 / 2 recruiting NCT04770207
Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs treatment 2 recruiting NCT04857684
SBRT + Atezolizumab + Bevacizumab in Resectable HCC treatment 0 recruiting NCT04572633
The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy No drug interventions treatment Not Available active_not_recruiting NCT05822752
Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC) treatment 2 recruiting NCT06109272
A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC) treatment 2 / 3 recruiting NCT06265285
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program No drug interventions health_services_research 2 recruiting NCT06478693
A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC No drug interventions treatment 1 recruiting NCT06537193
Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment No drug interventions screening Not Available not_yet_recruiting NCT06339424
Atezolizumab and Bevacizumab With Photon Radiotherapy for Unresectable Hepatocellular Carcinoma treatment 2 recruiting NCT05027425
Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant treatment 2 recruiting NCT06077591
Prospective Clinical Validation of Next Generation Sequencing (NGS) and Patient-Derived Tumor Organoids (PDO) Guided Therapy in Patients With Advanced/ Inoperable Solid Tumors No drug interventions treatment Not Available not_yet_recruiting NCT05953337
Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC) No drug interventions treatment Not Available recruiting NCT06248580
Find HDV and Determine Its Status in Turkey No drug interventions Not Available Not Available recruiting NCT06551272
Microbiota Modification for Immuno-oncology in Hepatocellular Carcinoma No drug interventions treatment 2 not_yet_recruiting NCT06526104
Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis treatment 2 not_yet_recruiting NCT06549829
the Effect of Nutrition-optimized Prehabilitation on Perioperative Intervention in Primary Hepatocellular Carcinoma No drug interventions treatment Not Available not_yet_recruiting NCT06553885
Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC treatment 2 not_yet_recruiting NCT02509507
Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Systemic Pembrolizumab MK-3475-611/Keynote-611 treatment 1 / 2 completed NCT01628640
Viral Therapy in Treating Patient With Refractory Liver Cancer or Advanced Solid Tumors treatment 1 active_not_recruiting NCT04521153
Camrelizumab Combined With Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma treatment 2 / 3 active_not_recruiting NCT05256381
A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors treatment 2 active_not_recruiting NCT05359861
Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma treatment 2 active_not_recruiting NCT05223816
An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma treatment 2 recruiting NCT05757492
Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid Tumors treatment 1 / 2 terminated NCT06005740
A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer No drug interventions treatment 1 recruiting NCT06070636
bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma treatment Not Available recruiting NCT06349317
Neoadjuvant IMRT Combined With Camrelizumab and Apatinib for Resectable HCC With PVTT treatment 2 recruiting NCT06519578
Prospective Real-World Study of HAIC With Raltitrexed or 5-Fluorouracil for the Treatment of Hepatocellular Carcinoma No drug interventions treatment Not Available recruiting NCT06541990
Psychoeducational Intervention for Patients With Hepatocellular Carcinoma No drug interventions supportive_care Not Available not_yet_recruiting NCT06544083
Early-stage Detection of Liver Cancer by Proteins in Peripheral Blood No drug interventions Not Available Not Available recruiting NCT06544629
Imjudo & Imfinzi PMS No drug interventions Not Available Not Available not_yet_recruiting NCT06544005
Implication of Long Non-coding RNA HOTTIP Haplotype on Liver Cancer Metastasis No drug interventions Not Available Not Available active_not_recruiting NCT06538935
SBRT Combined With Adbelimumab and Apatinib for Perioperative and Conversion Therapy of Hepatocellular Carcinoma treatment 2 not_yet_recruiting NCT06537908
Anti-PD-1/PD-L1 Antibodies Plus Anti-VEGF Antibody Treatment in Patients With Advanced-Stage HCC No drug interventions Not Available Not Available recruiting NCT06542796
Study on the Classification of Comprehensive Treatment Effect of Hepatocellular Carcinoma No drug interventions screening Not Available not_yet_recruiting NCT06543030
Transfemoral Versus Transradial Approach in Transarterial Chemoembolization of Hepatocellular Carcinoma No drug interventions Not Available Not Available not_yet_recruiting NCT02344680
Liver Fibrosis in Zambian HIV-HBV Co-infected Patients No drug interventions Not Available Not Available active_not_recruiting NCT03630640
Neoadjuvant and Adjuvant Nivolumab in HCC Patients Treated by Electroporation treatment 2 completed NCT04483284
Study of TACE Combined With Camrelizumab in the Treatment of HCC Patients treatment 2 active_not_recruiting NCT05007106
MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005) treatment 2 active_not_recruiting NCT05433467
CT-guided Localization for Micro Hepatocellular Carcinoma Before Surgical Resection No drug interventions treatment Not Available recruiting NCT06184152
CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules No drug interventions diagnostic Not Available recruiting NCT06530251
A Phase Ib/II Study of AK112 (PD-1/VEGF Bispecific Antibody) in Combination Therapy for Patients With Advanced Hepatocellular Carcinoma (HCC). treatment 1 / 2 not_yet_recruiting NCT02856126
HAIC Plus Sorafenib Versus TACE Plus Sorafenibfor Advanced HCC treatment 3 completed NCT04727307
Neoadjuvant Atezo, Adjuvant Atezo + Beva Combined With RF Ablation of Small HCC: a Multicenter Randomized Phase II Trial treatment 2 recruiting NCT05104567
A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203) treatment 2 active_not_recruiting NCT04823403
Hepatic Intra-Arterial Administration of Ipilimumab in Combination With Intra-venous Nivolumab for Advanced Hepatocellular Carcinoma treatment 1 recruiting NCT05775159
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer treatment 2 recruiting NCT06205706
BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors treatment 1 / 2 recruiting NCT05803928
Ablation in Combination With Lenvatinib and Anti-PD-1 Antibodies treatment 1 recruiting NCT06242470
A Study of MGC026 in Participants With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06518434
A Pilot Study on the Effect of Cannabis Oil in Untreatable Liver Cancer Patients treatment 2 recruiting NCT06523608
Prediction of Decompensation and HCC Development in Advanced Chronic Liver Disease No drug interventions Not Available Not Available not_yet_recruiting NCT03519997
A Study of Pembrolizumab and Bavituximab in Patients With Advanced Hepatocellular Carcinoma treatment 2 active_not_recruiting NCT03158818
Chronic Hepatitis B Virus Infection in Zambia No drug interventions Not Available Not Available active_not_recruiting NCT04194775
A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma treatment 3 active_not_recruiting NCT04563338
An Exploratory Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer With Liver Metastases (INTEGRATE) treatment 2 recruiting NCT06405061
Evaluation of Effectiveness and Safety of HAIC in Combination With Adebrelimab and Bevacizumab for Potentially Resectable Hepatocellular Carcinoma treatment 2 recruiting NCT06505291
Long-term Management of Patients With Ruptured HCC No drug interventions Not Available Not Available completed NCT06508307
A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors treatment 1 recruiting NCT04047173
RFA Versus SBRT for Recurrent Small HCC No drug interventions treatment 3 completed NCT03198546
GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression No drug interventions treatment 1 recruiting NCT04803318
Trametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid Tumors treatment 2 recruiting NCT04518852
TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC treatment 2 completed NCT06475287
HAIC Combined With TQB2450 and Anlotinib in Second-line Treatment of Advanced Hepatocellular Carcinoma treatment 2 not_yet_recruiting NCT06475118
Comparison of Serum Myokine Dosages and Imaging Methods in the Evaluation of Sarcopenia in Patients With Hepatocellular Carcinoma No drug interventions diagnostic Not Available not_yet_recruiting NCT05233098
TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA. No drug interventions Not Available Not Available completed NCT04952272
Intratumor CpG-ODN Injection Boosters Immune Killing Against in Situ Tumor Antigen Release for Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT05690451
Non-contrast Abbreviated MRI for Secondary Surveillance of HCC No drug interventions Not Available Not Available completed NCT05701488
SIRT With Tremelimumab and Durvalumab for Resectable HCC treatment 1 recruiting NCT06478719
To Evaluate Safety and Efficacy of FB-1603 in Hepatocellular Carcinoma Patient Receiving Transarterial Chemoembolization No drug interventions supportive_care 1 / 2 recruiting NCT06482008
HAIC Combined With Adebrelimab Plus Apatinib as the First-line Treatment for HCC in BCLC Stage C: An Open-label, Single-arm, Phase II Study treatment 2 not_yet_recruiting NCT06467799
Neoadjuvant HAIC and PD-1 Plus Adjuvant PD-1 for High-risk Recurrent HCC No drug interventions prevention 2 not_yet_recruiting NCT05705791
Clinical Investigation Evaluating Safety and Efficacy of Selective Intra-arterial 166Holmium Radiation Therapy in Combination With Atezolizumab and Bevacizumab for Non Resectable Hepatocellular Carcinoma No drug interventions treatment Not Available active_not_recruiting NCT06090656
Bevacizumab in Combination With Sintilimab Versus Transcatheter Arterial Chemoembolization for the Treatment of Intermediate Stage Hepatocellular Carcinoma (Beyond Up-To-Seven Criteria) treatment 2 recruiting NCT06166576
Radioembolization as a Spearhead Treatment of Hepatocellular Carcinoma With Localized Portal Vein Tumor Thrombosis No drug interventions treatment 2 recruiting NCT06138769
Lenvatinib After Progression on Atezolizumab-bevacizumab in Hepatocellular Carcinoma treatment 2 active_not_recruiting NCT06194461
LTFU for All Cell and Gene Therapy Studies No drug interventions Not Available Not Available not_yet_recruiting NCT06496113
Robotic Versus Laparoscopic Liver Resection for Hepatocellular Carcinoma No drug interventions Not Available Not Available completed NCT04315883
Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors No drug interventions Not Available Not Available terminated NCT04327700
Study Of Intrabucally Administered Electromagnetic Fields and Regorafenib treatment 2 suspended NCT05199259
Multi-analyte Blood Test Clinical Trial No drug interventions Not Available Not Available recruiting NCT06232759
TACE Combined With Tyrosine Kinase Inhibitors and Tislelizumab in Unresectable Hepatocellular Carcinoma treatment 2 completed NCT04123379
Neoadjuvant Nivolumab With CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer (NSCLC) or Hepatocellular Carcinoma (HCC) treatment 2 completed NCT04374877
Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors treatment 1 recruiting NCT04541173
Study of Atezolizumab and Bevacizumab With Y-90 TARE in Patients With Unresectable Hepatocellular Carcinoma (HCC) treatment 2 terminated NCT05304234
Liver Cancer Disparities in American Indian and Alaska Native Persons No drug interventions screening 2 recruiting NCT06434753
Zinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease. No drug interventions treatment 3 recruiting NCT06446154
FOLFOX Chemotherapy Plus Fruquintinib and Sintilimab After First-line Treatment in Unresectable Hepatocellular Carcinoma treatment 2 not_yet_recruiting NCT02109146
Postoperative TACE(Transhepatic Arterial Chemotherapy And Embolization) for Patients With Hepatocellular Carcinoma No drug interventions treatment 3 completed NCT04172571
A Study of the Combination of Anti-PD-1 AK105 and Anlotinib in First-line Hepatocellular Carcinoma (HCC) treatment 2 completed NCT06379256
Evaluation of Immune Responses and Outcomes in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy No drug interventions Not Available Not Available recruiting NCT06294548
A Study of Valemetostat Tosylate (DS-3201b) With Atezolizumab and Bevacizumab in HCC treatment 1 / 2 not_yet_recruiting NCT06435013
Lenvatinib vs Bevacizumab Plus ICIs and HAIC in Unresectable HCC Not Available Not Available completed NCT04152343
An Intraoperative Guidance Platform for Radio Frequency Ablation No drug interventions treatment Not Available completed NCT06204835
ITGA6 Targeting NIR-II Fluorescence Image Guided Surgery No drug interventions diagnostic 1 recruiting NCT06260943
Targeted Navigation in Hepatocellular Carcinoma (HCC) No drug interventions supportive_care Not Available recruiting NCT06420791
The Dual Impact of Cirrhosis on Transplantation for Hepatocellular Carcinoma：a Two-center Retrospective Cohort Study in China No drug interventions Not Available Not Available completed NCT06423144
PD-1/PD-L1 Inhibitors and Anti-angiogenic Therapy Combined With/Without TACE/HAIC in Patients With BCLC B/C Hepatocellular Carcinoma Beyond Up-to-7 No drug interventions Not Available Not Available not_yet_recruiting NCT04562428
The Safety and Efficacy Evaluation of XSLJZ in Advanced Hepatocellular Carcinoma Patients With Multiple Protein Kinase Inhibitor Therapy: A Randomized, Double-Blind, Controlled Trial No drug interventions treatment 4 completed NCT05866783
Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular Carcinoma No drug interventions Not Available Not Available recruiting NCT03507140
Microbiota Study in Liver Transplanted Patients No drug interventions Not Available Not Available completed NCT04242199
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT04401800
Preliminary Antitumor Activity, Safety and Tolerability of Tislelizumab in Combination With Lenvatinib for Hepatocellular Carcinoma treatment 2 completed NCT04864054
T-Cell Therapy (ECT204) in Adults With Advanced HCC treatment 2 recruiting NCT05497531
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers No drug interventions diagnostic Not Available recruiting NCT05448677
Ezurpimtrostat Autophagy Inhibitor in Association With Atezolizumab-Bevacizumab in First Line Treatment of Unresectable Hepatocellular Carcinoma treatment 2 terminated NCT05143619
Impact of "Teaching the Teachers" Concept on Global Education and Application of Hepatocellular Carcinoma Diagnosis Guidelines No drug interventions Not Available Not Available recruiting NCT05394259
A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer diagnostic 1 recruiting NCT06406634
Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma treatment 2 recruiting NCT06409507
Research and Application for New Clinical Diagnosis and Treatment System for HBV Related HCC Liver Transplantation No drug interventions Not Available Not Available completed NCT01840592
Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib treatment 2 active_not_recruiting NCT00617981
Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC) treatment 3 completed NCT02799212
Evaluation of Postoperative Ascites After Somatostatin Infusion Following Hepatectomy for Hepatocellular Carcinoma prevention 3 completed NCT03829501
Safety and Efficacy of KY1044 and Atezolizumab in Advanced Cancer treatment 1 / 2 active_not_recruiting NCT04039607
A Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular Carcinoma treatment 3 active_not_recruiting NCT05166239
HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT treatment 2 recruiting NCT05064553
ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk No drug interventions Not Available Not Available recruiting NCT04696055
Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors treatment 2 completed NCT05641896
Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers No drug interventions diagnostic 2 recruiting NCT06034860
Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types treatment 1 recruiting NCT06272656
Evaluation of AKR1B10 as a New Marker for Interventional Therapy of Hepatocellular Carcinoma No drug interventions Not Available Not Available recruiting NCT02705105
Study of Mogamulizumab + Nivolumab in Subjects w/Locally Advanced or Metastatic Solid Tumors treatment 1 / 2 completed NCT04444167
A Study of Anti-PD-1/CTLA-4 Bispecific AK104 Plus Lenvatinib in First-line Advanced Hepatocellular Carcinoma treatment 1 / 2 completed NCT04728321
A Study of Anti-PD-1/CTLA-4 Bispecific AK104 Alone or in Combination With Lenvatinib in Advanced Hepatocellular Carcinoma treatment 2 completed NCT06178198
Radiation Major Hepatectomy to Selectively Treat Large Unifocal Hepatocellular Carcinoma No drug interventions treatment 2 recruiting NCT06379334
Discovering Urinary Protein Biomarkers for Hepatocellular Carcinoma in Chronic Hepatitis B Population No drug interventions Not Available Not Available active_not_recruiting NCT06382103
Biomarkers and Molecular Mechanism Study of Hepatocellular Carcinoma After Radical Resection and Conversion Therapy No drug interventions Not Available Not Available not_yet_recruiting NCT03732105
Randomized Study of Adjuvant Radiotherapy After Curative Resection of HCC With Narrow Margin (RAISE) No drug interventions prevention Not Available recruiting NCT03316872
Study of Pembrolizumab and Radiotherapy in Liver Cancer treatment 2 active_not_recruiting NCT05620134
Study of JK08 in Patients With Unresectable Locally Advanced or Metastatic Cancer treatment 1 / 2 recruiting NCT05763277
Ate-Bev Early Response Prediction Model in Advanced HCC No drug interventions Not Available Not Available recruiting NCT06361758
Second-line Treatment With CAdonilimab and LEnvatinib for Unresectable HCC treatment 2 not_yet_recruiting NCT06364787
Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial for First-line Treatment of Hepatocellular Carcinoma No drug interventions treatment 1 not_yet_recruiting NCT06364800
Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial of Hepatocellular Carcinoma Resistant to PD-1 Monoclonal Antibody No drug interventions treatment 0 not_yet_recruiting NCT06371157
A Study of AK104+Lenvatinib in Combination With Transarterial Chemoembolization (TACE) Versus TACE in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma treatment 3 not_yet_recruiting NCT06375486
Ivonescimab Combined With HAIC for the Treatment of Unresectable Hepatocellular Carcinoma（uHCC）. treatment 2 recruiting NCT04310540
PSMA PET/MRI or PSMA PET/CT for Evaluation of Liver Cancer diagnostic 0 completed NCT04367805
COVID-19 Infection in Patients With Hepatocellular Carcinoma No drug interventions Not Available Not Available active_not_recruiting NCT05714124
Liver Embolization Approaches for Tumor Management No drug interventions Not Available Not Available recruiting NCT05823584
Cell-free DNA From Junction of Hepatitis B Virus Integration in HCC Patients for Monitoring Post-resection Recurrence No drug interventions Not Available Not Available completed NCT06241326
Immunotherapy for Hepatocellular Carcinoma No drug interventions Not Available Not Available recruiting NCT06355700
Hepatocellular Carcinoma Liver Organoids No drug interventions other Not Available recruiting NCT06354387
Alectinib in Combination With Nivolumab in the Treatment of Recurrent or Refractory HCC Patients Guided With Serum RNase1 and Tumor Expression of PD-L1 treatment 1 recruiting NCT06363006
Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer No drug interventions treatment 1 recruiting NCT06364007
HAIC Combined With Durvalumab and Tremelimumab and Lenvatinib in uHCC No drug interventions treatment 2 recruiting NCT05176483
Study of XL092 in Combination With Immuno-Oncology Agents in Subjects With Solid Tumors treatment 1 recruiting NCT05652920
Ori-C101Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of HCC No drug interventions treatment 1 / 2 recruiting NCT06248554
Adjuvant PD-1 Inhibitor for Patients With Early-stage Hepatocellular Carcinoma Following Microwave Ablation No drug interventions treatment Not Available recruiting NCT06248528
Comparing the Prognosis of Patients With HCC and PVTT Treated With Surgery Versus Locoregional Therapy. No drug interventions treatment Not Available recruiting NCT03958669
Fingerprint Characterization Tyrosine Kinase Inhibitors in Advanced HCC No drug interventions Not Available Not Available terminated NCT05626985
Refinement and Validation of a Diagnostic Model (GAMAD) for Early Detection of Hepatocellular Carcinoma No drug interventions Not Available Not Available recruiting NCT02273362
Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver prevention 1 / 2 completed NCT03755791
Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Subjects With Advanced HCC Who Have Not Received Previous Systemic Anticancer Therapy treatment 3 active_not_recruiting NCT03783871
NeuWave HCC China Study No drug interventions treatment Not Available completed NCT05616039
I-FIGS Feasibility Study No drug interventions treatment Not Available active_not_recruiting NCT06313047
Pharmacogenetic of Doxorubicin in HCC. Not Available Not Available completed NCT06325826
The Study of the Validation of General Evaluation Score (GES) in the Prediction of Hepatocellular Carcinoma Risk Among Patients With Advanced Fibrosis and Cirrhosis Who Achieved Sustained Virological Response for Hepatitis C Virus After Direct Acting Antiviral Drugs No drug interventions Not Available Not Available active_not_recruiting NCT06326502
A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Carcinoma No drug interventions treatment 1 recruiting NCT06334965
Multi-modal Characterisation of Hepatocellular Carcinoma (HCC) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort No drug interventions other Not Available not_yet_recruiting NCT06331273
Impact of "No-touch" Technique on the Outcome of Liver Transplantation for Hepatocellular Carcinoma No drug interventions Not Available Not Available not_yet_recruiting NCT06333561
HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma Not Available Not Available recruiting NCT06328283
The Diagnostic Efficacy of Glutamine Synthetaseand BCLAF1in Early Diagosis of Hepatocellular Carcinoma in Cirrhotic Patients No drug interventions Not Available Not Available not_yet_recruiting NCT02432963
Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy treatment 1 active_not_recruiting NCT02576509
An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular Carcinoma treatment 3 completed NCT02917759
Liver and Biliary Tumor Tissue Registry No drug interventions Not Available Not Available recruiting NCT04147078
Personalized DC Vaccine for Postoperative Cancer No drug interventions treatment 1 recruiting NCT04157985
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors treatment 3 recruiting NCT05095519
Hepatocellular Carcinoma Imaging Using PSMA PET/CT diagnostic 2 recruiting NCT04676633
Safety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy treatment 1 completed NCT06317896
Value of Dynamic Monitoring of Early Recurrence of Hepatocellular Carcinoma After Radical Resection Based on CTCS No drug interventions Not Available Not Available not_yet_recruiting NCT02908048
Extracellular RNA Markers of Liver Disease and Cancer No drug interventions Not Available Not Available active_not_recruiting NCT04451603
LiverMultiScan Analysis of MRI Scans in HCC No drug interventions Not Available Not Available completed NCT05239507
OREIOS International Study No drug interventions Not Available Not Available completed NCT06030895
Sorafenib In Egyptian Patients With Hepatocellular Carcinoma. treatment Not Available completed NCT06204159
Lipiodol Deposition Using Endhole vs. Pressure-Modulated Delivery No drug interventions other Not Available recruiting NCT06179602
Prospective Cohort Study on Thermal Ablation of Malignant Liver Tumors No drug interventions Not Available Not Available recruiting NCT06261125
Combination of SBRT, PD-L1 Inhibitor, and Lenvatinib in Hepatocellular Carcinoma (HSBRT2401) treatment 2 recruiting NCT06304766
Open Versus Laparoscopic Ablation of Liver Malignancies No drug interventions treatment Not Available recruiting NCT02881554
Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery diagnostic Not Available recruiting NCT02182687
Stereotactic Body Radiation Therapy (SBRT) Versus Trans-Arterial Chemoembolization (TACE) as Bridge to Liver Transplant treatment 2 completed NCT03612726
The Overall Survival of Patients With Unresectable HCC in Real-life No drug interventions Not Available Not Available recruiting NCT03899428
Immune Checkpoint Therapy vs Target Therapy in Reducing Serum HBsAg Levels in Patients With HBsAg+ Advanced Stage HCC treatment 2 recruiting NCT03959800
Molecular Basis of Pediatric Liver Cancer No drug interventions Not Available Not Available recruiting NCT04234113
Study of SO-C101 and SO-C101 in Combination With Pembro in Adult Patients With Advanced/Metastatic Solid Tumors treatment 1 active_not_recruiting NCT04103398
TACE Plus Sorafenib Versus TACE Alone for Recurrent Intermediate Hepatocellular Carcinoma treatment 3 completed NCT04580485
INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors treatment 1 completed NCT04627012
Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma Not Available Not Available completed NCT04780217
Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors treatment 1 / 2 active_not_recruiting NCT05359939
A Head-to-head Comparison of MRI, CT, 18F-FDGal and 18F-choline in Patients With Hepatocellular Carcinoma No drug interventions diagnostic Not Available recruiting NCT05148572
Prospective Cohort Study of Changes in Circulatory MicroRNA of Resected Hepatocellular Carcinoma No drug interventions Not Available Not Available recruiting NCT05546879
Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in First Line in Unresectable HCC treatment 1 recruiting NCT05443087
TARGETed Therapy Drug MONITOring in DIGestive Oncology No drug interventions treatment Not Available recruiting NCT05901519
A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma treatment 2 recruiting NCT05776875
Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCC treatment 2 recruiting NCT05970666
Single Arm, Prospective, Multicenter Clinical Study of TACE With Adebrelimab and Bevacizumab for Unresectable Hepatocellular Carcinoma treatment 2 recruiting NCT06253598
Efficacy and Safety of Intratumoral Injection of Recombinant Human Adenovirus Type 5 Combined With Tislelizumab and Lenvatinib in the Treatment of Advanced Hepatocellular Carcinoma treatment 2 not_yet_recruiting NCT06285019
Modified TOMOX-HAIC in Combination With Sintilimab and Bevacizumab Biosimilar for First-line Treatment of Advanced Hepatocellular Carcinoma treatment 2 recruiting NCT06280105
A Trial of Cadonilimab Plus Regorafenib in Patients With Hepatocellular Carcinoma Who Failed Camrelizumab Combined With Apatinib treatment 2 not_yet_recruiting NCT06298123
Postoperative Adjuvant Immunotherapy for Hepatocellular Carcinoma: Risk Factor Analysis and Prognostic Modelling No drug interventions Not Available Not Available completed NCT02859753
Comparison of Response and Recurrence Rates Following Percutaneous Microwave Coagulation Therapy Versus Percutaneous Radiofrequency Ablation No drug interventions other Not Available completed NCT03983954
Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumors treatment 1 active_not_recruiting NCT05292443
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver Cancer No drug interventions Not Available Not Available withdrawn NCT05178043
GT90001 Plus Nivolumab in Patients With Advanced Hepatocellular Carcinoma treatment 2 active_not_recruiting NCT06075849
Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent No drug interventions treatment 1 recruiting NCT03752398
A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) treatment 1 active_not_recruiting NCT02511522
Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases No drug interventions supportive_care Not Available active_not_recruiting NCT04282044
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies treatment 1 recruiting NCT05842174
Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma treatment 1 / 2 not_yet_recruiting NCT05842317
Lenvatinib Plus Tislelizumab With or Without TACE in First-line Treatment of Unresectable HCC treatment 1 / 2 recruiting NCT06061328
Project OASIS: Optimizing Approaches to Select Implementation Strategies No drug interventions health_services_research Not Available enrolling_by_invitation NCT06261047
Radiotherapy Delays Second-line Drug Therapy for Oligo Progressive Primary Liver Cancer No drug interventions Not Available Not Available recruiting NCT04114136
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies treatment 2 recruiting NCT04510129
A Multicenter Cancer Biospecimen Collection Study No drug interventions Not Available Not Available recruiting NCT06031818
Usability and Clinical Effectiveness of an Interpretable Deep Learning Framework for Post-Hepatectomy Liver Failure Prediction No drug interventions Not Available Not Available recruiting NCT06236568
Impact of Graft Reconditioning With Hypothermic Machine Perfusion on HCC Recurrence After Liver Transplantation No drug interventions prevention Not Available recruiting NCT06247293
Surgical Resection Combined With Intraperitoneal Hyperthermic Chemotherapy No drug interventions Not Available Not Available not_yet_recruiting NCT03782207
A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice Not Available Not Available active_not_recruiting NCT05516628
Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bevacizumab in Resected Hepatocellular Carcinoma treatment 2 recruiting NCT06018857
Registry 17-009: Multi-Institutional Study Examining Patients With HCC Undergoing Liver Transplantation No drug interventions Not Available Not Available active_not_recruiting NCT06199297
Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular Carcinoma Not Available Not Available completed NCT06233708
Association Between Pre-op Non-Selective Beta-Blockers and Hepatocellular Carcinoma Recurrence Post-Liver Transplant Not Available Not Available completed NCT02650271
Adjuvant Entecavir or Tenofovir for Postoperative HBV-HCC treatment 3 completed NCT02935478
Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver Transplantation No drug interventions treatment Not Available suspended NCT04912765
Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC treatment 2 recruiting NCT05062837
Hepatectomy Combined With Camrelizumab and Apatinib in CNLC Stage IIIb HCC treatment 2 / 3 recruiting NCT05910970
Adjuvant Tislelizumab Plus Lenvatinib for Patients at High-risk of HCC Recurrence After Curative Resection or Ablation treatment 3 not_yet_recruiting NCT06182644
Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors No drug interventions diagnostic Not Available recruiting NCT01918683
TACE With or Without SBRT as Bridging Therapy for Pre-transplant HCC Patients No drug interventions treatment Not Available active_not_recruiting NCT04762888
68Ga-PSMA-Dual-Contrast PET/MRI or PET/CT for Early Detection of Liver Cancer diagnostic 2 recruiting NCT04800497
The Role Of Circulating Tumor Cells As Markers Of Advanced Disease And Prognosis In HCC No drug interventions Not Available Not Available recruiting NCT04224480
Longitudinal Immune-phenotyping of HCC Following MK-3475 treatment 1 active_not_recruiting NCT05293158
Impact of Hepatitis B Immunoglobulins in Patients With Chronic Hepatitis B on Hepatocellular Carcinoma - a Proof of Concept Study treatment Not Available not_yet_recruiting NCT05120271
BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors treatment 1 / 2 recruiting NCT06190665
DEB-TACE With Visualable Microspheres Versus PVA Microspheres for HCC No drug interventions treatment Not Available recruiting NCT06201065
FOLFOX-HAIC Plus Lenvatinib and Toripalimab vs. FOLFOX-HAIC Plus Lenvatinib for Advanced Hepatocellular Carcinoma: a Randomized Controlled and Double-blind Trial treatment 3 recruiting NCT06205472
Phase II Study of Adjuvant SIB Radiotherapy Following Narrow-Margin Hepatectomy in Patients With HCC. No drug interventions treatment 2 recruiting NCT04791176
Phase II Study of Concurrent Lenvatinib and Radiotherapy for Advanced HCC No drug interventions treatment 2 active_not_recruiting NCT04658147
Feasibility and Efficacy of Perioperative Nivolumab With or Without Relatlimab for Patients With Potentially Resectable Hepatocellular Carcinoma (HCC) treatment 1 recruiting NCT05171166
Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial. treatment 2 / 3 recruiting NCT05021250
SBRT With DIBH for HCC After TACE and Lipiodol Marking No drug interventions treatment Not Available active_not_recruiting NCT06198296
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells No drug interventions treatment 1 not_yet_recruiting NCT06196775
A Study of Cadonilimab Combined With AK112 as Second-line Therapy in Patients With Advanced Hepatocellular Carcinoma treatment 2 not_yet_recruiting NCT01004978
Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery treatment 3 completed NCT04244552
A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies treatment 1 terminated NCT05342350
International Study of High-Risk Patients for Hepatocellular Carcinoma Using Liquid Biopsy No drug interventions Not Available Not Available recruiting NCT06178809
Clinical Research on Dynamic Monitoring MRD Via Plasma ctDNA After Systemic Therapy of Hepatocellular Carcinoma No drug interventions Not Available Not Available recruiting NCT06193733
Dendritic Cell Vaccination to Prevent Hepatocellular Carcinoma Recurrence After Liver Resection-phase II Clinical Trial No drug interventions prevention 2 not_yet_recruiting NCT04187872
LITT and Pembrolizumab in Recurrent Brain Metastasis treatment 1 terminated NCT04422249
A Study of Laparoscopic Middle Hepatic Vein Guidance and Traditional Anatomic Hemihepatectomy No drug interventions treatment Not Available recruiting NCT02764801
Contrast-enhanced Ultrasound Evaluation of Chemoembolization diagnostic 3 completed NCT04559607
TACE Combined With Camrelizumab and Apatinib in Intermediate and Advanced Hepatocelluar Carcinoma treatment Not Available active_not_recruiting NCT05103007
PVE/PVL Combined With DEB-TACE in the Treatment of Patients With Large and Unresectable Liver Cancer No drug interventions treatment Not Available recruiting NCT05468359
Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients treatment 1 / 2 recruiting NCT05520801
Primary Hepatobiliary Cancer Cohort of Central China No drug interventions Not Available Not Available recruiting NCT05520788
Ambispective Cohort Study of Precision Medicine for Primary Hepatobiliary Cancer Based on Next-generation Sequencing No drug interventions Not Available Not Available recruiting NCT05497453
A Phase 1/2 Study to Evaluate OTX-2002 in Patients With Hepatocellular Carcinoma and Other Solid Tumor Types Known for Association With the MYC Oncogene treatment 1 / 2 recruiting NCT05533892
Nocardia Rubra Cell Wall Skeleton (N-CWS) Plus HAIC, Lenvatinib and Tislelizumab in Treating Patients With Advanced HCC treatment 1 recruiting NCT01658878
An Immuno-therapy Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab or Nivolumab in Combination With Other Agents in Patients With Advanced Liver Cancer treatment 1 / 2 active_not_recruiting NCT04459468
Identify Proteomic Biomarkers for Outcome Prediction of Locoregional Treatments for HCC Not Available Not Available recruiting NCT04802954
Risk Stratification of Hepatocarcinogenesis Using a Deep Learning Based Clinical, Biological and Ultrasound Model in High-risk Patients No drug interventions diagnostic Not Available recruiting NCT04745390
Standard Versus Radiobiologically-Guided Dose Selected SBRT in Liver Cancer No drug interventions treatment Not Available recruiting NCT05440864
Durvalumab and Tremelimumab in Resectable HCC treatment 2 recruiting NCT05629845
Prevention of Variceal Rebleeding by EUS-guided vs Conventional Endoscopic Therapy in Hepatocellular Carcinoma Patients No drug interventions treatment Not Available recruiting NCT03638141
CTLA-4 /PD-L1 Blockade Following Transarterial Chemoembolization (DEB-TACE) in Patients With Intermediate Stage of HCC (Hepatocellular Carcinoma) Using Durvalumab and Tremelimumab treatment 2 active_not_recruiting NCT02802124
Carbon Ion Radiotherapy for the Treatment of Chinese Hepatocellular Carcinoma No drug interventions treatment Not Available terminated NCT03839706
Relationship Between 18FDG PET/MRI Patterns and ctDNA to Predict HCC Recurrence After Liver Transplantation No drug interventions diagnostic Not Available active_not_recruiting NCT05184283
Utilization of MAsS in Patients Undergoing LT for HCC No drug interventions Not Available Not Available terminated NCT02716012
First-in-Human Safety, Tolerability and Antitumour Activity Study of MTL-CEBPA in Patients With Advanced Liver Cancer treatment 1 active_not_recruiting NCT03867370
Toripalimab in Combination With Lenvatinib as Neoadjuvant Therapy in Resectable Hepatocellular Carcinoma treatment 1 / 2 terminated NCT04710641
Radomised Phase II Study of MTL-CEBPA Plus Sorafenib or Sorafenib Alone treatment 2 active_not_recruiting NCT04720430
Blood Sample Collection for Experimental Blood Test to Track Liver Cancer No drug interventions Not Available Not Available completed NCT01447667
Magnetic Resonance Elastography (MRE) as a Predictor of HCC Recurrence After Radiofrequency Ablation (RFA) No drug interventions diagnostic Not Available completed NCT01690715
Prognostic Value Related to the Presence of Thrombosis or Portal Vein Invasion in Patients With Hepatocellular Carcinoma Submitted to Surgery No drug interventions Not Available Not Available terminated NCT02460835
A Pilot Study of Individualized Adaptive Radiation Therapy for Hepatocellular Carcinoma No drug interventions treatment Not Available completed NCT02279719
A Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular Carcinoma treatment 1 / 2 completed NCT03383458
A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation treatment 3 active_not_recruiting NCT02232633
A Study of BBI503 in Adult Patients With Advanced Hepatobiliary Cancer treatment 2 completed NCT04745403
Redirected HBV-Specific T Cells in Patients With HBV-related HCC (SAFE-T-HBV) treatment 1 recruiting NCT04391348
Combination PET With 18F-fluorodeoxyglucose (18F-FDG) and 18 F-choline in Patient With HCC No drug interventions diagnostic Not Available completed NCT05137899
Neoadjuvant Combination of Atezolizumab/Bevacizumab Versus Neoadjuvant Radiation Therapy No drug interventions treatment 2 recruiting NCT05603572
KAT-101 in Subjects With Hepatocellular Carcinoma (HCC) No drug interventions treatment 1 / 2 active_not_recruiting NCT05528952
Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma treatment 2 recruiting NCT05871892
18F-FDGal PET/CT and PET/MRI in Patients With Hepatocellular Carcinoma No drug interventions diagnostic Not Available recruiting NCT04569799
Accuracy of Contrast-Enhanced Ultrasound for Hepatocellular Carcinoma Post TACE other 4 completed NCT05444478
Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular Carcinoma treatment Not Available recruiting NCT05482516
Evaluating Novel Therapies in ctDNA Positive GI Cancers treatment 3 recruiting NCT05657249
Alternative Surveillance Program for Patients With High Risk Group of HCC No drug interventions screening Not Available active_not_recruiting NCT06111326
BC3402 in Combination With Durvalumab in Patients With Advanced Hepatocellular Carcinoma treatment 1 / 2 not_yet_recruiting NCT02174549
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer treatment 1 / 2 active_not_recruiting NCT03033446
Study of Y90-Radioembolization With Nivolumab in Asians With Hepatocellular Carcinoma treatment 2 active_not_recruiting NCT03259867
Combination of TATE and PD-1 Inhibitor in Liver Cancer treatment 2 recruiting NCT03895359
Transarterial Chemoembolization (TACE) Versus TACE Plus Stereotactic Body Radiation Therapy (SBRT) in Liver Carcinoma No drug interventions treatment 3 recruiting NCT04258566
Electromagnetic Tracking and Optical Imaging With ICG for Hepatic Biopsies No drug interventions diagnostic 1 enrolling_by_invitation NCT04428437
Safety and Efficacy of Lenvatinib in Subjects With HCC Progression After First Line Treatment With Checkpoint Inhibitors Not Available Not Available terminated NCT04620538
Volatile Organic Compounds for the Assessment of Liver Disease No drug interventions Not Available Not Available recruiting NCT04792463
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome No drug interventions Not Available Not Available recruiting NCT05010434
Sintilimab and Bevacizumab Combined With Radiotherapy for Advanced Hepatocellular Carcinoma treatment 2 active_not_recruiting NCT05128032
Pressure-enabled Delivery in Radioembolization (TriNav Study) No drug interventions diagnostic Not Available recruiting NCT05250843
TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCC treatment 2 / 3 recruiting NCT05488522
SBRT With Atezo/Bev for HCC treatment 1 recruiting NCT05537402
LOcoregional vs Systemic Therapy in Patients With BCLC Stage B HCC treatment 2 recruiting NCT05622136
Dose-escalation of Regorafenib in Advanced Hepatocellular Carcinoma treatment 2 recruiting NCT06044506
Autologous Natural Killer Cell Therapy for Hepatocellular Carcinoma treatment 1 recruiting NCT06065592
Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms prevention 1 recruiting NCT06062706
Robotic vs. Laparoscopic vs. Open Living Donor Hepatectomy No drug interventions Not Available Not Available enrolling_by_invitation NCT06088459
NWRD06 DNA Plasmid for HCC After Radical Resection No drug interventions treatment 1 recruiting NCT06086002
Clinical Feasibility of Microwave Ablation Using Two Channel Microwave Generator and Two Antennas for Small Hepatocellular Carcinoma No drug interventions treatment Not Available recruiting NCT06089382
A Study to Evaluate Sintilimab Plus Lenvatinib as Adjuvant Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis (PVTT) After Surgical Resection treatment 3 not_yet_recruiting NCT06101758
Ultrasound Assessment of Sarcopenia in Patients With Chronic Liver Disease: the SARCOLIVER Study No drug interventions diagnostic Not Available recruiting NCT03447951
A Study of PTS100 in Primary HCC Patients treatment 2 recruiting NCT03781934
A Study to Evaluate MIV-818 in Patients With Liver Cancer Manifestations treatment 1 / 2 active_not_recruiting NCT05044676
Immune Cells as a New Biomarker of Response in Patients Treated by Immunotherapy for Advanced Hepatocellular Carcinoma No drug interventions Not Available Not Available recruiting NCT05448222
Effect of Sarcopenia on Hepatocellular Carcinoma(HCC) After Systemic Therapies No drug interventions Not Available Not Available enrolling_by_invitation NCT05371873
A Study of Chromosomal Abnormalities as a Predictor of Staging and Prognosis in Patients With Liver Cancer No drug interventions Not Available Not Available active_not_recruiting NCT05750030
FMT in IT-refractory HCC - FAB-HCC Pilot Study treatment 2 recruiting NCT05994859
SIRT for Potentially Resectable HCC No drug interventions treatment Not Available recruiting NCT05920863
Lenvatinib Combined With Tislelizumab and TACE Applied as Neoadjuvant Regimen for the Patients of CNLC Stage IB and IIA Hepatocellular Carcinoma With High-risk Recurrence Factors treatment 2 recruiting NCT06031285
Perioperative Sintilimab Plus Bevacizumab Biosimilar and TACE-HAIC for HCC Patients With PVTT: A Phase-2 Clinical Trial treatment 2 recruiting NCT06034977
Phase 2 Study of ADI-PEG 20 Plus Lenvatinib Treatment in Subjects With Unresectable Hepatocellular Carcinoma treatment 2 recruiting NCT06037343
Deep Learning Image Reconstruction for Abdominal CT of Hepatocellular Carcinoma Compared With 3-TESLA MRI No drug interventions Not Available Not Available recruiting NCT06031480
Anlotinib and TQB2450 in Advanced Hepatocellular Carcinoma After Failure of Prior Immune Checkpoint Inhibitors treatment 2 not_yet_recruiting NCT06039280
Comparison of Dexamethasone and N Acetylcysteine (NAC) Versus N Acetylcysteine (NAC) Alone in the Prevention of Post Embolization Syndrome in Patients With Hepatocellular Carcinoma Following Transarterial Chemoembolization. treatment Not Available not_yet_recruiting NCT03867084
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937) treatment 3 active_not_recruiting NCT05858736
Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06023147
A Real-world Study of the Short-term Efficacy and Safety of E-TACE in Patients With Hepatocellular Carcinoma (HCC) No drug interventions treatment Not Available not_yet_recruiting NCT06029829
The Clinical Significance of Peripheral Blood T Lymphocyte PD-1 Expression and T Cell Subset Distribution. treatment 2 recruiting NCT04050462
Nivolumab Combined With BMS-986253 in HCC Patients treatment 2 active_not_recruiting NCT03702998
Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population No drug interventions Not Available Not Available completed NCT04852211
Laparoscopic Versus Open Major Hepatectomy for HCC Hepatectomy for Hepatocellular Carcinoma No drug interventions treatment Not Available recruiting NCT05078047
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients With Metastatic Cancer in Response After 6 Months of Standard IO No drug interventions treatment 3 recruiting NCT04942665
Low Dose ICG for Biliary Tract and Tumor Imaging diagnostic 2 completed NCT05047510
GPC3 Targeted Fluorescence Image Guided Surgery of Hepatocellular Carcinoma No drug interventions diagnostic Not Available recruiting NCT00539643
Trial of Beads Versus Doxorubicin Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma No drug interventions treatment 2 completed NCT04135690
HAIC Plus Toripalimab vs. HAIC Plus Sorafenib for HCC With PVTT: a Non-comparative, Prospective, Randomized Trial treatment 2 recruiting NCT04566393
Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies Not Available Not Available available NCT05502198
Relevance of Sarcopenia in Advanced Liver Disease No drug interventions Not Available Not Available recruiting NCT05681949
Therapeutic Assistance and Decision-making Algorithms in Hepatobiliary Tumor Boards No drug interventions health_services_research Not Available not_yet_recruiting NCT05984511
TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT treatment Not Available not_yet_recruiting NCT05992220
Atezolizumab Plus Bevacizumab Alone or Combined With External Beam Radiotherapy for HCC With Macrovascular Invasion treatment 2 recruiting NCT06005883
Surgical Outcome of HCC With Portal Vein Tumor Thrombosis on the Basis of Risk Scoring No drug interventions Not Available Not Available completed NCT04116320
Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors treatment 1 active_not_recruiting NCT04642547
Lenvatinib Combined With Gefitinib in the Treatment of Lenvatinib-resistant Hepatocellular Carcinoma treatment Not Available completed NCT04680598
Comparison of HBV Reactivation Between Patients With High HBV-DNA and Low HBV-DNA Loads Undergoing ICI and Concurrent Antiviral Prophylaxis: a Prospective Observational Study No drug interventions Not Available Not Available recruiting NCT05971199
Phase II Study of Fruquintinib Combined With Sintilimab and TACE for Inoperable Primary Hepatocellular Carcinoma treatment 2 recruiting NCT05971628
Resection And Partial LIver Transplantation With Delayed Hepatectomy for Hepatocellular Carcinoma No drug interventions treatment Not Available not_yet_recruiting NCT05970159
Impact of Preoperative Serum Albumin Level on Postoperative Outcomes in Chinese HCC Patients Treated With Surgery No drug interventions Not Available Not Available recruiting NCT03170960
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors treatment 1 / 2 active_not_recruiting NCT05317819
Study of ADI-PEG 20 Versus Placebo in Subjects With High Arginine Level and Unresectable Hepatocellular Carcinoma treatment 3 recruiting NCT05291338
Pharmacogenetic Study in Hepatocellular Carcinoma Patients. Not Available Not Available completed NCT05954897
Lenvatinib, Tislelizumab Combined With RALOX Regimen HAIC in Advanced Hepatocellular Carcinoma treatment 2 recruiting NCT00699816
Efficacy and Safety of Immuncell-LC Group and Non-treatment Group in Hepatocelluar Carcinoma Patients No drug interventions treatment 3 completed NCT03591965
Dual TORC1/TORC2 Inhibitor ATG-008 (CC-223) in HBV Positive Advanced Hepatocellular Carcinoma (HCC) Subjects No drug interventions treatment 2 terminated NCT03970616
A Study of Tivozanib in Combination With Durvalumab in Subjects With Advanced Hepatocellular Carcinoma treatment 1 / 2 terminated NCT03722498
Phase Ⅱ Study of HAIC of FOLFOX vs. Sorafenib in HCC Refractory to TACE treatment 2 withdrawn NCT03829436
TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers treatment 1 completed NCT03785210
Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers treatment 2 completed NCT04445532
Hepatobiliary Tumors Tissue Samples Acquisition No drug interventions Not Available Not Available recruiting NCT04823754
Perception of the Doctor/Patient Relationship, Disease and Treatment Among Physicians and Their Patients Treated With Systemic Therapy for Hepatocellular Carcinoma "PERCEPTION1" No drug interventions Not Available Not Available completed NCT04975932
Efficacy and Safety of TACE in Combination With ICIs for HCC: a Real-world Study No drug interventions Not Available Not Available completed NCT05072041
Safety and Efficacy of Degradable Microsphere in Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma No drug interventions treatment Not Available recruiting NCT05109052
Trial of PXS-5505 Combined With First Line Atezolizumab Plus Bevacizumab For Treating Patients With Unresectable Hepatocellular Carcinoma treatment 1 / 2 withdrawn NCT05198609
Camrelizumab, Apatinib Plus HAIC Versus Camrelizumab and Apatinib for HCC With Portal Vein Invasion: a Randomized Trial treatment 3 recruiting NCT05576909
Donafenib Combined With Hepatic Artery Chemoembolization for Perioperative Treatment of Liver Transplantation treatment 2 recruiting NCT05882370
TIPS Plus Cadonilimab in Advanced HCC With Tumor Thrombosis-associated Portal Hypertension:a Prospective, Single-arm, Phase II Study treatment 2 not_yet_recruiting NCT05932836
An Organoid-on-chips Technique Based on Biopsy Samples and Its Efficacy in Predicting the Response to HAI in HCC No drug interventions Not Available Not Available recruiting NCT05932719
Multicentric Evaluation of COVID-19 Impact on Cancer Patients' Diagnostic and Management: Set-up of Indicators No drug interventions Not Available Not Available recruiting NCT01890291
Long Term Follow-Up Study of Immuncell-LC Group and Non-Treatment Group in Hepatocellular Carcinoma Patients. No drug interventions Not Available Not Available completed NCT04512833
CyberKnife Stereotactic Body Radiation Therapy for Small Hepatocellular Carcinoma Patients With Decompensated Cirrhosis No drug interventions Not Available Not Available recruiting NCT05925413
Cadonilimab Plus TACE in Patients With Intermediate-stage Unresectable Hepatocellular Carcinoma treatment 2 active_not_recruiting NCT02513199
Combination Chemoembolization and Stereotactic Body Radiation Therapy in Unresectable Hepatocellular Carcinoma No drug interventions treatment 2 completed NCT05908916
Atezolizumab and Bevacizumab With Combined Radiotherapy for Advanced Hepatocellular Carcinoma No drug interventions treatment 2 not_yet_recruiting NCT05913583
Correlation Between Pre-transplant ICI Exposure and Post-transplant Graft Rejection No drug interventions Not Available Not Available recruiting NCT02973685
HAIC Versus TACE for Large Hepatocellular Carcinoma Staged BCLC A/B. No drug interventions treatment 3 completed NCT04044313
HAIC Plus Lenvatinib and Toripalimab for Advanced HCC treatment 2 completed NCT04418401
Study on the Safety and Efficacy of Donafinib Combined With Anti-PD-1 Antibody as Adjuvant Therapy for HCC Patients prevention 1 recruiting NCT04930315
SHR-1210 Combined With Apatinib Mesylate in the Perioperative Therapy for Hepatocellular Carcinoma treatment 2 recruiting NCT05304572
Multi-Detector CT Angiography With 3D Reconstruction Versus Digital Subtraction Angiography No drug interventions Not Available Not Available completed NCT05128123
Influence of Social Determinants of Health on the Management of HCC in the French National Cohort Study CHIEF No drug interventions Not Available Not Available recruiting NCT05221398
Adjuvant Immune Checkpoint Inhibitors in Postoperative Hepatocellular Carcinoma No drug interventions Not Available Not Available completed NCT05409482
A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma No drug interventions Not Available Not Available recruiting NCT05887505
Effects of Vitamin D Status and Multiple Mega-dose Supplementation on Health Care Disparities in Perioperative Patients With Hepatocellular Carcinoma Receiving Hepatectomy No drug interventions treatment Not Available not_yet_recruiting NCT05887661
Goal-directed LCVP Based on HP in Laparoscopic Hepatectomy No drug interventions treatment Not Available recruiting NCT05903456
Icaritin Soft Capsule Combined With Lenvatinib and TACE for the Treatment of Hepatocellular Carcinoma treatment 2 not_yet_recruiting NCT05703750
Impact of Clinical Evident Portal Hypertension on HCC With TACE (CHANCE-CHESS 2301) No drug interventions Not Available Not Available recruiting NCT05475613
Downstaging Protocol Containing Immunotherapy for HCC Beyond the Milan Criteria Before Liver Transplantation No drug interventions treatment 2 recruiting NCT05886465
HAIC Plus A+T for Patients With High-risk HCC: a Single-arm Phase 2 Trial treatment 2 recruiting NCT05886257
Candonilimab Plus Bevacizumab for Patients With Advanced HCC Who Progressed on A+T treatment 2 withdrawn NCT05879328
The ImmunoXXL Study No drug interventions Not Available Not Available recruiting NCT04837742
The Effect of Ultrasound-guided Erector Spinae Plane Block on Postoperative Analgesia in Radiofrequency Ablation Therapy No drug interventions treatment Not Available completed NCT05864105
PM8002 in Combination With Chemotherapy as First Line Therapy in Hepatocellular Carcinoma No drug interventions treatment 2 recruiting NCT05875558
M-TACE Treatment for Unresectable Hepatocellular Carcinoma No drug interventions treatment Not Available enrolling_by_invitation NCT05876052
HOPE to Reduce Tumour Recurrence After LT In Patients With HCC No drug interventions treatment Not Available not_yet_recruiting NCT05612477
Blood Salvage in Orthotopic Liver Transplantation With HCC No drug interventions other Not Available enrolling_by_invitation NCT05859945
Navigating the Clinical Trial Process for Hepatocellular Carcinoma No drug interventions Not Available Not Available not_yet_recruiting NCT05866172
HAIC Combined Withzoledronic Acid for the Prevention of Bone Metastases in Advanced HCC treatment 3 recruiting NCT05862337
Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence. treatment 3 recruiting NCT05039736
A Phase II Study to Evaluate the Effects of Sequential Therapy With the Anti c-MET/VEGFR Tyrosine Kinase Inhibitor (TKI), Cabozantinib, Followed by an Anti-PD-1 Antibody (Nivolumab) in Patients With Advanced HCC Who Progressed on First-line Therapy treatment 2 withdrawn NCT05828446
Improving Hepatocellular Carcinoma Screening No drug interventions screening Not Available recruiting NCT02174575
Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery prevention 4 withdrawn NCT03268499
TACE Emulsion Versus Suspension treatment 2 completed NCT04641637
Substudy: Interconnection of Arterial Tumor Feeders Through Tumor Sinusoid in HCC No drug interventions treatment Not Available completed NCT05249569
Study of Bavituximab, Axitinib, and Avelumab in Advanced Hepatocellular Carcinoma treatment 2 terminated NCT05134532
Regorafenib After Progression on Atezolizumab Plus Bevacizumab in Advanced HCC treatment 2 active_not_recruiting NCT03869034
HAIC Combined With PD-1 Inhibitor in Potentially Resectable Locally Advanced HCC treatment 2 active_not_recruiting NCT04652440
Ablation Combined With PD-1 in HCC: Phase II Study treatment 1 / 2 recruiting NCT05582018
Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation Procedures No drug interventions other Not Available not_yet_recruiting NCT05810402
Liver Cancer and Immunotherapy in the Liquid Biopsy Era other Not Available not_yet_recruiting NCT01943318
Boramae Hospital Liver Cirrhosis Patient Cohort Study No drug interventions Not Available Not Available completed NCT04150874
Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAE No drug interventions diagnostic 0 terminated NCT05349331
Watch and Wait Versus Surgical Treatment for Clinical Complete Responders After Non-Curative Therapy for Hepatocellular Carcinoma No drug interventions treatment Not Available recruiting NCT05811481
Regorafenib Alone or in Combined With Transcatheter Arterial ChEmoembolization in Treatment of Advanced Hepatocellular Carcinoma After First Line Targeted Therapy Not Available Not Available recruiting NCT05809869
Immunotherapy and Radioembolisation for Metastatic Hepatocellular Carcinoma treatment 2 recruiting NCT04653818
HCV Related Hepatocellular Carcinoma Recurrence After Directly Acting Antivirals: A Randomized Controlled Trial other 4 completed NCT05800561
Prognostic Role of HVPG and ICG-R15 in the Short- and Medium-term Results of the Surgery of HCC on Cirrhosis No drug interventions Not Available Not Available recruiting NCT02821754
A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC) treatment 2 completed NCT03859128
Toripalimab or Placebo as Adjuvant Therapy in Hepatocellular Carcinoma After Radical Resection treatment 2 / 3 active_not_recruiting NCT04348838
Prospective Cohort of Patients With Hepatocellular Carcinoma in France No drug interventions Not Available Not Available recruiting NCT04443309
Lenvatinib in Combination With Camrelizumab as First-Line Therapy in Patients With Advanced HCC treatment 1 / 2 recruiting NCT04368078
Lenvatinib Combined Toripalimab in Advanced Hepatocellular Carcinoma treatment 2 recruiting NCT04601961
Effects of TIVA Versus Inhalational Anaesthesia on Circulating Tumour Cells in Hepatocellular Carcinoma Patients health_services_research Not Available recruiting NCT05048017
Regorafenib Combined With PD-1 Inhibitor Therapy for Second-line Treatment of Hepatocellular Carcinoma treatment 2 recruiting NCT05157451
Y-90 Versus SBRT for Inoperable HCC No drug interventions device_feasibility 2 withdrawn NCT05407519
A Study to Evaluate Tislelizumab Combined With Sitravatinib as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection treatment 2 recruiting NCT05670561
Effects of Esketamine on Acute Abdominal Pain After TACE in Patients With Hepatocellular Carcinoma treatment 4 recruiting NCT05764551
The Application of Serum DNA Methylation for Patients With HCC No drug interventions diagnostic Not Available recruiting NCT04124991
Safety and Efficacy Study of Radioembolization in Combination With Durvalumab in Locally Advanced and Unresectable HCC treatment 1 / 2 completed NCT05751343
TACE-HAIC Plus Atezolizumab and Bevacizumab for Unresectable HCC: a Phase 2 Clinical Trial treatment 2 recruiting NCT04649671
The Effect of Mobile Health-based Exercise on Hepatocellular Carcinoma Patients With Insulin Resistance No drug interventions treatment Not Available terminated NCT05408221
the Efficacy and Safety of Rulonilimab in Combination With Lenvatinib in Hepatocellular Carcinoma treatment 2 / 3 recruiting NCT05759858
Identification and Prognostic Value of Key Genes in Hepatocellular Carcinoma No drug interventions Not Available Not Available recruiting NCT05760430
The Synergistic Effect of Portal Venous Supply Control and Immunotherapy in Hepatocellular Carcinoma treatment 2 recruiting NCT05760599
Candonilimab Plus Bevacizumab for Patients With Advanced HCC Who Progressed on A+T treatment 2 recruiting NCT03475953
A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors treatment 1 / 2 recruiting NCT05197504
Predictive Biomarkers in Patients With Advanced Hepatocellular Carcinoma Treated With Systemic Therapy Not Available Not Available recruiting NCT05738447
Application of mRNA Immunotherapy Technology in Hepatitis B Virus-related Refractory Hepatocellular Carcinoma No drug interventions treatment 1 recruiting NCT03248375
Impact of Y90 Radiation Segmentectomy on HCC No drug interventions treatment Not Available completed NCT04248816
Hepatocellular Carcinoma Surveillance in Cirrhotics No drug interventions screening Not Available completed NCT05602974
Adjuvant Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma After Hepatectomy With Narrow Margin: a Prospective, Multi-center, Randomized Controlled, Open-labelled, Phase III Study No drug interventions treatment Not Available not_yet_recruiting NCT05721300
Study on Screening, Verification and Intervention of High-risk Patients With Liver Cancer treatment Not Available recruiting NCT02905188
Glypican 3-specific Chimeric Antigen Receptor Expressing T Cells for Hepatocellular Carcinoma (GLYCAR) treatment 1 completed NCT03099564
Pembrolizumab Plus Y90 Radioembolization in HCC Subjects treatment 0 active_not_recruiting NCT04194801
A Phase Ib/II Study of Fisogatinib(BLU-554) in Subjects With Hepatocellular Carcinoma treatment 1 / 2 completed NCT04911959
Study of TACE Combined With Lenvatinib to Prevent Postoperative Recurrence in Patients With MVI Positive HCC treatment 1 / 2 recruiting NCT05029973
HAIC Combined With Sintilimab and Bevacizumab Biosimilar for Unresectable HCC treatment 2 recruiting NCT05225116
Safety and Efficacy of Lenvatinib and Anti-PD1 Antibody Combined With Radiotherapy Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT treatment 1 recruiting NCT05620771
Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk treatment 2 recruiting NCT05716620
Utility of Abbreviated Magnetic Resonance Imaging as a Screening Tool for Hepatocellular Carcinoma in Cirrhotic Patients No drug interventions Not Available Not Available recruiting NCT02438436
Simo Decoction and Gum Chewing for Bowel Activity No drug interventions supportive_care 3 completed NCT04612504
SynOV1.1 Intratumoral Injection Study treatment 1 recruiting NCT05185505
Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria treatment 4 recruiting NCT05683548
Replicor Compassionate Access Program Not Available Not Available available NCT05701553
Anti-PD-1/PD-L1 Antibodies Plus S-adenosyl-methionine Treatment in Patients With Advanced-Stage Hepatocellular Carcinoma No drug interventions Not Available Not Available recruiting NCT02125396
Adjuvant Radiotherapy Comparing TACE for Curative HCC No drug interventions treatment 3 recruiting NCT05312216
Durvalumab Plus Lenvatinib as First-line Treatment for Unresectable Hepatocellular Carcinoma treatment 2 not_yet_recruiting NCT05693519
GastroIntestinal Cancer in Children and Adolescents No drug interventions Not Available Not Available active_not_recruiting NCT02435433
A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein treatment 3 completed NCT04213118
Anlotinib Combined With TACE in Hepatocellular Carcinoma Patients at High Risk of Post Surgery Recurrence treatment 2 active_not_recruiting NCT05687747
Single Centre Prospective Evaluation of 68Gallium-FAPI PET/MRI in Hepatocellular Carcinoma No drug interventions diagnostic 1 not_yet_recruiting NCT03648073
[68Ga]DOTATATE-PET/MRI in Hepatocellular Carcinoma diagnostic 1 / 2 completed NCT03582618
CVM-1118 and Sorafenib Combination in Subjects With Advanced Hepatocellular Carcinoma treatment 2 terminated NCT04763707
Serum Visfatin and Serum Vaspin in Patients With Hepatocellular Carcinoma on Top of Liver Cirrhosis No drug interventions Not Available Not Available completed NCT04442334
The European NAFLD Registry No drug interventions Not Available Not Available recruiting NCT05332496
TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Intermediate HCC Not Available Not Available recruiting NCT05344924
TACE Combined With Penpulimab and Anlotinib for Advanced HCC treatment 2 / 3 recruiting NCT05280444
Lipiodol-TACE With Idarubicin for Hepatocellular Carcinoma treatment 2 / 3 recruiting NCT05557656
A Real World Study of Regogfinib in HCC Not Available Not Available not_yet_recruiting NCT05631613
Lipiodol-TACE With Idarubicin Based On a Specific Emulsion Ratio for Hepatocellular Carcinoma No drug interventions Not Available Not Available recruiting NCT05666271
Radiofrequency Ablation for Hepatocellular Carcinoma Using Octopus MP Electrodes No drug interventions Not Available Not Available recruiting NCT05668793
GNB4 and Riplet Gene Methylation Combined Detection Kit (Fluorescence PCR Method) No drug interventions Not Available Not Available not_yet_recruiting NCT05662488
FAPI PET for Response Evaluation and Prognosis Prediction in Liver and Biliary Cancer Patients Treated With PD-1 Combination Therapy No drug interventions Not Available Not Available active_not_recruiting NCT05650151
Peri-operative Vitamin D Therapy for Hepatectomy No drug interventions treatment Not Available not_yet_recruiting NCT05627297
Applying Artificial Intelligence to Optimize Early-stage Hepatocellular Carcinoma Treatment Based on Multi-modal Image No drug interventions Not Available Not Available recruiting NCT05625893
Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion No drug interventions treatment 2 recruiting NCT05617430
Combination Therapy of HAIC, Sintilimab and Bevacizumab for Advanced Hepatocellular Carcinoma treatment 2 recruiting NCT05621499
HAIC or Lenvatinib Combined With Sintilimab for High Recurrence Risk Resectable Solitary Hepatocellular Carcinoma treatment Not Available not_yet_recruiting NCT05613478
Camrelizumab Combined With Apatinib Mesylate and TACE in the Perioperative Treatment of Hepatocellular Carcinoma treatment 3 recruiting NCT05595473
A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Hepatocellular Carcinoma No drug interventions treatment 1 / 2 recruiting NCT05575622
Clinical Study for Combined Analysis of CTC and Exosomes on Predicting the Efficacy of Immunotherapy in Patients With Hepatocellular Carcinoma No drug interventions Not Available Not Available recruiting NCT05572528
Lenvatinib Therapy in HCC Patients After LDLT No drug interventions Not Available Not Available recruiting NCT05580224
Anatomical Radiofrequency Ablation for Small Hepatocellular Carcinoma No drug interventions treatment Not Available recruiting NCT05550025
TACE Combined With Camrelizumab and Apatinib in the Treatment of Advanced Liver Cancer treatment 2 recruiting NCT05546619
Research on Effectiveness and Safety of the Treatment, Hyperthermic Intraperitoneal Chemotherapy Combined With Tislelizumab and Targeted Therapy, That is Used for High-risk Hepatocellular Carcinoma After R0 Resection treatment Not Available active_not_recruiting NCT05534906
The Detection of Small Early Liver Cancer With Natural History Follow up No drug interventions Not Available Not Available recruiting NCT05545124
Study of Donafenib Combined With Tislelizumab in the Adjuvant Treatment of Primary HCC With High Risk of Recurrence treatment 2 not_yet_recruiting NCT05545046
Predictive Model for Pain After TACE No drug interventions Not Available Not Available completed NCT05541601
Prospective Cohort for Early Detection of Liver Cancer No drug interventions Not Available Not Available recruiting NCT05544253
Safety and Efficacy of Mitomycin C-based HIPEC After srHCC and PM of HCC No drug interventions prevention 2 / 3 recruiting NCT05535998
TACE-HAIC Combined With TKIs and Immunotherapy Versus TACE Alone for Hepatocellular Carcinoma With PVTT No drug interventions Not Available Not Available completed NCT05502458
Effect of Propofol and Desflurane on Nucleic Acid of Liver Circulating Tumor treatment 2 completed NCT05493332
HAIC Combined With Donafenib Tosilate and Toripalimab for Unresectable HCC treatment 2 not_yet_recruiting NCT05490147
Effect of Low Tidal Ventilation on Intraoperative Bleeding in Laparoscopic Major Hepatectomy No drug interventions treatment Not Available not_yet_recruiting NCT05489289
A Phase III Study of AK104 as Adjuvant Therapy in HCC With High Risk of Recurrence After Curative Resection treatment 3 not_yet_recruiting NCT05491889
Outcome of Hepatocellular Carcinoma Patients With Portal Vein Thrombosis After Trans-Arterial Chemo Embolization No drug interventions Not Available Not Available not_yet_recruiting NCT05488587
Serum Levels of Some Trace Elements in Hepatocellular Carcinoma Patients No drug interventions Not Available Not Available recruiting NCT05472896
TACE With Dicycloplatin(TP21) in Unresectable HCC treatment 3 recruiting NCT05476432
HAIC With One-day FOLFOX vs. HAIC With Two-day FOLFOX for Unresectable HCC: a Non-inferiority Study No drug interventions treatment 3 recruiting NCT05466565
Antiviral Therapy for Patients With Liver Cancer After Surgery No drug interventions Not Available Not Available recruiting NCT05441475
A Phase 2, Open-Label Study of ABSK-011 Combined Atezolizumab in HCC Patients treatment 2 recruiting NCT05420922
Real-world Study of Efficacy and Safety of ICIs and TKIs Therapy for HCC Not Available Not Available recruiting NCT05418387
A Social Support Intervention to Improve Treatment Among Hispanic Kidney and Liver Cancer Patients in Arizona No drug interventions health_services_research Not Available withdrawn NCT05411926
Effect of PD-1 /PD-L1 Inhibitor Therapy Before Liver Transplantation on Acute Rejection After Liver Transplantation in Patients With Hepatocellular Carcinoma No drug interventions Not Available Not Available recruiting NCT05391867
Assessment of the Efficacy of Lenvatinib Versus Sorafenib in the Management of Advanced Hepatocellular Carcinoma treatment Not Available recruiting NCT05396937
Efficacy and Safety of T+A+RAD in HCC treatment 2 recruiting NCT05375370
Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Monitoring Circulating Tumor DNA No drug interventions diagnostic Not Available not_yet_recruiting NCT05363722
A Clinical Study to Observe the Effectiveness and Safety of IBI310, Bevacizumab Combined With Sintilimab in the Treatment of Advanced Hepatocellular Carcinoma treatment 1 not_yet_recruiting NCT05355662
Prognosis Analysis of Elderly Donor Liver in Liver Transplantation No drug interventions Not Available Not Available completed NCT05339581
IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver Transplantation treatment Not Available not_yet_recruiting NCT05331911
Impact of Propofol-Based Total Intravenous Anesthesia Versus Anesthesia With Sevoflurane on Long-term Outcomes With Patients Undergoing Elective Excision of Primary Liver Tumors treatment 4 recruiting NCT05286099
The Surveillance of Hepatocellular Carcinoma No drug interventions Not Available Not Available recruiting NCT05281926
A Phase I, Open-label Study to Assess the Safety and Efficacy of Poly-ICLC Plus Nivolumab in Unresectable Hepatocellular Carcinoma Patients screening 1 recruiting NCT05281783
RFA for Treatment of Intermediate Stage HCC No drug interventions treatment Not Available completed NCT05276037
Value of Negative 18FDG PET/CT in Milan Out, Up-to-seven in, HCC Transplant Candidates No drug interventions Not Available Not Available recruiting NCT05270642
Plan for Microwave Thermal Field No drug interventions treatment Not Available active_not_recruiting NCT05233358
HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure treatment Not Available not_yet_recruiting NCT05242237
Prognostic Value of Liver Cancer CTCs Isolated by a Novel Microfluidic Platform No drug interventions Not Available Not Available recruiting NCT05220020
TACE Combined With Lenvatinib Versus TACE Sequential Lenvatinib in the Treatment of Intermediate/Advanced Liver Cancer treatment 3 recruiting NCT05202015
Non-invasive MRI Subclassification of Heptocellular Carcinoma - HepCaSt-Study No drug interventions Not Available Not Available recruiting NCT05193253
Long-term Outcomes of Ablation, Liver Resection, and Liver Transplant as First-line Treatment for Solitary HCC of 3 cm or Less No drug interventions Not Available Not Available completed NCT05178524
Clinical Study on BIFICO Accelerating Postoperative Liver Function Recovery in Patients With Hepatocellular Carcinoma No drug interventions treatment Not Available completed NCT05171309
Camrelizumab in Combination With Apatinib Plus NK Cell for Advanced HCC treatment 2 recruiting NCT05171335
Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients treatment 2 enrolling_by_invitation NCT05162352
Donafenib Plus Sintilimab for Advanced HCC treatment 2 recruiting NCT05166772
Donafenib Combine With Sintilimab and HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）in the First-line Treatment of Unresectable Hepatocellular Carcinoma treatment 2 not_yet_recruiting NCT05152498
Fu Zheng Jie Du Hua Yu Principle For Treatment Of Severe HBV Related Hepatocellular Carcinoma (FZJDHYPFTOSHBVHCC) No drug interventions treatment 0 recruiting NCT05154812
Yang Yin Fu Zheng Jie Du Therapy in HBV Associated Hepatocellular Carcinoma Based on the Platelet Count/Splenic Length-Diameter Ratio No drug interventions treatment 0 active_not_recruiting NCT05121571
The Efficacy and Safety of HAIC With FOLFOX vs Sorafenib for Patients Who Showed TACE-resistant: a Retrospective Study treatment Not Available completed NCT05105815
Safety and Efficacy of Autoimmune Cell Therapy for Patients With Hepatocellular Carcinoma No drug interventions treatment 0 not_yet_recruiting NCT05105828
Predictive Power of Share Wave Fibro Scan in HCC After HCV Infection No drug interventions Not Available Not Available completed NCT05111795
Holmium-166 Retrospective Collection of Real-World Data No drug interventions Not Available Not Available completed NCT05093608
SELINEXOR in Combination w/Bevacizumab and Atezolizumab in Newly Diagnosed Advanced Hepatocellular Carcinoma treatment 1 terminated NCT05095714
FAST-IRM for HCC suRveillance in pAtients With High risK of Liver Cancer. No drug interventions screening Not Available not_yet_recruiting NCT05088811
The Role of Long Non-coding RNAs WRAP53 and UCA-1 as Potential Biomarkers in Diagnosis of Hepatocellular Carcinoma No drug interventions Not Available Not Available recruiting NCT05088733
Yang Yin Fu Zheng Jie Du Therapy in HBV Related Hepatocellular Carcinoma Induced Anemia (YYFZJDTIHBVRHCIA) No drug interventions treatment 0 recruiting NCT05068193
A Clinical Trial to Compare the Pharmacokinetics and Bioequivalence of "BR2008" With "BR2008-1" in Healthy Volunteers No drug interventions treatment 1 completed NCT05059821
Personalized Cancer Vaccine in Egyptian Cancer Patients No drug interventions treatment 1 recruiting NCT05053386
Idarubicin vs. Epirubicin TACE in the Treatment of Hepatocellular Carcinoma treatment Not Available not_yet_recruiting NCT05056337
Toripalimab in Combination With Lenvatinib and TACE for Conversion Therapy in Patients With Potentially Resectable HCC treatment 3 enrolling_by_invitation NCT05017922
Efficacy of TACE With Endoscopic Therapy for Unresectable Hepatocellular Carcinoma No drug interventions treatment Not Available completed NCT05024539
Real-World Effectiveness of Regorafenib in the Treatment of Patients With Hepatocellular Carcinoma No drug interventions Not Available Not Available recruiting NCT05002452
Observational Study of Factors Predicting Therapeutic Effects and Clinical Prognosis After HAIC for Locally Advanced HCC No drug interventions Not Available Not Available recruiting NCT05003700
Hepatic Arterial Infusion Combined With Lenvatinib and Camrelizumab for Unresectable Hepatocellular Carcinoma treatment 2 recruiting NCT04996459
Tislelizumab in the Systematic Treatment of Advanced Hepatocellular Carcinoma Not Available Not Available active_not_recruiting NCT04994236
Hepatic Artery Infusion Chemotherapy for Unresectable Hepatocelluar Carcinoma Who Failed to Systemic Therapy treatment 2 recruiting NCT04981665
A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection treatment 2 recruiting NCT04974281
PD-1 Antibody and Lenvatinib Plus TACE on Downstaging BCLC B/C HCC treatment 0 recruiting NCT04961918
The Efficacy of Hepatic Arterial Infusion Chemotherapy (HAIC) Combine Lenvatinib and Durvalumab (HILL) in Advanced Hepatocellular Carcinoma (HCC) No drug interventions treatment 2 recruiting NCT04947371
Adjuvant Therapy With Anlotinib for HCC treatment 2 withdrawn NCT04954339
DYNAmic Immune Microenvironment of HCC Treated With atezolIzumab Plus bevaCizumab treatment 2 recruiting NCT04955119
Fusion Imaging Contrast-enhanced Ultrasound LI-RADS No drug interventions diagnostic Not Available not_yet_recruiting NCT04943679
Anti-PD-1/PD-L1 Antibodies Plus Pegylated Interferon Alfa-2b Treatment in Patients With Advanced-Stage HCC Not Available Not Available recruiting NCT04926532
Toripalimab Plus Sorafenib in Patients With Advanced-Stage Hepatocellular Carcinoma treatment 1 / 2 recruiting NCT04920214
Application Value of CEUS Li-RADS in Hepatic Focal Lesions in Patients With Non-high Risk Factors for HCC No drug interventions Not Available Not Available recruiting NCT04891874
Adjuvant Radiotherapy for Resected Hepatocellular Carcinoma With MVI No drug interventions treatment Not Available completed NCT04847726
Contrast-enhanced Ultrasound With Perfluorobutane and Sulfur Hexafluoride for Hepatocellular Carcinoma No drug interventions diagnostic Not Available completed NCT04820712
Surgical Therapy and Survival in HCC/ C.F. Zhang et al. No drug interventions Not Available Not Available completed NCT04826406
A Study of Camrelizumab Combined Apatinib in Hepatocellular Carcinoma Previously Treated With Immune Checkpoint Inhibitors (ICIs). treatment 2 recruiting NCT04813861
Sequential Treatment of Hepatocellular Carcinoma by Transarterial Chemoembolization and Local Ablation or External Radiation No drug interventions Not Available Not Available completed NCT04814043
PD-1 Antibody and Lenvatinib Plus TACE-HAIC for Potential Resectable HCC: a Single-arm, Phase 2 Clinical Trial treatment 2 recruiting NCT04792801
PET TDM FDG-Choline as a Decision-making Tool for Routine Care on the Liver Transplant List for HCC No drug interventions Not Available Not Available recruiting NCT04780802
Balloon Assisted Transarterial Therapy for Hepatocellular Carcinoma No drug interventions treatment Not Available completed NCT04777942
Neo-TACE-HAIC for High-risk BCLC A Stage HCC (NeoconceptA) No drug interventions treatment Not Available recruiting NCT04767906
Cabozantinib Treatment in a Phase II Study for Patients With Hepatocellular Carcinoma (HCC) Refractory to PD-1 Inhibitors treatment 2 recruiting NCT04771988
Radioembolization for Hepatocellular Carcinoma With Portal Vein Tumoral Thrombosis No drug interventions Not Available Not Available completed NCT04741165
Study of HX008 in Combination With Bevacizumab or Lenvatinib for the Treatment of Advanced Hepatocellular Carcinoma (HCC) treatment 2 recruiting NCT04738188
Efficacy and Safety of TACE on Downstaging Hepatocellular Carcinoma Beyond UCSF Criteria; treatment Not Available recruiting NCT04721470
Combined Therapy for Hepatocellular Carcinoma >3-<5 cm No drug interventions treatment Not Available completed NCT04720716
A Study to Compare the Effectiveness and Safety of IBI310 Combined With Sintilimab Versus Sorafenib in the First-line Treatment of Advanced HCC treatment 3 recruiting NCT04722120
Low Contrast Agent and Radiation Dose Protocol for Liver CT in Patients With HCC No drug interventions diagnostic Not Available completed NCT04724226
Cryoablation Combined With Camrelizumab and Apatinib in Advanced Hepatocellular Carcinoma treatment 2 recruiting NCT04687280
Comparison of Multiphase and Monophasic Arterial Hepatic MRI in the Detection of Arterial Enhancement of CHC Nodules No drug interventions Not Available Not Available completed NCT04687163
Sorafenib or Lenvatinib Plus HAIC of 130 mg/m² Oxaliplatin, and 5-fu vs Sorafenib or Lenvatinib Plus HAIC of 85mg/m² Oxaliplatin, and 5-fu for Unresectable Advanced HCC: a Randomised Phase 3 Trial treatment 3 unknown_status NCT04667351
HAIC of Oxaliplatin, and 2400 mg/m² 5-fu vs HAIC of Oxaliplatin, and 1200 mg/m² 5-fu for Unresectable HCC: a Randomised Phase 3 Non-inferiority Trial treatment 3 unknown_status NCT04665609
Thermal Ablation Combined With Anlotinib and TQB2450 Solution for HCC treatment 3 not_yet_recruiting NCT04652947
MR Quality + Diagnostic Performance for CHC Diagnosis - Gadoxetic Acid, Gadoteric Acid and P03277 Comparison No drug interventions Not Available Not Available completed NCT04653389
Perioperative Therapy for Hepatocellular Carcinoma treatment 2 terminated NCT04659005
Nurse-led Decision Counseling on Hepatocellular Carcinoma Screening No drug interventions screening Not Available completed NCT04652492
Tislelizumab in Combination With TACE in Advanced Hepatocellular Carcinoma treatment 2 recruiting NCT04640116
TIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites No drug interventions treatment Not Available not_yet_recruiting NCT04639284
Anti-angiogenic Agents Plus Anti-PD-1 Antibodies for uHCC No drug interventions Not Available Not Available recruiting NCT04597970
TACE Plus HAIC With Oxaliplatin and Raltitrexed for BCLC Stage C HCC treatment 2 unknown_status NCT04595864
Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma Beyond Milan/UCSF Criteria Who Underwent Liver Transplantation No drug interventions treatment 3 recruiting NCT04564313
Safety and Efficacy of Camrelizumab (Anti-PD-1 Antibody) in Recurrent HCC After Liver Transplantation treatment 1 recruiting NCT04552236
Evaluation of Liver Stiffness by Ultrasound Elastography for Predicting Early HCC Recurrence After Treatment No drug interventions Not Available Not Available unknown_status NCT04553458
Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular Carcinoma Not Available Not Available completed NCT04550663
NKG2D CAR-T(KD-025) in the Treatment of Relapsed or Refractory NKG2DL+ Tumors treatment 1 not_yet_recruiting NCT04531228
TACE-HAIC Plus Lenvatinib for Patients With Unresectable HCC: an Open-label, Single-arm, Phase 2 Trial No drug interventions treatment Not Available recruiting NCT04525833
Liver Disease and Other Systemic Diseases No drug interventions Not Available Not Available unknown_status NCT04520906
To Evaluate the Safety and Efficacy of Microwave Ablation Therapy in Patients With Primary Liver Cancer No drug interventions treatment Not Available recruiting NCT04518774
Allogeneic "Gammadelta T Cells (γδ T Cells)" Cell Immunotherapy in Phase 1 Hepatocellular Carcinoma Clinical Trial No drug interventions treatment 0 unknown_status NCT04526080
Intrabucally Administered Electromagnetic Fields Versus Placebo as Third-line Therapy For Patients With Advanced Hepatocellular Carcinoma No drug interventions treatment 2 withdrawn NCT04523467
Anti-angiogenic Targeted Drugs Plus Rg3 to Improve the Efficacy of TACE for Unresectable Hepatocellular Carcinoma treatment Not Available not_yet_recruiting NCT04510935
Effects of Anesthetic Methods on Hepatic Cancer Cell Function in Vitro No drug interventions treatment Not Available completed NCT04506983
GPC3-CAR-T Cells for the Hepatocellular Carcinoma No drug interventions treatment 1 suspended NCT04454762
A Study to Evaluate the Safety, Tolerability and Efficacy of Cabozantinib in Patients With Hepatocellular Carcinoma and Impaired Liver Function treatment 2 recruiting NCT04455932
HCC Surveillance: Comparison of Abbreviated Non-contrast MRI and Ultrasound Surveillance in Cirrhotic Patients With Suboptimal Ultrasound Visualisation No drug interventions screening Not Available recruiting NCT04443049
To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma. treatment Not Available recruiting NCT04420026
Study of Automatic Image Fusion of a CT Volume With Ultrasound During Percutaneous Ablation Treatment of Hepatic Tumors No drug interventions diagnostic Not Available completed NCT04414956
Combining Biomarkers (AFP, AFP-L3, and PIVKA-II) and Image Tools for Early Detection of Hepatocellular Carcinoma No drug interventions screening Not Available recruiting NCT04404647
Irreversible Electroporation of Unresectable Liver Tumors No drug interventions treatment Not Available withdrawn NCT04412161
Liver Transplant for Larger Hepatocellular Carcinoma in Malatya: The Role of GGT and AFP No drug interventions Not Available Not Available completed NCT04411706
A Study of Sintilimab Combined With Apatinib and Capecitabine in Advanced Hepatocellular Carcinoma treatment 2 unknown_status NCT04395118
STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention for Elevated LFTs No drug interventions screening Not Available withdrawn NCT04365751
To Compare the Efficacy of Microwave Ablation and Laparoscopic Hepatectomy for Hepatocellular Carcinoma No drug interventions other Not Available recruiting NCT04368182
AFP Specific T Cell Receptor Transduced T Cells Injection(C-TCR055) in Unresectable Hepatocellular Carcinoma No drug interventions treatment 1 unknown_status NCT04317248
"Cocktail" Therapy for Hepatitis B Related Hepatocellular Carcinoma treatment 2 unknown_status NCT04319484
Lenvatinib Following Liver Transplantation in Patients of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus treatment 2 / 3 not_yet_recruiting NCT04299919
The AI Prognostic Assessment and Pathological Basis Research of Early HCC After Minimally Invasive Treatment No drug interventions Not Available Not Available active_not_recruiting NCT04270461
NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors treatment 1 withdrawn NCT04268888
Nivolumab in Combination With TACE/TAE for Patients With Intermediate Stage HCC treatment 2 / 3 recruiting NCT04264754
Characterization of Methylation Patterns in Hepatocellular Carcinoma No drug interventions Not Available Not Available terminated NCT04239781
A Survey for Factors That Influence Postoperative Treatment Decision-making for Hepatocellular Carcinoma No drug interventions Not Available Not Available unknown_status NCT04231929
BioPearl™ Microspheres Loaded With Doxorubicin: Prospective, Single Arm, Multi-centre Post-market Follow-up Study. No drug interventions other Not Available withdrawn NCT04233840
P1101 and Anti-PD1 for After Curative Surgery of Hepatitis B-related Hepatocellular Carcinoma treatment 1 / 2 recruiting NCT04220151
Epigenetic Changes in Hepatocellular Carcinoma Developed After Direct Acting Antiviral Therapy for Chronic Hepatitis C No drug interventions Not Available Not Available unknown_status NCT04221347
Novel Molecular Spectrometric Biomarkers in Blood Plasma as an Early Diagnostic Tool in HCC No drug interventions Not Available Not Available recruiting NCT04229355
DEB-TACE Plus Lenvatinib or Sorafenib or PD-1 Inhibitor for Unresectable Hepatocellular Carcinoma treatment 3 recruiting NCT04193696
RT+ Anti-PD-1 for Patients With Advanced HCC (RT+PD-1-HCC) No drug interventions treatment 2 unknown_status NCT04189809
Discrepancies in Management of Hepatocellualr Carcinoma Between Practice and Recommendations No drug interventions Not Available Not Available unknown_status NCT04178642
The Impact on Hepatic Recurrence After Adjuvant Chemotherapy With Intraarterial Infusion of Idarubicin-Lipiodol treatment 2 withdrawn NCT04181931
Neo-TACE-HAIC for PVTT-HCC No drug interventions treatment Not Available recruiting NCT04190498
Sleep Apnoea Syndrome and Hepatocellular Carcinoma No drug interventions Not Available Not Available withdrawn NCT04169399
Toripalimab Plus Stereotactic Body Radiotherapy for HCC With PVTT treatment 2 unknown_status NCT04167293
Combination of Sintilimab and Stereotactic Body Radiotherapy in Hepatocellular Carcinoma (ISBRT01) treatment 2 / 3 recruiting NCT04170179
Systemic Chemotherapy Plus Lenvatinib and Toripalimab for HCC With Extrahepatic Metastasis treatment 2 recruiting NCT04174781
Anti-PD-1 Antibody Plus DEB-TACE for BCLC Stage A/B HCC treatment 2 active_not_recruiting NCT04168944
Lenvatinib Following Liver Transplantation in Patients With High-Risk Hepatocellular Carcinoma treatment 2 / 3 unknown_status NCT04161911
A Study to Assess Overall Survival and Treatment Patterns for Advanced Liver Cancer Participants Who Received Nivolumab Therapy No drug interventions Not Available Not Available completed NCT04152356
Combined Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma Not Available Not Available unknown_status NCT04162158
Safety and Efficacy of Allogeneic NK Cells Therapy in Patients With Advanced Hepatocellular Carcinoma treatment 1 / 2 recruiting NCT04160897
Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated Cirrhosis Not Available Not Available unknown_status NCT04157140
Anlotinib In Combination With RFA And TACE in Patients With Middle-advanced HCC treatment 2 recruiting NCT04121273
GPC3-targeted CAR-T Cell for Treating GPC3 Positive Advanced HCC No drug interventions treatment 1 recruiting NCT04104074
Safety and Efficacy of Radiotherapy Plus Sintilimab for HCC With Portal Vein Tumor Thrombosis treatment 1 unknown_status NCT04099277
A Study of LY3435151 in Participants With Solid Tumors treatment 1 terminated NCT04076631
Surgical Stages of Liver Cirrhosis In Patients With Hepatocellular Carcinoma No drug interventions Not Available Not Available unknown_status NCT04080154
Study of Anlotinib After Lenvatinib in Patients With Hepatocellular Carcinoma treatment 2 unknown_status NCT04060342
GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma treatment 1 terminated NCT04053985
The Efficacy of Transarterial Chemoinfusion (TAI) Combine Lenvatinib in Advanced Hepatocellular Carcinoma (HCC) treatment 3 recruiting NCT04044651
Lenvatinib Plus Nivolumab Versus Lenvatinib for Advanced Hepatocellular Carcinoma With Hepatitis B Virus Infection treatment 2 / 3 withdrawn NCT04042805
Sintilimab Combined With Lenvatinib in Local Advanced Hepatocellular Carcinoma treatment 2 recruiting NCT04032392
Immunotherapy of Advanced Hepatitis B Related Hepatocellular Carcinoma With γδT Cells No drug interventions treatment 1 unknown_status NCT04025437
Neoadjuvant Radiotherapy for HCC Involving Type I PVTT No drug interventions treatment 2 / 3 unknown_status NCT04015245
SNMC (Stronger Neo-Minophagen C ) for Acute Hepatitis Post Transarterial Chemoembolization Therapy No drug interventions treatment 4 completed NCT04014101
SHR-1210 Plus Apatinib in Patients With Advanced-Stage Hepatocellular Carcinoma treatment 2 unknown_status NCT04011033
Study of Adoptive Transfer of iNKT Cells Combined With TACE to Treat Advanced HCC treatment 2 / 3 unknown_status NCT04021056
Observational Study on Patients With Hepatocellular Carcinoma (HCC) No drug interventions Not Available Not Available recruiting NCT04012021
EXplanted LIver and Ex-vivo Pancreatic Specimen Evaluation by 7 TESLA MRI No drug interventions basic_science Not Available unknown_status NCT04006275
Comparing SonoVue With Sonazoid Using CEUS-LIRADS in HCC diagnostic 3 unknown_status NCT03998033
Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma No drug interventions treatment 1 terminated NCT03996681
TACE Combined With Methylcantharidimide Tablets in the Treatment of Large and Unresectable Hepatocellular Carcinoma treatment 4 unknown_status NCT03990974
Postoperative Antimicrobial Prophylaxis Versus Placebo for Infection Prevention in HCC After Liver Resection No drug interventions prevention 3 suspended NCT03988998
Radiofrequency Ablation Plus Radiotherapy for Small Hepatocellular Carcinoma No drug interventions treatment 3 not_yet_recruiting NCT03979547
EXALT: EXercise Attenuates Liver Tumors Trial No drug interventions treatment Not Available terminated NCT03971747
AFP Specific T Cell Receptor Transduced T Cells Injection(C-TCR055) in Unresectable Hepatocellular Carcinoma No drug interventions treatment 1 unknown_status NCT03974074
Albumin for Hepatocellular Carcinoma treatment 3 unknown_status NCT03982407
68 Ga PSMA PET/MRI for Hepatocellular Carcinoma diagnostic 0 completed NCT03981848
Radiomics-based Non-invasive Classifier Research for HCC-related Liver Transplantation No drug interventions Not Available Not Available unknown_status NCT03966209
Safety and Efficacy of PD-1 Inhibitors in Patients With Liver Transplant treatment 1 unknown_status NCT03963206
Cabozantinib toLERANCE Study in HepatoCellular Carcinoma (CLERANCE) treatment 4 completed NCT03965546
ET 140202 -T Cell Combined With TAE or Sorafenib in the Treatment of Liver Cancer treatment 0 unknown_status NCT03950102
SBRT as Bridging Therapy for Hepatocellular Carcinoma Patients on Transplant Waitlist No drug interventions treatment Not Available unknown_status NCT03945799
A Multicenter Study of Anlotinib in Hepatocellular Carcinoma (HCC) Patients at High Risk of Post Surgery Recurrence prevention 1 / 2 terminated NCT03919383
Phase II of Lenvatinib Plus Toripalimab for Advanced HCC treatment 2 withdrawn NCT03914352
A Novel Immunotherapy PD-1 Antiboty to Suppress Recurrence of HCC Combined With PVTT After Hepatic Resection prevention Not Available unknown_status NCT03908255
Branched-chain Amino Acid Supplementation for Hepatocellular Carcinoma supportive_care 2 withdrawn NCT03908840
Open-label Multicenter Phase 1 Study of TBI 302 as Second-Line Therapy in Patients With Hepatocellular Carcinoma No drug interventions treatment 1 unknown_status NCT03898921
RFA vs. SBRT for Small HCC No drug interventions treatment 3 unknown_status NCT03896958
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) No drug interventions Not Available Not Available recruiting NCT03899415
TCR-Redirected T Cells Therapy in Patient With HBV Related HCC No drug interventions treatment 1 recruiting NCT03889093
Radioembolization of Primary and Secondary Liver Malignancies and The Effect On The Immune System No drug interventions other Not Available recruiting NCT03884751
Chimeric Antigen Receptor T Cells Targeting Glypican-3 No drug interventions treatment 1 completed NCT03888859
ET1402L1-ARTEMIS™2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular Carcinoma No drug interventions treatment 0 completed NCT03880721
By Developing a Radiomics Model to Predict the Prognosis of Patients With Hepatocellular Carcinoma After Microwave Ablation No drug interventions Not Available Not Available unknown_status NCT03869151
Pretreatment Lymphocyte Monocyte Ratio on Outcome HCC Patients No drug interventions Not Available Not Available unknown_status NCT03857815
Stereotactic Body Radiation Therapy Combined With Anti-PD-1 Antibody in Patients With Hepatocellular Carcinoma No drug interventions treatment 2 unknown_status NCT03853928
Probiotics in the Prevention of Hepatocellular Carcinoma in Cirrhosis No drug interventions treatment Not Available not_yet_recruiting NCT03851887
The Efficacy of Transarterial Chemoinfusion (TAI) Combine Stereotactic Body Radiation Therapy (SBRT) in Unresectable Hepatocellular Carcinoma (HCC) No drug interventions treatment 2 unknown_status NCT03851913
The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Beyond Milan Criteria BCLC Stage A/B Hepatocellular Carcinoma Who Underwent Hepatectomy No drug interventions treatment 3 recruiting NCT03851471
Jiu-wei-zhen-xiao Granule for Advanced Hepatocellular Carcinoma No drug interventions treatment 0 completed NCT03838796
Lenvatinib Combined With TACE to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma treatment Not Available active_not_recruiting NCT03836352
Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors treatment 2 active_not_recruiting NCT03812783
HAIC of FOLFOX Plus Sorafenib vs HAIC of FOLFIRINOX Plus Sorafenib for Advcanced HCC treatment 2 unknown_status NCT03804593
HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC) No drug interventions Not Available Not Available completed NCT03803254
HAIC Plus Lenvatinib and PD-1 Antibody Versus HAIC Plus Lenvatinib for Advanced HCC treatment 2 withdrawn NCT03807947
Radial Versus Femoral Access for Superselective Embolization of Hepatocellular Carcinoma No drug interventions treatment Not Available unknown_status NCT03812770
Phase 2 Study of Sorafenib Plus HAIC of FOLFOX vs. Sorafenib Plus HAIC of OXA for Advanced HCC treatment 2 unknown_status NCT03806218
Bipolar RFA Using Twin ICW Electrodes vs. Switching Monopolar RFA for Recurrent HCC No drug interventions treatment Not Available completed NCT03791918
Lenvatinib Plus PD-1 Antibody vs TACE for Intermediate-stage HCC Beyond Up-to-seven Criteria treatment 3 withdrawn NCT03790059
Radiofrequency Ablation Combined With Recombinant Human Adenovirus Type 5 in the Treatment of Hepatocellular Carcinoma. No drug interventions treatment Not Available unknown_status NCT03793725
A Trial of SHR-1210 in Combination With Apatinib in Patients With Unresectable HCC treatment 2 unknown_status NCT03775707
Lenvatinib Plus PD-1 Antibody for Intermediate-stage HCC Beyond Up-to-seven Criteria treatment 2 withdrawn NCT03780049
HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-B No drug interventions treatment 3 recruiting NCT03775395
HAIC Plus Lenvatinib vs HAIC Plus Sorafenib for Advanced HCC treatment 3 unknown_status NCT03781960
Abemaciclib and Nivolumab for Subjects With Hepatocellular Carcinoma treatment 2 terminated NCT03780634
HAIC Plus PD-1 Antibody vs HAIC Plus Sorafenib for Advanced HCC treatment 2 withdrawn NCT03777475
the Effect of Different Oxaliplatin Dose in Transarterial Infusion (TAI) in Unresectable Hepatocellular Carcinoma No drug interventions treatment Not Available recruiting NCT03767764
Yliver as a Test to Early Diagnose HCC No drug interventions Not Available Not Available completed NCT03754192
Perfusion and Dual Energy Computer Tomography in Hepatocellular Carcinoma No drug interventions diagnostic Not Available unknown_status NCT03748927
Natural History Study of Children and Adults With Fibrolamellar Hepatocellular Carcinoma No drug interventions Not Available Not Available withdrawn NCT03738111
Study of TG02 Citrate in Patients With Advanced Hepatocellular Carcinoma treatment 1 withdrawn NCT03742453
Evaluation of Diagnostic Accuracy of CEUS for HCC Diagnosis No drug interventions diagnostic Not Available active_not_recruiting NCT03744247
Lenvatinib Plus PD-1 Antibody Versus Lenvtinib Alone for Advanced HCC treatment 3 withdrawn NCT03746249
Phase II of Lenvatinib Plus PD-1 Antibody for Advanced HCC treatment 2 withdrawn NCT03744624
Application of 3D Printing in Laparoscopic Surgery of Liver Tumors No drug interventions treatment Not Available active_not_recruiting NCT03730675
Irradiation Stent Placement Plus TACE for HCC and PVTT treatment Not Available unknown_status NCT03722628
The Assesment of MMP-1 Genotypes Polymorphism as a Risk Factor for HCC in Chronic HCV Patients With LC No drug interventions Not Available Not Available unknown_status NCT03722875
SHR-1210 Plus Apatinib in Patients With Hepatocellular Carcinoma After Surgery treatment Not Available unknown_status NCT03734926
A Phase 1 Study of ZSP1241 in Participants With Advanced Solid Tumors No drug interventions treatment 1 unknown_status NCT03707080
Direct Acting Antiviral-Post Authorization Safety Study No drug interventions Not Available Not Available completed NCT03699657
Dual and Single Switching Monopolar RFA Using Separable Clustered Electrode for Treatment of HCC No drug interventions treatment Not Available completed NCT03706742
STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention No drug interventions screening Not Available completed NCT03708705
Liquid Biopsy-based Monitoring System for Relapse of HCC After Liver Transplantation: A Multi-center and Prospective Study No drug interventions Not Available Not Available unknown_status NCT03695952
A Prospective Cohort Study of Patients With Hepatobiliary Cancer Treated With Immune Checkpoint Inhibitors Not Available Not Available recruiting NCT03686709
Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment No drug interventions health_services_research Not Available recruiting NCT03674073
A Study Combining Personalized Neoantigen-based Dendritic Cell Vaccine With Microwave Ablation for the Treatment of Hepatocellular Carcinoma No drug interventions treatment 1 unknown_status NCT03682276
Safety and Bioactivity of Ipilimumab and Nivolumab Combination Prior to Liver Resection in Hepatocellular Carcinoma treatment 1 / 2 recruiting NCT03668158
Multi-center Study on Therapy-oriented Molecular Subtyping of Hepatocellular Carcinoma No drug interventions Not Available Not Available unknown_status NCT03644511
Use of Sorafenib and/or Regorafenib in Liver Cancer (Hepatocellular Carcinoma) Subsequent to Another Systemic First-line Treatment Not Available Not Available terminated NCT03652077
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies treatment 1 completed NCT03645980
DKN-01 Inhibition in Advanced Liver Cancer treatment 1 / 2 unknown_status NCT03655613
APL-501 or Nivolumab in Combination With APL-101 in Locally Advanced or Metastatic HCC and RCC treatment 1 / 2 terminated NCT03642561
Evaluation the Treatment Outcome for RFA in Patients With BCLC Stage B HCC in Comparison With TACE No drug interventions treatment 2 / 3 unknown_status NCT03636620
TACE Combined With RFA/MV Treatment in Hepatocellular Carcinoma Beyond Milan Criterial No drug interventions treatment 3 completed NCT03630068
Computer-assisted Tumor Ablation for Patients With Liver Cancer No drug interventions Not Available Not Available completed NCT03628651
Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma No drug interventions Not Available Not Available completed NCT03608878
Adagloxad Simolenin/OBI-821 in Combination With TACE Therapy in HCC Patients With GALNT14-rs9679162-non-TT Genotype treatment 2 terminated NCT03609151
Stereotactic Body Radiotherapy and Surgery for Early-stage Hepatocellular Carcinoma No drug interventions treatment Not Available unknown_status NCT03606590
Effect of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Sorafenib For Advanced Hepatocellular Carcinoma (HCC) (HEPANOVA) treatment 2 unknown_status NCT03594188
Effects of Anesthetic Methods on Hepatic Cancer Cell Malignancy No drug interventions treatment Not Available completed NCT03592706
Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy No drug interventions treatment 2 / 3 unknown_status NCT03591705
TACE-HAIC vs. HAIC for Potentially Resectable HCC No drug interventions treatment Not Available recruiting NCT03575806
Combine TACE and Autologous Tcm Immunotherapy Versus TACE Alone for HCC With MVI After Radical Resection No drug interventions treatment 2 completed NCT03578874
SECOX as Neoadjuvant Therapy in Patients With Locally Advanced HCC treatment 2 completed NCT03551444
Recurrence Rate of Hepatocellular Carcinoma After Treatment of Chronic Hepatits C Patients With Direct Acting Antivirals: Randomized Controlled Phase 3 Trial No drug interventions treatment 3 unknown_status NCT03538028
A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies treatment 1 completed NCT03534843
A Comparison Between Child-Pugh and Albumin-Bilirubin Scores No drug interventions Not Available Not Available completed NCT03517332
Circulating Tumor DNA Exposure in Peripheral Blood No drug interventions Not Available Not Available unknown_status NCT03517488
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors treatment 1 completed NCT03520257
The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus treatment 2 unknown_status NCT03507998
Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors treatment 1 unknown_status NCT03493763
Study on Recurrence Monitoring of Hepatocellular Carcinoma With 5-Hydroxymethylcytosine Test No drug interventions Not Available Not Available unknown_status NCT03490461
Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver Transplantation No drug interventions Not Available Not Available completed NCT03483922
HCC Screening Using DNA Methylation Changes in ctDNA No drug interventions Not Available Not Available completed NCT03476421
R1vascular Hepatectomy for HCC Patients No drug interventions Not Available Not Available completed NCT03482102
Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer treatment 2 recruiting NCT03468231
HAIC of FOLFOX vs. HAIC of OXA for Advanced HCC treatment 3 unknown_status NCT03460080
Diagnostic Value of AFP-L3 and PIVKA-II in HCC No drug interventions Not Available Not Available unknown_status NCT03430635
Role of Choline PET/CT in Predicting Survival in Patients With Hepatocellular Carcinoma No drug interventions Not Available Not Available completed NCT03405909
Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study No drug interventions Not Available Not Available completed NCT03402607
Trial Comparing PLA to HIGRT (PROVE-HCC) No drug interventions other Not Available terminated NCT03382886
Nivolumab and Bevacizumab in Patients With Advanced and or Metastatic Hepatocellular Carcinoma treatment 1 terminated NCT03380130
A Study of the Safety and Antitumoral Efficacy of Nivolumab After SIRT for the Treatment of Patients With HCC treatment 2 completed NCT03368651
The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) Who Underwent Hepatectomy : A Random, Controlled, Stage III Clinical Trial. No drug interventions treatment 3 recruiting NCT03356535
Metabolic Signature of Healthy Lifestyle and HCC No drug interventions Not Available Not Available completed NCT03342677
Evaluation of Gd-EOB-DTPA MRI for Detection and Characterization of Liver Nodules in Cirrhotic Patients Undergoing Liver Transplantation and Potential Impact on Transplant Eligibility No drug interventions diagnostic Not Available recruiting NCT03337841
Pembrolizumab as Neoadjuvant Treatment in HCC prevention 2 unknown_status NCT03338166
Role of LDH as a Predictor of Treatment Outcomes in Hepatocellular Carcinoma No drug interventions Not Available Not Available unknown_status NCT03338647
SBRT or TACE for Advanced HCC treatment 3 recruiting NCT03326375
Comparison of SBRTand Repeat TACE for HCC No drug interventions treatment Not Available unknown_status NCT03319459
FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors treatment 1 completed NCT03322280
TACE Combined With Iodine-125 Seeds Implantation for HCC No drug interventions treatment Not Available active_not_recruiting NCT03313596
Multicenter RCT of ADV-TK Gene Therapy Improving the Outcome of Liver Transplantation for Advanced HCC treatment 3 unknown_status NCT03311152
Circulating Cell-free DNA-based Epigenetic Biomarker mSEPT9 for Hepatocellular Carcinoma Detection in Cirrhosis No drug interventions diagnostic Not Available recruiting NCT03300401
Contrast-Enhanced Ultrasound in Diagnosing Patients With Liver Cancer Undergoing Yttrium-90 Radioembolization diagnostic Not Available withdrawn NCT03292991
REgistry of Selective Internal Radiation Therapy in TaiwaN (RESIN) No drug interventions Not Available Not Available unknown_status NCT03300414
Biologic Basis of Liver Cancer From Chronic Hepatitis B No drug interventions Not Available Not Available completed NCT03303469
Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: Fluorine18 (18F) Fluoromisonidazole (FMISO) Imaging No drug interventions diagnostic 2 terminated NCT03295006
A TheraSphere® Advanced Dosimetry Retrospective Global Study in HCC No drug interventions Not Available Not Available completed NCT03285867
Liver Stiffness Measurement (LSM) in Predicting Progress of Liver Fibrosis After TACE for Hepatocellular Carcinoma No drug interventions Not Available Not Available unknown_status NCT03267641
Prospective Cohort Study on the Clinical Trajectory of Resected Hepatocellular Carcinoma No drug interventions Not Available Not Available completed NCT03273608
Observation Study: Superselective Drug-Eluting Chemoembolization in Unresectable Intermediate and Advanced HCC Patients No drug interventions Not Available Not Available unknown_status NCT03254121
Genome Studies of Hepatocellular Carcinoma Developed in Hepatitis C Patients With Sustained Virological Response No drug interventions Not Available Not Available completed NCT03243916
Targeted and Staged Cyber Knife Combined With Interventional Therapy in the Treatment of MHCC No drug interventions treatment Not Available unknown_status NCT03245190
Study of Chiauranib in Patients With Advanced Hepatocellular Carcinoma treatment 1 / 2 completed NCT03232593
A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s) Not Available Not Available completed NCT03227510
MicroRNAs as Diagnostic Biomarkers in Hepatocellular Carcinoma Among Somali Patients No drug interventions Not Available Not Available unknown_status NCT03219372
Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence prevention 2 terminated NCT03203005
IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma Patients treatment 1 / 2 completed NCT03208335
Recombinant Human Endostatin(Rh-endostatin) Combine With Radiotherapy in the Treatment of Hepatocellular Carcinoma(HCC) treatment 2 unknown_status NCT03211598
Surefire Institutional DEB-TACE No drug interventions other Not Available unknown_status NCT03203837
Biomarker Analyses in Hepatocellular Carcinoma (HCC) Patients Treated With TheraSphere® No drug interventions Not Available Not Available terminated NCT03197155
Direct-acting Antivirals and Hepatocellular Carcinoma Recurrence No drug interventions Not Available Not Available completed NCT03192618
The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial. treatment 3 recruiting NCT03198975
Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma No drug interventions Not Available Not Available unknown_status NCT03192644
The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial. treatment 3 recruiting NCT03175705
Adoptive Transfer of Specific HCC Antigens CD8+ T Cells for Treating Patients With Relapsed/Advanced HCC treatment 1 unknown_status NCT03176485
Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors No drug interventions prevention Not Available completed NCT03172559
Radiotherapy Versus no Intervention in Adult Patients With Hepatocellular Carcinoma Not Eligible for Transarterial Chemoembolization or Ablation Prior to Liver Transplant (RADBRI) No drug interventions treatment Not Available withdrawn NCT03162198
Frequency of Circulating Tumor Cells (CTCs) and Amount of Cell-free DNA (cfDNA) in Cirrhotic Patients With Hepatocellular Carcinoma (HCC) No drug interventions Not Available Not Available completed NCT03139487
A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism treatment 2 unknown_status NCT03140332
Contribution of the Perfusion Scanner in the Prediction of the Tumor Control of Patients With Hepatocellular Carcinoma Treated With Sorafenib. No drug interventions other Not Available completed NCT03146234
CAR-GPC3 T Cells in Patients With Refractory Hepatocellular Carcinoma No drug interventions treatment Not Available completed NCT03124498
A Study to Evaluate Autologous CIK Cells in Patients With Hepatocellular Carcinoma After TACE, PEIT or RFA No drug interventions treatment 1 / 2 unknown_status NCT03129685
Ipsilateral Liver Lobe Devascularization of the Large Hepatocellular Carcinoma No drug interventions treatment Not Available unknown_status NCT03109886
Study of Milciclib in Patients With Unresectable/Metastatic Hepatocellular Carcinoma treatment 2 completed NCT03116945
Novel Gallium Imaging in Hepatocellular Carcinoma diagnostic 2 unknown_status NCT03114085
Apatinib Combined With Capecitabine Compared With Apatinib Treat Advanced Hepatocellular Carcinoma treatment 2 unknown_status NCT03084380
Anti-GPC3 CAR-T for Treating GPC3-positive Advanced Hepatocellular Carcinoma (HCC) treatment 1 / 2 unknown_status NCT03093688
Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor No drug interventions treatment 1 / 2 active_not_recruiting NCT03082378
Central Obesity and Hepatocellular Carcinoma No drug interventions Not Available Not Available unknown_status NCT03079778
Transarterial Chemoembolization (TACE) With or Without Stereotactic Body Radiotherapy (SBRT) in Hepatocellular Carinoma No drug interventions treatment Not Available withdrawn NCT03081637
FLNA in HCC Patients No drug interventions Not Available Not Available completed NCT03071458
Mutational Landscape in Hepatocellular Carcinoma No drug interventions Not Available Not Available completed NCT03069508
Clemizole HCl for Subjects With Hepatocellular Carcinoma treatment 2 unknown_status NCT03045497
Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Liver Cancer Receiving Transarterial Chemoembolization With Drug Eluting Beads diagnostic 1 completed NCT03053596
LifePearl Anthracyclin Registry in Selective Chemo-Embolization of Patients With Unresectable HCC (PARIS Registry) No drug interventions Not Available Not Available completed NCT03035006
Lipotecan Based Concurrent Chemoradiotherapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis treatment 1 / 2 terminated NCT03040453
Immunological Response After Ablative Therapy in the Liver No drug interventions basic_science Not Available withdrawn NCT03042520
Long-term Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based Treatment No drug interventions Not Available Not Available recruiting NCT03024684
Statin for Preventing Hepatocellular Carcinoma Recurrence After Curative Treatment prevention 4 recruiting NCT03009461
Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC With Major Portal Vein Tumor Thrombosis treatment 2 completed NCT02997956
Study of Tocilizumab in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transarterial Chemoembolization (TACE) treatment 1 / 2 withdrawn NCT02989870
Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma treatment 1 withdrawn NCT02981498
Phase II Trial of Sorafenib Combined With Concurrent HAIC for Hepatocellular Carcinoma treatment 2 completed NCT02987907
The Impact on Therapeutic Effect and Tolerance of Treatment for Patients With Hepatocellular Carcinoma in Transcatheter Arterial Chemoembolization (TACE) of Dexamethasone Application: A Random, Double-blind, Controlled, Clinical Trial. treatment 3 unknown_status NCT02987699
Phase II Study of HAIC Using Cisplatin,Leucovorin and 5-Fluorouracil treatment 2 unknown_status NCT02971345
Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus treatment 3 unknown_status NCT02973516
Proof of Concept Study Concerning Efficacy of P03277 MR Imaging in HCC Diagnosis diagnostic 2 completed NCT02960620
Therasphere for Unresectable Primary or Secondary Liver Neoplasia No drug interventions Not Available Not Available no_longer_available NCT02960594
hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse prevention 1 completed NCT02959359
DAA in the Risk of Recurrence After Curative Treatment of HCC prevention 4 withdrawn NCT02961998
Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail treatment 4 completed NCT02942329
Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer treatment 1 / 2 unknown_status NCT02936856
Hepatic Arteriography in Liver Cancer Diagnosis and Staging Applications No drug interventions diagnostic Not Available unknown_status NCT02908165
Randomized Phase II Trial of Chemoembolization and Sorafenib treatment 2 withdrawn NCT02886897
A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors No drug interventions treatment 1 / 2 unknown_status NCT02882659
Dendritic Killer Cell-based Immunotherapy for Solid Tumors No drug interventions treatment 1 unknown_status NCT02868255
Myeloid Derived Suppressor Cells Control by Signal Regulatory Protein-alpha: Investigation in Hepatocellular Carcinoma No drug interventions Not Available Not Available completed NCT02854241
Comparison of Biannual Ultrasonography and Annual Unenhanced Magnetic Resonance Imaging for HCC Surveillance No drug interventions screening Not Available active_not_recruiting NCT02854839
A Study of MG4101 (Allogeneic Natural Killer Cell) for Intermediate-stage of Hepatocellular Carcinoma treatment 2 completed NCT02839954
CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor treatment 1 / 2 unknown_status NCT02833298
Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening No drug interventions prevention Not Available completed NCT02830737
No-touch RFA Versus Traditional RFA for Small Hepatocellular Carcinoma No drug interventions treatment Not Available unknown_status NCT02828124
A Study of the Safety and Tolerability of BMS-986183 in Patients With Liver Cancer treatment 1 / 2 terminated NCT02828865
A Clinical Trial Using Irreversible Electroporation for the Treatment of Liver Cancers No drug interventions treatment Not Available completed NCT02819869
The Combination Effect of Statin Plus Metformin on Relapse-free treatment 2 terminated NCT02821533
Chemoembolization for Hepatocellular Carcinoma treatment 2 terminated NCT02809287
A Novel Laparoscopic Hepatectomy Posture, Left Lateral Position Plus Jackknife Position No drug interventions Not Available Not Available completed NCT02809534
A Study of Anlotinib in Patients With Hepatocellular Carcinoma treatment 2 unknown_status NCT02785380
Laparoscopic Surgery VS RFA for Recurrent HCC No drug interventions treatment 4 not_yet_recruiting NCT02785835
Hepatocellular Carcinoma in HIV-infected Patients No drug interventions Not Available Not Available completed NCT02786342
Italian Study Of Validation Of Angiogenesis Polymorphisms In HCC Patients Treated With Sorafenib No drug interventions Not Available Not Available active_not_recruiting NCT02783261
Prospective Post Y90 Liver Hypertrophy No drug interventions Not Available Not Available unknown_status NCT02771405
Impact of Interferon Free Regimens in Patients With Chronic HCV and Successfully Treated HCC treatment 3 unknown_status NCT02772029
A Study of Apatinib for Advanced Hepatocellular Carcinoma Patients After First-line Treatment Failure treatment 1 / 2 unknown_status NCT02774187
Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC treatment 3 completed NCT02767375
Hepatic Arterial Infusion Chemotherapy(HAIC) for Hepatoma After Resection prevention 2 / 3 unknown_status NCT02745483
Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies: Follow-up Study No drug interventions treatment 2 completed NCT02748161
DEB-TACE for Hepatocellular Carcinoma No drug interventions treatment Not Available terminated NCT02745600
Clinical Intervention Modelling, Planning and Proof for Ablation Cancer Treatment No drug interventions diagnostic Not Available unknown_status NCT02748304
Sorafenib Combined With Aspirin to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma treatment Not Available terminated NCT02755311
Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma treatment 3 unknown_status NCT02743065
HepaSphere Chemoembolization in Advanced HCC Patients: Safety & Efficacy Registry in China No drug interventions Not Available Not Available unknown_status NCT02733809
Mechanism of Sorafenib Resistance in Patients With Advanced Hepatocellular Carcinoma basic_science 4 recruiting NCT02724358
Rg3 in Combination With TACE in Hepatocellular Carcinoma Patients With High Expression of Notch1 No drug interventions treatment Not Available completed NCT02727309
A Study of Second-line Treatment With Apatinib After TACE in Advanced Hepatocellular Carcinoma Patients treatment 1 / 2 unknown_status NCT02724345
Postoperative Adjuvant TACE Treatment in CK18 Positive Patients No drug interventions Not Available Not Available completed NCT02728193
Standard Treatments of Very-early Stage Hepatocellular Carcinoma No drug interventions treatment Not Available completed NCT02725996
By Using Adoptive Transfer of Autologous NK Cells to Prevent Recurrence of Hepatocellular Carcinoma After Curative Therapy treatment 2 unknown_status NCT02730611
Metabolic Syndrome, Bile Acids, Hepatocellular Carcinoma and Cholangiocarcinoma No drug interventions Not Available Not Available completed NCT02729506
Transarterial Radioembolization Versus Chemoembolization for the Treatment of Hepatocellular Carcinoma No drug interventions treatment 4 unknown_status NCT02724436
Radioembolization With Yittrium-90 for Intermediate and Advanced Hepatocellular Carcinoma No drug interventions treatment Not Available completed NCT02724475
Laser Ablation for Intermediate and Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus No drug interventions treatment Not Available completed NCT02724332
Adjuvant Anti-Recurrence Treatment With Rapamycin on Early-stage HCC treatment 1 completed NCT02709070
Resection+Highly Purified CTL Versus Resection Alone for HCC No drug interventions treatment 3 unknown_status NCT02718235
Prospective, Multicenter HCCIS Evaluation Study No drug interventions Not Available Not Available unknown_status NCT02705118
Evaluation of Performance of Automatic Fusion for Radiofrequency Ablation of Hepatocellular Carcinoma No drug interventions treatment Not Available completed NCT02693847
Natural History of Liver Cirrhosis Diagnosed by Transient Elastography in HIV/HCV-coinfected Patients No drug interventions Not Available Not Available completed NCT02702401
Study of Pembrolizumab (MK-3475) vs. Best Supportive Care in Participants With Previously Systemically Treated Advanced Hepatocellular Carcinoma (MK-3475-240/KEYNOTE-240) treatment 3 completed NCT02702960
Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC) treatment 2 withdrawn NCT02678013
RFA+Highly-purified CTL vs. RFA Alone for Recurrent HCC No drug interventions treatment 3 unknown_status NCT02672488
Metformin Plus Sorafenib for Advanced HCC treatment 2 unknown_status NCT02678806
Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) and / or Microvascular Invasion No drug interventions treatment Not Available unknown_status NCT02658019
Pembrolizumab (Keytruda) in Advanced Hepatocellular Carcinoma treatment 2 completed NCT02642913
Study of Enzalutamide With and Without Sorafenib in Advanced Hepatocellular Carcinoma Patients treatment 1 completed NCT02649712
Unilateral Stenting Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction No drug interventions treatment Not Available completed NCT02616926
Hepatic Resection Versus TACE+RFA for BCLC Stage B Hepatocellular Carcinoma No drug interventions treatment Not Available unknown_status NCT02599909
Gut Microbiota in People With Hepatocellular Carcinoma (HCC) No drug interventions Not Available Not Available withdrawn NCT02575339
MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma treatment 1 / 2 terminated NCT02584556
Adjuvant Transcatheter Arterial Chemoembolization Versus Adjuvant Systemic Chemotherapy for Hepatocellular Carcinoma No drug interventions prevention 2 / 3 withdrawn NCT02586285
Effect of S-Adenosyl Methionine Treatment on Recurrence After Curative Resection of Hepatocellular Carcinoma treatment 1 unknown_status NCT02580253
Adjuvant Chemotherapy Based on the Adenosine Triphosphate Tumor Chemosensitivity Assay for Hepatocellular Carcinoma After Liver Transplantation No drug interventions treatment 2 withdrawn NCT02587793
Primary Culture of Residual Specimens Obtained From Aspiration of Hepatic Tumor to Predict the Prognosis of the Patients No drug interventions Not Available Not Available completed NCT02585687
Liver Perfusion MRI With Quantification of Tumoral Perfusion for Early Assessment of the Response of Antiangiogenics Treatments in Hepatocellular Carcinoma No drug interventions screening Not Available terminated NCT02585479
Systemic Chemotherapy Versus Transcatheter Arterial Chemoembolization(TACE) for Hepatocellular Carcinoma treatment 2 / 3 withdrawn NCT02572687
A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignancies treatment 1 completed NCT02562963
Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor No drug interventions treatment 1 / 2 recruiting NCT02560779
Trial of TRC105 and Sorafenib in Patients With HCC treatment 1 / 2 completed NCT02558205
Correlation Between CT Perfusion and Post Y-90 TARE PET/CT Dosimetry No drug interventions Not Available Not Available withdrawn NCT02552745
Preventive Effects of Parecoxib on Postoperative Complications in Hepatocellular Carcinoma Patients Undergoing Hepatic Transcatheter Arterial Chemoembolization Not Available Not Available completed NCT02550613
Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular Carcinoma No drug interventions Not Available Not Available unknown_status NCT02537158
Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection treatment Not Available unknown_status NCT02525965
The Influence of Resection Margin on the Recurrence of Early-stage Hepatocellular Carcinoma No drug interventions treatment Not Available unknown_status NCT02535117
Laparoscopic Surgery Versus Radiofrequency Ablation for Recurrent HCC No drug interventions treatment 4 unknown_status NCT02523053
Effect of Intraoperative Controlled Release 5-Fluorouracil Therapy on Recurrence in Hepatocellular Carcinoma Patients treatment Not Available unknown_status NCT02525380
Safety and Efficacy of Doxorubicin-eluting-bead Embolization in Patients With Advanced Hepatocellular Carcinoma No drug interventions treatment 4 unknown_status NCT02534337
Gemcitabine Plus Oxaliplatin Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma treatment 2 / 3 withdrawn NCT02525952
Treatment for Patients With Multiple Hepatocellular Carcinomas Based on the NDR Scoring System No drug interventions treatment Not Available unknown_status NCT02529761
TACE With or Without Sorafenib in Intermediate Stage Hepatocellular Carcinoma treatment Not Available unknown_status NCT02534961
Prophylactic Antibiotics Before RFA for HCC prevention 4 unknown_status NCT02524119
LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma treatment 2 terminated NCT02504983
Clinical Trial for GALNT14 Genotype - Guided, Sorafenib in Combination With TACE in Hepatocellular Carcinoma treatment 4 unknown_status NCT02487017
DC-CIK Combined With TACE in the Treatment of Hepatocellular Carcinoma No drug interventions treatment 2 unknown_status NCT02472249
Pharmacological Manipulation of Intrahepatic Arterial Blood Flow in HCC diagnostic 4 completed NCT02471313
Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization No drug interventions diagnostic 2 completed NCT02452853
HR Combined With FOLFOX4 for HCC With PVTT No drug interventions treatment 2 unknown_status NCT02436902
Adjuvant Therapies for Patients With HCC and MVI treatment 3 unknown_status NCT02436044
HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC Not Available Not Available approved_for_marketing NCT02435953
TACE+RFA Versus TACE Alone for Intermediate-stage Hepatocellular Carcinoma No drug interventions treatment 4 recruiting NCT02420678
Quality of Life in Patients With Hepatocellular Carcinoma No drug interventions Not Available Not Available unknown_status NCT02425605
Efficacy of Localized Concurrent Chemo-radiation Therapy and Sorafenib Sequential Therapy in Advanced Hepatocellular Carcinoma treatment 2 completed NCT02415036
Melphalan for Use With the Hepatic Delivery System Treatment in Patients With Unresectable Hepatocellular Carcinoma or Intra Hepatic Cholangiocarcinoma treatment 2 terminated NCT02399735
Safety Study of NK Cells From Sibship to Treat the Recurrence of HCC After Liver Transplantation treatment 1 unknown_status NCT02395523
Hypofractionated Proton Beam Radiotherapy for Inoperable Hepatocellular Carcinoma No drug interventions treatment Not Available completed NCT02400788
Resminostat (YHI-1001) in Combination With Sorafenib in Asian Patients With Advanced Hepatocellular Carcinoma (HCC) treatment 1 / 2 completed NCT02399033
Xihuang Capsules Prevention of Recurrence in Patients With Hepatocellular Carcinoma After Hepatectomy No drug interventions supportive_care 4 unknown_status NCT02358395
A Study of BBI608 Administrated With Sorafenib in Adult Patients With Advanced Hepatocellular Carcinoma treatment 1 completed NCT02358070
Epidemiologic Study of Hepatocellular Carcinoma in the US No drug interventions Not Available Not Available completed NCT02354898
A Study of BBI503 in Advanced Solid Tumors, or BBI503/ Sorafenib in Advanced Hepatocellular Carcinoma treatment 1 completed NCT02323360
A Trial on SBRT After Incomplete TAE or TACE Versus Exclusive TAE or TACE For Treatment of Inoperable HCC No drug interventions treatment Not Available terminated NCT02319200
Primary Prevention Hepatocellular Carcinoma by Metformin prevention 3 terminated NCT02314052
Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular Carcinoma No drug interventions treatment 1 / 2 terminated NCT02311205
Efficacy and Safety of Concurrent TACE and Sorafenib in Patients With HCC and Extrahepatic Metastasis (COTSOM Study) treatment 2 unknown_status NCT02309788
Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) or Portal Vein Thrombosis No drug interventions Not Available Not Available unknown_status NCT02304289
Dose-Escalation Study Evaluating the Safety and Pharmacokinetics of Artesunate in Patients With Hepatocellular Carcinoma treatment 1 terminated NCT02289300
A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer Patients No drug interventions treatment 2 withdrawn NCT02299843
RALPPS Venus ALPPS for Hepatocellular Carcinoma No drug interventions treatment Not Available unknown_status NCT02288910
Blood Volume Assessment of Hepatocellular and Metastatic Carcinomas in the Liver No drug interventions Not Available Not Available completed NCT02290977
Transarterial Chemoembolization (TACE) With Radiation Therapy (RT) in Advanced Hepatocellular Carcinoma (HCC) No drug interventions treatment 2 unknown_status NCT02267213
Efficacy and Safety Study of TLC388 to Advanced Hepatocellular Carcinoma treatment 2 terminated NCT02253511
A Prospective Control Study of Cidan Capsule Combined With TACE in Hepatocellular Carcinoma No drug interventions treatment 4 unknown_status NCT02259647
Sorafenib Plus Vitamin K1 Versus Sorafenib in Advanced Hepatocellular Carcinoma treatment Not Available completed NCT02243384
Laparoscopic Hepatectomy and Radiofrequency Ablation in the Treatment of Early Hepatocellular Carcinoma No drug interventions treatment Not Available completed NCT02240771
Transarterial Chemotherapy Compared With Oral Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma No drug interventions treatment 2 / 3 unknown_status NCT02240433
A Study of LY2157299 in Participants With Unresectable Hepatocellular Cancer (HCC) treatment 1 completed NCT02220088
The Efficacy and Safety of Retreatment With TAI for Patients Who Showed TACE-resistant: a Randomized Controlled Trial treatment 2 / 3 terminated NCT02210182
A Phase I Clinical Study on a New Oral Pentamidine Formulation in Hepatocellular Carcinoma treatment 1 completed NCT02191878
Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma No drug interventions treatment 1 / 2 completed NCT02178358
A Study of LY2157299 in Participants With Advanced Hepatocellular Carcinoma treatment 2 completed NCT02147301
TACE Using Doxorubicin-eluting Beads for Patients With HCC and Marginal Hepatic Reserve No drug interventions treatment Not Available terminated NCT02156700
Quantitative Real-time Ultrasound Elastography for Characterisation of Liver Tumors No drug interventions Not Available Not Available completed NCT02149771
Combination Treatment for Advanced Liver Cancer No drug interventions treatment 3 withdrawn NCT02131441
Surgical Specification and Efficacy Evaluation of Total Laparoscopic Left Liver Resection No drug interventions treatment Not Available recruiting NCT02129829
PROLIFICA - West African Treatment Cohort for Hepatitis B Not Available Not Available completed NCT02128958
Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC) treatment 2 completed NCT02113865
Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients No drug interventions Not Available Not Available completed NCT02101593
Ph 1 Trial of ADI PEG 20 Plus Sorafenib to Treat Patients With Liver Cancer treatment 1 completed NCT02095678
Assessment of Novel MRI Quantification Free Breathing Technique in Evaluation of Liver Lesions No drug interventions diagnostic Not Available completed NCT02089633
Pegylated Recombinant Human Arginase 1 in Combination With Oxaliplatin and Capecitabine for the Treatment of HCC treatment 2 completed NCT02089763
Efficacy Study of Pegylated Recombinant Human Arginase 1 as a Second-line Therapy in Patients With Advanced Liver Cancer treatment 2 completed NCT02074202
To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma diagnostic 3 unknown_status NCT02061956
A Simple Prognostic Scoring System for Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma No drug interventions Not Available Not Available completed NCT02046356
Recurrence Risk Factors of Early-Stage Hepatocellular Carcinoma After Radio Frequency Ablation No drug interventions Not Available Not Available unknown_status NCT02051283
Pretreatment MRI Predicting Outcome After Radio-frequency Ablation of HCC No drug interventions Not Available Not Available unknown_status NCT02032368
Decrease in Circulating Tumour Cell Count Reflects the Effectiveness of Postoperative Adjuvant Transarterial Chemoembolization (TACE) in Preventing Hepatocellular Carcinoma Recurrence No drug interventions screening Not Available completed NCT02036216
Circulating Cell-free DNA as a Predictive Biomarker for Hepatocelluar Carcinoma. No drug interventions Not Available Not Available unknown_status NCT02029690
Ph 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and Cisplatin treatment 1 terminated NCT02031952
Hepatectomy Versus Hepatectomy With Lymphadenectomy in Hepatocellular Carcinoma No drug interventions treatment Not Available completed NCT02013778
Phase 1-2 Trial HCQ Plus TACE in Unresectable HCC No drug interventions treatment 1 / 2 terminated NCT02025842
Hepatitis B Virus HBeAg-negative Genotype D Patients and Hepatocellular Carcinoma No drug interventions Not Available Not Available completed NCT02021253
Influence of Probiotics Administration Before Liver Resection in Liver Disease No drug interventions other Not Available completed NCT02013492
Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery treatment 0 completed NCT02007954
Doxorubicin-eluting LC Bead M1 for Patients With Hepatocellular Carcinoma No drug interventions treatment 2 completed NCT02008929
to Evaluate the Efficacy and Safety of MG4101(Ex Vivo Expanded Allogeneic NK Cell) treatment 2 completed NCT02009176
Laparoscope Anatomical and Aon-anatomical Hepatectomy No drug interventions treatment Not Available recruiting NCT02004210
A Phase 3 Trial Comparing TACE and TARE in Unilobar Advanced Hepatocellular Carcinoma No drug interventions treatment 3 withdrawn NCT01997957
A RCT of Oral S-1 in Combination With Sequential HAIC of Oxaliplatin After TACE in Patients With Advanced HCC No drug interventions treatment 4 unknown_status NCT01995227
An Individualized Anti-Cancer Vaccine Study in Patients With HCC No drug interventions treatment 1 / 2 withdrawn NCT01992978
Radiofrequency-assisted Hepatectomy on the Outcomes of HCC Patients With Cirrhosis No drug interventions treatment Not Available unknown_status NCT01974661
Phase I Safety Study of Dendritic Cell Vaccine to Treat Patients With Hepatocellular Carcinoma treatment 1 completed NCT01962649
A Pilot Study of Optical Molecular Imaging for Percutaneous Biopsy of Hepatocellular Carcinoma Using Indocyanine Green diagnostic 0 completed NCT01966133
TACE as an Adjuvant Therapy After Hepatectomy for HCC prevention 3 unknown_status NCT01963949
Prospective, Observational Study of Biomarkers in Liver Cancer - Identification of Actionable Events No drug interventions Not Available Not Available withdrawn NCT01970748
Primary Prevention of Patients With Hepatocellular Carcinoma and Concomitant Esophageal Varices treatment 4 recruiting NCT01957241
PLA for HCC and Esophageal ca Serum No drug interventions Not Available Not Available unknown_status NCT01953406
The Efficacy of 5-fluorouracil/Mitomycin for the Patients With Pulmonary Metastasis of Hepatocellular Carcinoma treatment 2 withdrawn NCT01935700
Effect of Colchicine for the Palliative Management of Hepatocellular Carcinoma treatment 2 completed NCT01936233
Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery treatment 3 recruiting NCT01923233
In-Situ Therapeutic Cancer Vaccine for Refractory Liver Cancer No drug interventions treatment 1 / 2 withdrawn NCT01924624
Adjuvant Therapy With Thalidomide After Curative Resection of Hepatocellular Carcinoma prevention Not Available unknown_status NCT01904942
Study of Hepatocellular Carcinoma in Cirrhotic Patients No drug interventions Not Available Not Available completed NCT01887717
Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal Vein treatment 3 terminated NCT01892072
VEGF Signaling Promotes Cell Growth and Metastasis in Hepatocellular Carcinoma in a VEGF Receptor Mediated Pathway No drug interventions Not Available Not Available unknown_status NCT01875549
Comparison Between Unilateral Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction to Use a LCD Stent No drug interventions treatment Not Available withdrawn NCT01872988
Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma treatment 3 terminated NCT01871545
Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI) No drug interventions diagnostic Not Available completed NCT01869088
TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma No drug interventions treatment 3 unknown_status NCT01857726
Comparison of TACE Versus TACE/TACI Combination in Advanced Hepatocellular Carcinoma With Portal Vein Invasion treatment Not Available withdrawn NCT01858207
Combine TACE and RFA Versus RFA Monotherapy in Unilobar HCC of 3.1 to 7 cm Patient treatment 2 unknown_status NCT01850368
Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion No drug interventions treatment 2 completed NCT01850316
Hepatocellular Carcinoma Using Stereotactic Body Radiotherapy No drug interventions health_services_research Not Available unknown_status NCT01853618
Tremelimumab With Chemoembolization or Ablation for Liver Cancer treatment 1 / 2 completed NCT01833286
TACE+RFA Versus Re-resection for Recurrent Small Hepatocellular Carcinoma No drug interventions treatment 3 unknown_status NCT01833299
Transcatheter Arterial Chemoembolization Combined With Sorafenib for Unresectable Hepatocellular Carcinoma No drug interventions treatment 3 completed NCT01825824
Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma ≤ 5 cm No drug interventions treatment 2 unknown_status NCT01825213
Stratification of Patients With Chronic Liver Disease Using Multi Spectral CT No drug interventions Not Available Not Available completed NCT01817205
Combined Chemoembolization and Systemic Hyperthermia for Unresectable Hepatocellular Carcinoma No drug interventions treatment Not Available terminated NCT01804829
Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients. prevention 3 completed NCT01798134
Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy in Hepatocellular Carcinoma No drug interventions treatment Not Available completed NCT01801163
A Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) Plus Sorafenib in Patients With Unresectable Hepatocellular Carcinoma (HCC) treatment 1 withdrawn NCT01786980
The Methylation Phenotype Screening and Determination Mode Study of Liver Cancer Prognosis Related Gene No drug interventions Not Available Not Available completed NCT01777698
Body Composition Analysis in Patients Undergoing Chemoembolization No drug interventions Not Available Not Available completed NCT01768741
Laparoscopic Versus Open Liver Resection in the Treatment of Hepatocellular Carcinoma No drug interventions treatment Not Available unknown_status NCT01764438
Utility Study of Primovist-MRI on HCC Staging No drug interventions Not Available Not Available unknown_status NCT01755767
Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma (HCC) Who Have Been Treated With One Prior Therapy treatment 3 completed NCT01721941
TH-302 Plus Doxorubicin Delivered by Trans-Arterial Chemoembolization (TACE) in Patients With Hepatocellular Carcinoma No drug interventions treatment 1 unknown_status NCT01713244
Radiofrequency Ablation Assisted Hepatectomy Versus Hepatectomy Alone for Advanced Hepatocellular Carcinoma No drug interventions treatment Not Available unknown_status NCT01715402
Optimization of Health Expenditure in Liver Surgery No drug interventions Not Available Not Available unknown_status NCT01710293
Intervention Protocol for Automated Point-of-Care Surveillance of Outpatient Delays in Cancer Diagnosis No drug interventions health_services_research Not Available withdrawn NCT01687673
Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma treatment 2 completed NCT01681446
Adjuvant IFN-α for Patients Underwent Curative Surgery for HCC With a Low miR-26 Expression treatment 3 unknown_status NCT01677468
Survival According to the Feeding Artery Obliteration by Chemoembolization for Unresectable Hepatocellular Carcinoma No drug interventions treatment Not Available unknown_status NCT01676194
Transarterial Chemoembolization Prior to Transplantation for Hepatocellular Carcinoma No drug interventions treatment 3 terminated NCT01665937
STA-9090 in Patients With Advanced Hepatocellular Cancer treatment 1 completed NCT01668017
A Multicentre, Open Label, Phase 1 Trial in Japan of the Mitogen Activated Protein Extracellular Signal Regulated Kinase (MEK) Inhibitor Pimasertib Given Orally to Subjects With Solid Tumors as Monotherapy treatment 1 terminated NCT01643824
Hypofractionated Proton Beam Radiotherapy for Hepatocellular Carcinoma No drug interventions treatment Not Available completed NCT01643447
Ulinastatin Preventing Postoperative Hepatic Failure in Hepatocellular Carcinoma (HCC) treatment Not Available completed NCT01639352
Phase II Trial of SOM230 in Patients With Unresectable Hepatocellular Carcinoma treatment 2 completed NCT01631552
Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer treatment 1 / 2 completed NCT01607788
Prospective Liver Tumor (ProLiT) Database No drug interventions Not Available Not Available unknown_status NCT01618253
Radiation Therapy With Sorafenib for TACE-Resistant Hepatocellular Carcinoma treatment 1 withdrawn NCT01575717
The Effect of Vitamin D Repletion in Patients With Hepatocellular Carcinoma on the Orthotopic Liver Transplant List treatment Not Available unknown_status NCT01575574
Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive Diagnosis diagnostic 4 completed NCT01570075
Radiofrequency Ablation Versus Liver Resection for Elderly Patients With Hepatocellular Carcinoma (HCC) Within the Milan Criteria No drug interventions treatment 4 unknown_status NCT01559844
Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant treatment 2 completed NCT01549275
Primary Cell Culture of Hepatic Tumorous Cells From Routine Fine-needle Aspiration No drug interventions Not Available Not Available completed NCT01533324
S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC) treatment 2 unknown_status NCT01540461
Determine the Pharmacokinetics and Safety of Brivanib in Chinese Subjects With Advanced Primary Liver Cancer (Hepatocellular Carcinoma: HCC) basic_science 1 completed NCT01539681
Sorafenib in Hepatocellular Carcinoma Clinical Practice in Italy Not Available Not Available completed NCT01520779
Recurrence of Hepatocellular Carcinoma No drug interventions Not Available Not Available completed NCT01518829
Procalcitonin in Hepatocellular Carcinoma No drug interventions Not Available Not Available completed NCT01519232
A Study of Changes in Hepatic Function During Radiation Therapy Using Hepatobiliary Single Photon Emission Tomography (SPECT) No drug interventions Not Available Not Available completed NCT01506115
Safety and Efficacy of Photodynamic Therapy for Bile Duct Invasion of Hepatocellular Carcinoma treatment Not Available completed NCT01512407
RCT on Adjuvant TACE After Hepatectomy for HCC No drug interventions treatment Not Available completed NCT01507064
Neoadjuvant Sorafenib Therapy Prior to Laser Ablation for Hepatocellular Carcinoma treatment 2 completed NCT01492127
Evaluation of Proteasome as a Marker of Hepatocellular Carcinoma in Cirrhotic Patients Following Curative Treatment No drug interventions Not Available Not Available unknown_status NCT01481805
Biomarker Analysis in Sorafenib Treated Hepatocellular Carcinoma Patients No drug interventions Not Available Not Available completed NCT01480817
Sorafenib VS TACE in HCC Patients With Portal Vein Invasion treatment 2 terminated NCT01473121
Hepatocellular Carcinoma Registry for Turkey (3K Trial) No drug interventions Not Available Not Available completed NCT01466504
Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin No drug interventions Not Available Not Available terminated NCT01451658
A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (S-HCC) treatment 4 unknown_status NCT01462903
A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors No drug interventions treatment 1 unknown_status NCT01441453
Transient Elastography in Hepatectomy for Hepatocellular Carcinoma No drug interventions diagnostic Not Available unknown_status NCT01438437
Trial of Ablation of Small Hepatocellular Carcinomas in Patients of Cirrhosis No drug interventions treatment 4 unknown_status NCT01409499
Palliative Treatments for Patients With Advanced Hepatocellular Carcinoma (HCC) treatment 4 completed NCT01387061
Resection for Multiple Hepatocellular Carcinomas (HCC) No drug interventions treatment Not Available completed NCT01387932
HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer No drug interventions treatment 3 terminated NCT01392131
Safety and Efficacy of Oncoxin in Hepatocellular Carcinoma (HCC) No drug interventions treatment 1 / 2 unknown_status NCT01381211
Transarterial RAdioembolization Versus ChemoEmbolization for the Treatment of Hepatocellular Carcinoma (HCC) treatment 2 terminated NCT01374750
Efficacy of Sirolimus In Liver Transplantation for Hepatocellular Carcinoma (HCC) treatment 2 completed NCT01360255
AFP- L3% and DCP as Tumor Markers in Patients With Hepatocellular Carcinoma (HCC) Treated With Transarterial Chemoembolisation (TACE) No drug interventions Not Available Not Available completed NCT01349075
TheraSphere for the Treatment of Unresectable Hepatocellular Carcinoma No drug interventions Not Available Not Available completed NCT01352728
Hepatocellular Carcinoma (HCC) Transarterial Chemoembolisation (TACE) +Axitinib treatment 2 completed NCT01347333
Stereotactic Body Radiotherapy for Liver Tumors No drug interventions treatment Not Available completed NCT01343212
Stiffness Measurement of Liver Tumors and Visceral Parenchyma No drug interventions Not Available Not Available unknown_status NCT01341132
Evaluation of Cirrhosis and Malignant Hepatic Lesions Using Novel MR Contrast Agents No drug interventions Not Available Not Available unknown_status NCT01340105
Effectiveness of Microwave Ablation of Hepatocellular Carcinoma as Compared to Radiofrequency Ablation No drug interventions treatment Not Available completed NCT01334112
Study of Axitinib in Patients With Unresectable Hepatocellular Carcinoma treatment 2 completed NCT01319942
Combined Radiotherapy and Sorafenib in Patients With Hepatoma No drug interventions Not Available Not Available unknown_status NCT01320852
PET Scan as a Screening Tool for Liver Transplant in Patients With Hepatocellular Carcinoma (HCC) No drug interventions Not Available Not Available completed NCT01322477
Contribution of F-18 Fluoro-Deoxy-Glucose PET/CT (Positron Emission Tomography) to the Assessment of HCC (Hepato-cellular Carcinoma) Treatment Efficiency No drug interventions Not Available Not Available unknown_status NCT01308645
Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Primary Hepatocellular Carcinoma (HCC) No drug interventions treatment 2 unknown_status NCT01287585
Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy treatment 3 completed NCT01281683
Dynamic Contrast-enhanced Magnetic Resonance Imaging in Evaluation of Liver Functional Status and Treatment Efficacy in Patients With Hepatocellular Carcinoma After Locoregional Therapy No drug interventions Not Available Not Available unknown_status NCT01270178
Entecavir for Chronic Hepatitis B in Hepatocellular Carcinoma Patients Underwent Radiofrequency Ablation Therapy Not Available Not Available unknown_status NCT01277653
Study of PIVKA-II and AFP Measurement in Surveillance Program for Early Detection of Hepatocellular Carcinoma No drug interventions Not Available Not Available unknown_status NCT01266707
Antiangiogenic Peptide Vaccine Therapy in Treating Patient With Hepatocellular Carcinoma No drug interventions treatment 1 unknown_status NCT01271504
E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Participants With Hepatocellular Carcinoma treatment 1 / 2 completed NCT01264705
Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer treatment 1 / 2 completed NCT01265810
Caphosol in Oral Mucositis Due to Targeted Therapy No drug interventions supportive_care 3 completed NCT01259024
The LC Bead Trial; Transarterial Chemoembolization of Hepatocellular Carcinoma (HCC)With a Drug-eluting Bead No drug interventions treatment Not Available terminated NCT01259193
Clinical Study of Sorafenib and Zoledronic Acid to Treat Advanced HCC treatment 2 unknown_status NCT01247506
Different Genetic Features Associated With Hepatic Carcinogenesis No drug interventions Not Available Not Available unknown_status NCT01232296
A Study of Dovitinib Versus Sorafenib in Adult Patients With Hepatocellular Carcinoma (HCC) as a First Line Treatment treatment 2 completed NCT01215565
Study of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar Carcinoma treatment 2 terminated NCT01203787
Sorafenib Dose Ramp-Up in Hepatocellular Carcinoma (HCC) treatment 4 completed NCT01205828
ABT-888 and Temozolomide for Liver Cancer treatment 2 terminated NCT01210495
Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma treatment 2 completed NCT01213758
Changes in Liver Function After Stereotactic Body Radiation Therapy Measured by PET/CT No drug interventions Not Available Not Available completed NCT01177397
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma treatment 1 / 2 completed NCT01157013
Role of Positron Emission Tomography in the Evaluation of Response to Sorafenib in Advanced Hepatocellular Carcinoma No drug interventions diagnostic Not Available completed NCT01140347
A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Participants With Hepatocellular Carcinoma After 1st-Line Therapy With Sorafenib treatment 3 completed NCT01147380
Safety Study of Liver Natural Killer Cell Therapy for Hepatoma Liver Transplantation No drug interventions treatment 1 completed NCT01125020
Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver Transplantation treatment Not Available unknown_status NCT01135056
Study to Compare Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (HCC) treatment 3 unknown_status NCT01126645
Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver Cancer No drug interventions treatment 2 completed NCT01116635
Clinical Study Examining the Safety and Efficacy of Doxorubicin Drug Eluting Microspheres Transarterial Embolization in the Setting of Hepatocellular Carcinoma (HCC) treatment 1 / 2 completed NCT01098760
Hepatocellular Carcinoma - Advanced Stage - Sorafenib Trial in Taiwanese Patients treatment 4 completed NCT01033578
Efficacy of Postoperative Adjuvant Treatments for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis No drug interventions treatment Not Available unknown_status NCT01042041
Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer treatment 1 completed NCT01032850
Sorafenib With Capecitabine for Patients With Measurable Hepatocellular Carcinoma treatment 2 terminated NCT01029418
AZD6244 and Sorafenib in Advanced Hepatocellular Carcinoma treatment 1 / 2 terminated NCT01008917
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma treatment 1 completed NCT01008358
Anti-CTLA-4 Human Monoclonal Antibody CP-675,206 in Patients With Advanced Hepatocellular Carcinoma treatment 2 completed NCT01005875
Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular Carcinoma treatment Not Available terminated NCT00999843
Safety Study of Sorafenib Following Combined Therapy of Radiation and TACE for Liver Cancer treatment 1 / 2 unknown_status NCT00986661
A Study to Assess PV-10 Chemoablation of Cancer of the Liver treatment 1 active_not_recruiting NCT00988195
Study of Pegylated Human Recombinant Arginase for Liver Cancer treatment 1 completed NCT00978107
Trial of TG4023 Combined With Flucytosine in Liver Tumors treatment 1 completed NCT00976170
Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma) treatment 1 completed NCT00960518
TACE and Adefovir Compared With Transarterial Chemoembolization (TACE) Alone for Hepatitis B Virus (HBV)-Related Unresectable Hepatocellular Carcinoma (HCC) treatment 2 unknown_status NCT00960167
A Dose Escalation Trial of Radiation Therapy (RT) for Hepatocellular Carcinoma (HCC) No drug interventions treatment 1 unknown_status NCT00956436
Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC) treatment 1 completed NCT00963612
Non-invasive Prediction of Microvascular Invasion in Hepatocellular Carcinoma by Blood-Oxygen-Level Dependent Magnetic Resonance Imaging (BOLD MRI) No drug interventions diagnostic Not Available completed NCT00943449
4SC-201 (Resminostat) and Sorafenib in Advanced Hepatocellular Carcinoma treatment 2 completed NCT00946153
Study of Lenvatinib (E7080) in Participants With Advanced Hepatocellular Carcinoma (HCC) treatment 1 / 2 completed NCT00945568
Preoperative Oral Supplementation With Branched-Chain Amino Acids (BCAA) Improves Postoperative Quality of Life No drug interventions supportive_care Not Available completed NCT00933816
Study of Sorafenib In Combination With Low-dose 5-fluorouracil/Cisplatin (FP) Intraarterial Infusion Chemotherapy treatment 1 / 2 completed NCT00911196
Analysis of Expression of Specific Markers and Their Prognostic Significance in Hepatocellular Carcinoma No drug interventions Not Available Not Available completed NCT00921531
Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular Carcinoma treatment 3 unknown_status NCT00923897
Palliative Radiotherapy (RT) for Liver Metastases (Mets) and Hepatocellular Carcinoma (HCC)(COLD 4) No drug interventions supportive_care 2 completed NCT00914355
Stereotactic Body Radiation Therapy (SBRT) Hepatocellular Carcinoma (COLD 2) No drug interventions treatment 2 completed NCT00908752
Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC treatment 3 completed NCT00892658
Sorafenib-RT in Treating Hepatocellular Carcinoma (SHEP) treatment 1 completed NCT00877071
LC Drug Eluting Bead for Treatment of Liver Cancer Which Cannot be Surgically Removed treatment 2 completed NCT00877136
A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere® No drug interventions Not Available Not Available completed NCT00883454
Estimation of Functional Liver Reserve Using Cholinesterases No drug interventions Not Available Not Available completed NCT00867750
SIR-Spheres® Microspheres Versus Transarterial Chemoembolisation in Patients With Unresectable Hepatocellular Carcinoma No drug interventions treatment 2 completed NCT00858000
Analysis of Expression of Specific Markers in Hepatocellular Carcinoma No drug interventions Not Available Not Available completed NCT00844688
Study of Sorafenib and Gemcitabine in Advanced Hepatocellular Carcinoma (HCC) treatment 2 unknown_status NCT00846131
Y-90 Alone or With Sorafenib for Pre-Transplant Hepatocellular Carcinoma treatment 1 completed NCT00848952
Performance of Imaging for the Diagnosis of Small Hepatocellular Carcinoma (< 3 cm)on Cirrhosis No drug interventions diagnostic Not Available unknown_status NCT00851968
A Trial of Complete Versus Selective HepaticVascular Clamping in Hepatectomy No drug interventions treatment Not Available completed NCT00844883
Study of Sorafenib and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma treatment 2 completed NCT00849264
Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients treatment 2 completed NCT00848094
Radiation Dose Escalation Study for Advanced Liver Cancer No drug interventions treatment 1 completed NCT00832637
Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree Cancers treatment 2 terminated NCT00842647
Diagnosis of Hepatic Tumors in Cirrhosis: Prospective Validation of the Noninvasive Diagnostic Criteria for Hepatocellular Carcinoma No drug interventions Not Available Not Available unknown_status NCT00834860
Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular Carcinoma treatment 4 unknown_status NCT00834158
Efficacy of Sequential TACE and PVE on the Resectability of Hepatitis B Related HCC No drug interventions treatment Not Available completed NCT00844454
Multi-pronged Ethanol Ablation and Radiofrequency Ablation of Early-stage Hepatocellular Carcinoma No drug interventions treatment Not Available completed NCT00834028
Recurrence and Distant Metastases in Hepatocellular Carcinoma Treated by Transcatheter Arterial Chemoembolization No drug interventions Not Available Not Available completed NCT00820053
A Trial of Adjuvant Transarterial Chemoembolization (TACE) for Preventing Tumor Recurrence After Liver Resection prevention 2 completed NCT00829335
Anatomical Resection of the Liver for Hepatocellular Carcinoma: a New Ultrasound Guided Approach No drug interventions Not Available Not Available completed NCT00827047
Total Hemihepatic Vascular Exclusion in Hepatectomy in Hepatocellular Carcinoma Treatment No drug interventions treatment Not Available completed NCT00825877
Long-term Follow-up of HALT-C Sustained Virological Responders No drug interventions Not Available Not Available completed NCT00823290
Sorafenib and LBH589 in Hepatocellular Carcinoma (HCC) treatment 1 terminated NCT00827554
The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma treatment 2 / 3 completed NCT00822562
Research on Surgery and Micro-Invasive Treatment in Recurrent Primary Liver Cancer No drug interventions treatment Not Available completed NCT00814242
Hepatectomy Versus Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to Major Blood Vessels No drug interventions treatment 2 / 3 completed NCT00807300
Computed Tomography (CT) - Guided Brachytherapy Versus Transarterial Chemoembolization in Patients With Unresectable Hepatocellular Carcinoma No drug interventions treatment 2 completed NCT00805896
Songyou Granule and Transarterial Chemoembolization for Hepatocellular Carcinoma No drug interventions treatment 2 unknown_status NCT00817895
Intraoperative Chemotherapy Against Hepatocellular Carcinoma Recurrence prevention Not Available completed NCT00808145
Study of Sorafenib, Gemcitabine, and Cisplatin in Advanced Hepatocellular Carcinoma (HCC) treatment 2 withdrawn NCT00797251
Anatomical Right Posterior Sectionectomy of the Liver by IOUS-Guided Finger Compression No drug interventions Not Available Not Available unknown_status NCT00802555
Safety Study of ARQ 197 in Cirrhotic Patients With Hepatocellular Carcinoma (HCC) treatment 1 completed NCT00784290
Phase I/II Study of TSU-68 for Advanced Hepatocellular Carcinoma treatment 1 / 2 completed NCT00790218
A Phase 1-2 Study of CF102 in Patients With Advanced Hepatocellular Carcinoma treatment 1 / 2 completed NCT00769535
Relationship Between Polymorphism of Heat Shock Protein 70 Gene and Hepatocellular Carcinoma No drug interventions basic_science Not Available completed NCT00768937
Sorafenib and Transarterial Chemoembolization for Hepatocellular Carcinoma treatment 1 / 2 completed NCT00768157
Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma treatment 4 unknown_status NCT00769106
Study of Cytokine-induced Killer Cell (CIK) Treatment in Patients After Resection of Liver Cancer No drug interventions treatment 3 completed NCT00764140
Tumor Growth Factors in Hepatocellular Carcinoma Not Available Not Available completed NCT00728078
Low-Dose Thalidomide as Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma treatment 2 / 3 unknown_status NCT00725335
Effect of I/R Injuries by Pringle Manoeuvre on the Prognosis of HCC Patients After Curative Hepatectomy No drug interventions treatment Not Available completed NCT00712855
A Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma treatment 1 completed NCT00707681
Evaluation of Quality of Life and Survival With MS-20 in Patient With Advanced Hepatocellular Carcinoma (FDA IND 74572) No drug interventions treatment 2 unknown_status NCT00679692
Evaluation the Growth Factors(IGF-1,IGFBP-3and HGH)in Patients With Chronic Liver Disease No drug interventions Not Available Not Available completed NCT00652587
Hepatectomy With or Without Transcatheter Arterial Chemoembolization for Stage IIIA Hepatocellular Carcinoma No drug interventions treatment 3 completed NCT00646100
Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis No drug interventions treatment 4 completed NCT00644020
Phase ⅡStudy of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) Patients Not Available Not Available unknown_status NCT00630240
Risk Factors for the Leakage of Anticancer Drugs to Systemic Circulation by Transcatheter Arterial Chemoembolization No drug interventions Not Available Not Available completed NCT00629486
Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular Carcinoma No drug interventions basic_science Not Available completed NCT00627042
Study of IMC-1121B (Ramucirumab) in Participants With Liver Cancer Who Have Not Previously Been Treated With Chemotherapy treatment 2 completed NCT00619541
Study of Sorafenib and Infusional 5-Fluorouracil in Advanced Hepatocellular Carcinoma (HCC) treatment 2 completed NCT00614913
Proton Beam Therapy for Treatment of Hepatocellular Carcinoma No drug interventions treatment 1 / 2 completed NCT00606385
Prospective Randomized Trial of Laparoscopic Versus Open Liver Resection for HCC No drug interventions treatment Not Available unknown_status NCT00600522
Alternative Surgical Policy for Central Liver Tumors No drug interventions Not Available Not Available completed NCT00568308
Phase III Study of PI-88 in Post-resection Hepatocellular Carcinoma treatment 3 terminated NCT00554905
Radiofrequency Ablation With or With Transcatheter Arterial Embolization for Hepatocellular Carcinoma No drug interventions treatment 4 unknown_status NCT00556803
TACE as an Adjuvant Therapy After Radiofrequency Ablation (RFA) for Hepatocellular Carcinoma No drug interventions treatment 4 unknown_status NCT00557024
Radiotherapy as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma No drug interventions treatment 4 unknown_status NCT00555334
Nucleoid as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma treatment 4 unknown_status NCT00561522
Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection treatment 2 / 3 unknown_status NCT00539253
Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI. diagnostic Not Available completed NCT00532441
Erlotinib in Combination With Docetaxel in Advanced Hepatocellular and Biliary Tract Carcinomas treatment 2 terminated NCT00526617
A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients treatment 1 completed NCT00524498
A Phase II Study of a Continuous Hepatic Arterial Infusion Combination Therapy With OPC-18 and 5-FU in Patients With Highly Advanced Hepatocellular Carcinoma treatment 2 completed NCT00519688
UFUR Plus Thalidomide for Advanced Hepatocellular Carcinoma treatment 2 completed NCT00522405
Randomized Control Trial (RCT) of Transarterial Chemoembolization (TACE) Versus TACE and Oral Drug Therapy in the Treatment of Unresectable Hepatocellular Carcinoma No drug interventions treatment 2 / 3 unknown_status NCT00501813
Multimodality Therapy for Palliative Resectable Hepatocellular Carcinoma With Intrahepatic Vessels Invasion No drug interventions treatment 3 unknown_status NCT00493428
Treatment of Non-Metastatic Hepatocellular Carcinoma in Humans by Increasing Gabaergic Activity: A Pilot Study treatment 2 withdrawn NCT00493402
Different Regimens of Transarterial Chemoembolization for Hepatocellular Carcinoma No drug interventions treatment 3 completed NCT00474734
Intravascular Ultrasound for Hepatocellular Carcinoma Staging No drug interventions Not Available Not Available unknown_status NCT00484211
Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Hepatocellular Carcinoma (HCC) treatment 2 completed NCT00465842
Protein Biomarker in Hepatocellular Carcinoma No drug interventions Not Available Not Available terminated NCT00464919
Sorafenib Plus Tegafur/Uracil (UFUR®) for Hepatocellular Carcinoma (HCC) treatment 2 completed NCT00423306
A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma treatment 2 unknown_status NCT00415155
A Study of LY2181308 in Patients With Advanced Hepatocellular Carcinoma treatment 1 / 2 withdrawn NCT00405873
Study to Evaluate Tumour Response in Cancer Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) With AMT2003 No drug interventions treatment 2 terminated NCT00357422
Comparison Study of Operation and PEIT for Small, Solitary Hepatocellular Carcinoma (HCC) No drug interventions treatment Not Available completed NCT00355862
Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma treatment 3 completed NCT00361309
SU011248 in Advanced Hepatocellular Carcinoma treatment 2 completed NCT00356161
HAI Via Interventionally Implanted Port Catheter Systems No drug interventions treatment 2 unknown_status NCT00357474
Comparison Study of Transarterial Chemoembolization and Percutaneous Ethanol Injection for Multiple, Small HCCs No drug interventions treatment 3 completed NCT00341705
The Second Multicenter Hemophilia Cohort Study No drug interventions Not Available Not Available completed NCT00319683
A Study of ADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma No drug interventions treatment 1 / 2 terminated NCT00322361
Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056) prevention 2 completed NCT00287222
Bevacizumab and Erlotinib in Inoperable and Metastatic Hepatocellular Carcinoma treatment 2 completed NCT00290316
Accuracy of Endoscopic Ultrasound for Detection of Tumors of the Liver No drug interventions diagnostic 2 unknown_status NCT00280007
Transarterial Chemoembolisation Plus Bevacizumab for Treatment of Hepatocellular Carcinoma treatment 2 terminated NCT00273247
Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis treatment 3 completed NCT00273312
Patupilone Activity in Advanced/Metastatic Hepatocellular Carcinoma treatment 2 completed NCT00183885
A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma treatment 2 unknown_status NCT00172640
Genetic Studies in Liver Cancer Patients No drug interventions Not Available Not Available unknown_status NCT00168987
Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors No drug interventions treatment 4 completed NCT00154817
A Phase II Study of Radiotherapy for Locally Advanced Hepatocellular Carcinoma (HCC) No drug interventions treatment 2 completed NCT00154544
Searching for the Liver Cancer-Related Biomarkers No drug interventions Not Available Not Available unknown_status NCT00154531
Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDI No drug interventions Not Available Not Available unknown_status NCT00162669
Bevacizumab in Advanced Hepatocellular Carcinoma treatment 2 unknown_status NCT00165633
A Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular Carcinoma treatment 2 / 3 terminated NCT00142428
Cetuximab in Patients With Unresectable or Metastatic Hepatocellular Carcinoma treatment 2 completed NCT00151671
Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver Cancer No drug interventions prevention 2 / 3 terminated NCT00149565
Phase Ⅲ Randomized Trial in Postoperative Hepatocellular Carcinoma No drug interventions treatment 3 completed NCT00096733
Adult-to-Adult Living Donor Liver Transplantation Study No drug interventions Not Available Not Available completed NCT00076609
Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma treatment 1 / 2 completed NCT00073736
Safety and Tolerability of I.V. Infusion of MB07133 in Patients With Unresectable Hepatocellular Carcinoma treatment 1 / 2 completed NCT00057382
T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients treatment 2 / 3 terminated NCT00057395
A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies treatment 1 / 2 unknown_status NCT00043433
Study of T900607-Sodium in Chemotherapy Naive Patients With Hepatocellular Carcinoma. treatment 2 unknown_status NCT00054951
Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads treatment 1 / 2 unknown_status NCT01489566
Study of Tyroserleutide for Injection in Hepatocellular Carcinoma (HCC) Patients treatment 3 unknown_status NCT03496051
Single Patient Access (Compassionate Use) for Continued Treatment of RO7070179 for Adult Subjects With Advanced Hepatocellular Carcinoma (HCC) Not Available Not Available available NCT03081377
Galunisertib (LY2157299) Plus Stereotactic Body Radiotherapy (SBRT) in HCC treatment 1 not_yet_recruiting NCT01024530
Phase II/III Trial of Hepatocellular Carcinoma Patients Treated by ex Vivo Expanded Autologous Immune Killer Cells as the Adjunct Therapy No drug interventions supportive_care 2 / 3 unknown_status NCT05495529
Biliary or Digestive Protection by Room Air Interposition for Thermal Ablation of Central Hepatic Tumors No drug interventions Not Available Not Available completed NCT06483594
Prediction and Prognostic Analysis of Liver Abscess Formation After Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma (CHANCE 2407) No drug interventions Not Available Not Available not_yet_recruiting NCT01163526
Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies No drug interventions Not Available Not Available terminated NCT05794048
METabolic PROFILE of Hepatocarcinoma and Pancreatic Tumors No drug interventions basic_science Not Available recruiting NCT03382327
Benefit of the Use of 3D Models and Tools in Hepatectomy Planning for Hepatocarcinomas No drug interventions diagnostic Not Available completed NCT02650427
A Pilot Study to Evaluate the Safety of a 3 Weeks Sitagliptin Treatment in HCC Patients Undergoing Liver Resection treatment 1 completed NCT03956940
Analysis of cfDNA in Patients With Hepatocarcinoma and Treated by Sorafenib or Regorafenib No drug interventions diagnostic Not Available terminated NCT06041490
Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation prevention 2 not_yet_recruiting NCT01411579
Use of DwI-MR to Predict Chemotherapy Response of Liver Metastases and Hepatocarcinoma No drug interventions Not Available Not Available completed NCT03755739
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors treatment 2 / 3 recruiting NCT03356236
Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma Following Local Ablation No drug interventions Not Available Not Available recruiting NCT06028724
A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN) No drug interventions Not Available Not Available recruiting NCT05464706
Study on the Quality of Life (QoL) After Liver Surgery No drug interventions supportive_care Not Available completed NCT05311319
HAIC Combined With Anlotinib and TQB2450 as Adjuvant Therapy in HCC Patients With High Risk of Recurrence After Resection treatment 2 recruiting NCT04811898
A Dose Escalation Study of LNA-i-Mir-221 for Cancer Treatment No drug interventions treatment 1 completed NCT04435977
Efficacy and Safety of Cabozantinib in Patients With Hepatocellular Carcinoma treatment 2 recruiting NCT03718078
Robotic Endomicroscopy to Better Define Resection Strategies Applied to Hepatic Surgery No drug interventions other Not Available unknown_status NCT02519075
11C-Choline PET/CT and DWI MRI for Response Assessment of HCC Candidate to TARE No drug interventions Not Available Not Available completed NCT01102335
Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy treatment 4 unknown_status NCT04791735
Value of the Laparoscopic Approach in the Surgical Management of Resectable Hepatocellular Carcinoma No drug interventions treatment Not Available recruiting NCT05975463
Hepatic Artery Infusion of Adebrelimab Combined With Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma With Failure of Systemic Therapy Combined With Interventional Therapy treatment 2 not_yet_recruiting NCT01834963
P2 Study of Postoperative Interferon/Fluorouracil vs Cisplatin/Fluorouracil for Hepatocellular Carcinoma. treatment 2 unknown_status NCT01415063
Radiofrequency Ablation Combined With Transcatheter Arterial Chemoembolization Versus Radiofrequency Ablation Alone for Recurrent Hepatocellular Carcinoma No drug interventions treatment 4 unknown_status NCT05131763
NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors treatment 1 unknown_status NCT04627363
HAIC Combined With Bevacizumab and Toripalimab for Advanced Hepatocellular Carcinama treatment 2 unknown_status NCT01914263
Safety Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical Resection No drug interventions treatment 1 unknown_status NCT05724563
Domvanalimab and Zimberelimab in Advanced Liver Cancers treatment 2 recruiting NCT04340986
Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma No drug interventions Not Available Not Available recruiting NCT04303286
The Effect of Gut Microbiota on Postoperative Liver Function Recovery in Patients With Hepatocellular Carcinoma No drug interventions Not Available Not Available completed NCT02242786
Diffusion-Weighted Magnetic Resonance Imaging No drug interventions diagnostic 2 unknown_status NCT01357486
Palliative Treatment of Hepatocellular Carcinoma in Patient With CHILD B Cirrhosis treatment 2 completed NCT05113186
Neoadjuvant and Adjuvant Lenvatinib in HCC Patients Treated by Percutaneous Ablative treatment 2 active_not_recruiting NCT05848739
A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors treatment 1 recruiting NCT05669339
AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma treatment 1 recruiting NCT06550739
Comprehensive Prognostic Model: The Study Introduces a Novel Prognostic Model That Incorporates a Wide Range of Clinical and Laboratory Variables, Providing a More Holistic Approach to Predicting Overall Survival in HCC Patients No drug interventions Not Available Not Available completed NCT02003339
Interest of Functional MRI (Magnetic Resonance Imagery) (in Patients Suffering From Hepatocellular Carcinoma and Treated With Yttrium No drug interventions diagnostic Not Available completed NCT00820339
Pringle's Maneuver Versus Selective Hepatic Vascular Exclusion in Hepatectomy No drug interventions treatment 2 / 3 completed NCT02156739
Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions diagnostic Not Available active_not_recruiting NCT04587739
Neoadjuvant Hypofractionated Stereotactic Body Radiation Therapy Prior to Surgery for Hepatocellular Carcinoma: a Feasibility Study. No drug interventions treatment 1 unknown_status NCT04629339
Study of INCB086550 in Select Solid Tumors treatment 2 terminated NCT02423239
A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours treatment 1 unknown_status NCT05171439
Surufatinib in Advanced Hepatocellular Carcinoma Based on Single-cell Sequencing of Tumor Samples treatment 2 unknown_status NCT03851939
The Efficacy of Transarterial Chemoinfusion (TAI) Combine Toripalimab in Advanced Hepatocellular Carcinoma (HCC) treatment 2 unknown_status NCT01229839
Chemoembolization With or Without Mixing the Chemotherapy With Lipiodol for Unresectable HCC No drug interventions treatment 3 completed NCT05185739
Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC) treatment 2 recruiting NCT02129322
Effect of Adjuvant Therapy by Sorafenib, Oxaliplatin and S-1 treatment 2 withdrawn NCT03511222
Vorolanib (X-82) Combined With Checkpoint Inhibitors in Patients With Solid Tumors treatment 1 terminated NCT03398122
Study of Apatinib Combined With TACE in Advance Hepatocellular Carcinoma treatment Not Available unknown_status NCT06463522
Safety and Efficacy of Autologous Tumor-infiltrating Lymphocytes Therapy in Patients With Hepatocellular Carcinoma No drug interventions treatment 1 / 2 recruiting NCT03539822
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies treatment 1 / 2 active_not_recruiting NCT04494022
Role of CEUS as a Secondary Diagnostic Modality No drug interventions diagnostic Not Available unknown_status NCT02102022
Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular Carcinoma treatment 1 / 2 terminated NCT06389422
Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis treatment 2 recruiting NCT06498622
Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With Envafolimab treatment 2 recruiting NCT01640522
Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms No drug interventions supportive_care Not Available completed NCT02670122
Prospective Study to Evaluate Safety of Deb-TACE With 100µ Beads in Patients With Non Resectable HCC No drug interventions Not Available Not Available completed NCT03316222
Study of GNS561 in Patients With Liver Cancer treatment 1 / 2 terminated NCT05220722
Pressure Enabled Delivery of SD-101 With Checkpoint Blockade for Primary Liver Tumors treatment 1 / 2 active_not_recruiting NCT03793322
The Application of Indocyanine-Green(ICG) Fluorescence Imaging in Hepatocellular Carcinoma diagnostic 1 unknown_status NCT05641922
Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation Procedures (PANORAMA2) No drug interventions other Not Available withdrawn NCT05033522
Immunotherapy for Advanced Liver Cancer treatment 2 / 3 recruiting NCT03007225
Efficacy and Safety of Drug Eluting Beads TACE in Treatment of HCC in Egyptian Patients No drug interventions treatment 4 completed NCT02446925
Surefire Catheter Versus Standard End-hole Microcatheter: A Pilot Study No drug interventions device_feasibility Not Available terminated NCT00554125
Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria prevention 3 unknown_status NCT06244225
HAIC (Hepatic Artery Infusion Chemotherapy，HAIC）Plus Sintilimab and Donafenib in the First-line Treatment of Unresectable Hepatocellular Carcinoma treatment 2 recruiting NCT02950025
Daily Online Adaptation Versus Localization for MRI-Guided SBRT for Unresectable Primary or Oligometastatic Abdominal Malignancies No drug interventions treatment 2 terminated NCT03212625
The Effect of Urea Cream on Sorafenib-associated Hand-Foot Skin Reaction treatment 4 completed NCT02899325
FDGal PET/CT to Detect Hepatocellular Carcinoma Not Available Not Available withdrawn NCT06041425
The Effects of Oxycodone Versus Sufentanil on Pain and Inflammatory Response After TACE treatment 4 completed NCT04796025
TACE Combined With Sintilimab Plus Bevacizumab Biosimilar in Hepatocellular Carcinoma (BCLC-C Stage ): a Prospective Single-arm Phase II Clinical Study treatment 2 unknown_status NCT04568330
Prevention of Hand-foot Skin Reaction No drug interventions prevention Not Available completed NCT00769730
Evaluation the Possible Influence of Transcatheter Arterial Chemoembolization on Hepatitis B Viral Replication No drug interventions Not Available Not Available completed NCT05729230
PAtient-PHYsician Relationship Assessment No drug interventions Not Available Not Available completed NCT05263830
Glypican-3 as a Prognostic Factor in Patients With Hepatocellular Carcinoma Treated by Immunotherapy No drug interventions Not Available Not Available recruiting NCT04814030
Transarterial Infusion of PD-1 Antibody Plus TACE-HAIC for Unresectable HCC: a Single-arm, Phase 2 Clinical Trial No drug interventions treatment 2 unknown_status NCT03937830
Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract Carcinoma treatment 2 recruiting NCT04637048
Observational Study on Patients With Hepatobiliary Tumors No drug interventions Not Available Not Available unknown_status NCT04903548
Evaluating the Effects of Selective Treatment Utilizing Flex-dosing for Unresectable HCC With Y90 SIR-Spheres No drug interventions Not Available Not Available recruiting NCT02519348
A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma treatment 2 active_not_recruiting NCT01923948
Preoperative Pain Control in Liver Surgery Patients treatment Not Available completed NCT03516448
Expanding Phase III Study of Tyroserleutide for Injection treatment 3 unknown_status NCT04093648
T Cells co- Expressing a Second Generation Glypican 3-specific Chimeric Antigen Receptor With Cytokines Interleukin-21 and 15 as Immunotherapy for Patients With Liver Cancer (TEGAR) treatment 1 withdrawn NCT05099848
A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma treatment 2 active_not_recruiting NCT00518557
Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using TACE With Antiangiogenesis No drug interventions treatment Not Available unknown_status NCT03066557
Study of the Combination of TACE With Apatinib in Patients With Hepatocellular Carcinoma No drug interventions treatment Not Available unknown_status NCT00820157
Cytoreductive Surgery and Transarterial Chemoembolization (TACE) Versus TACE for Hepatocellular Carcinoma No drug interventions treatment Not Available completed NCT03448757
Determination of Autonomic Responses to the Exposure of Low Energy Electromagnetic Fields With Frequency Modulation in Patients With Advanced Hepatocellular Carcinoma and Healthy Individuals. No drug interventions treatment Not Available recruiting NCT04460157
Prediction of Liver-related Outcomes After HCV Cure No drug interventions Not Available Not Available unknown_status NCT06168357
Role of Abbreviated MRI in Follow-up of Hepatocellular Carcinoma . No drug interventions Not Available Not Available not_yet_recruiting NCT00971126
Study of Sorafenib With Combination of Thalidomide in Hepatocellular Carcinoma (HCC) treatment 1 / 2 terminated NCT06312826
Abbreviated MRI Using Gadoxetic Acid Versus Ultrasonography for Surveillance of Early-stage HCC in Patients at High Risk No drug interventions screening Not Available recruiting NCT05926726
GPC3-directed CAR-T in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma No drug interventions treatment Not Available recruiting NCT05307926
Postoperative Adjuvant Therapy of HCC Based on PD-1 Not Available Not Available completed NCT02927626
Yang Yin Fu Zheng Therapy in HBV Associated Hepatocellular Carcinoma No drug interventions treatment 0 completed NCT01908426
Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib treatment 3 completed NCT03006926
A Trial of Lenvatinib Plus Pembrolizumab in Participants With Hepatocellular Carcinoma treatment 1 completed NCT05111366
TQB2450 Plus Anlotinib as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Resection treatment 2 unknown_status NCT04909866
The Efficacy and Safety of TACE, Lenvatinib and Camrelizumab in the Treatment of BCLC Stage B/C Hepatocellular Carcinoma: a Single-arm, Single-center, Open-label Study treatment 2 / 3 unknown_status NCT01570166
Percutaneous Radiofrequency Ablation Versus Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma No drug interventions treatment Not Available unknown_status NCT02564666
The Effect of Telephone Counseling on the Compliance and Satisfaction for Advanced HCC Patients Receiving Sorafenib No drug interventions Not Available Not Available unknown_status NCT05429866
Immunological Variables Associated to ICI Toxicity in Cancer Patients other 2 recruiting NCT02595866
Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer treatment 1 completed NCT00562666
Immunotherapy of Hepatocellular Carcinoma With Gamma Delta T Cells No drug interventions treatment 1 terminated NCT04842565
cTACE Plus Sintilimab for Unresectable Intermediate-stage HCC With Beyond Up-to-seven Criteria treatment 2 completed NCT06418165
Vienna Hypothermic Oxygenated Machine Perfusion Study No drug interventions Not Available Not Available recruiting NCT05063565
TheraSphere With Durvalumab and Tremelimumab for HCC treatment 2 recruiting NCT04555265
Cytokine Change in Hepatocellular Carcinoma Treated by Thermal Ablation No drug interventions treatment Not Available completed NCT00516165
RAD001 in Advanced Hepatocellular Carcinoma treatment 1 / 2 completed NCT02169765
HR Versus RFA for Early Stage HCC No drug interventions treatment 3 unknown_status NCT05837065
Prognostic Models for HCC Based on Tumor Micronecrosis No drug interventions Not Available Not Available recruiting NCT00467974
Transarterial Ethanol Ablation (TEA) Versus Transcatheter Arterial Chemoembolisation (TACE) for Hepatocellular Carcinoma No drug interventions treatment 3 completed NCT03190174
Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers treatment 1 / 2 completed NCT00478374
Sorafenib With TACE to Treat Hepatocellular Carcinoma treatment 1 completed NCT00825474
A Prospective Randomized Trial Comparing Partial Hepatectomy and TACE Plus PEI for Small Hepatocellular Carcinoma No drug interventions treatment Not Available completed NCT04681274
Phenotyping Liver Cancer Registry No drug interventions Not Available Not Available completed NCT05471674
Neoadjuvant Anti-PD1 in HCC treatment 2 completed NCT03199274
Perflutren Protein-Type A Microspheres and Contrast-Enhanced Ultrasound in Improving Response to Radioembolization Therapy in Patients With Liver Cancer treatment 2 active_not_recruiting NCT01335074
Temsirolimus + Sorafenib in Advanced Hepatocellular Carcinoma (HCC) treatment 1 / 2 withdrawn NCT01406574
Phase I/II Study of OPB-31121 in Patients With Progressive Hepatocellular Carcinoma No drug interventions treatment 1 / 2 completed NCT01167374
Carbon Ion Radiotherapy for Hepatocellular Carcinoma No drug interventions treatment Not Available terminated NCT00428220
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study. treatment Not Available completed NCT05203120
A National Phase II Study of Proton Therapy in Hepatocellular Carcinoma No drug interventions treatment Not Available recruiting NCT04945720
Hepatic Artery Infusion Chemotherapy (HAIC) Plus Durvalumab for Advanced Hepatocellular Carcinoma treatment 2 recruiting NCT06218420
Evaluation of Stereotactic Body Radiotherapy as a Bridge Therapy for Hepatocellular Carcinoma Patients Enlisted for Liver Transplantation No drug interventions prevention 2 recruiting NCT05093920
Role of DEB-TACE Versus c-TACE in Treatment of HCC treatment 0 active_not_recruiting NCT01482520
Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell Carcinoma No drug interventions Not Available Not Available completed NCT01377220
Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular Carcinoma diagnostic 2 unknown_status NCT05573282
Observation Study of Sequential Regorafenib Plus ICIs After HAIC for Advanced Hepatocellular Carcinoma No drug interventions Not Available Not Available recruiting NCT05718882
Lenvatinib Plus VIC-1911 in Lenvatinib-unresponsive or Lenvatinib-resistant HCC treatment Not Available recruiting NCT04502082
Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1) treatment 1 / 2 terminated NCT05231382
Hepatic Arterial Infusion of Raltetrexed With Oxaliplatin(SALOX) Versus FOLFOX in Advanced Hepatocellular Carcinoma No drug interventions treatment 3 recruiting NCT00862082
Randomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) treatment 1 / 2 terminated NCT04316182
Cabozantinib in Patients With Hepatocellular Carcinoma (ACTION) treatment 2 completed NCT00234182
Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC treatment 1 / 2 completed NCT06114082
TACE Using Idarubicin Versus Doxorubicin Chemoemulsion in Patients With Hepatocellular Carcinoma (IDADOX) No drug interventions treatment 2 recruiting NCT03156582
Impacts of the α-fetoprotein (AFP) Score in Real Life for Patient Selection for Liver Transplantation (LT) for Hepatocellular Carcinoma (HCC) No drug interventions Not Available Not Available completed NCT00683631
TheraSphere HUD For Treatment of Unresectable Hepatocellular Carcinoma (HCC) No drug interventions Not Available Not Available completed NCT03782831
TACE Plus PD-1 Antibody vs TACE Alone for Unresectable HCC No drug interventions treatment 2 withdrawn NCT04631731
Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity No drug interventions diagnostic 1 / 2 recruiting NCT05185531
A Study of Neoadjuvant Tislelizumab With SBRT in Patients With Resectable Hepatocellular Carcinoma No drug interventions treatment 1 active_not_recruiting NCT02727673
Relationship Between Circulating Tumor Stem Cells and the Clinical Pathology No drug interventions Not Available Not Available completed NCT00775073
Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001 treatment 2 completed NCT04459273
Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers basic_science 1 recruiting NCT04946773
Deep Liver Phenotyping and Immunology Study No drug interventions Not Available Not Available recruiting NCT06134973
A Prospective Study on the Application of Liquid Biopsy in the Surveillance of High-risk Population of HCC. No drug interventions Not Available Not Available recruiting NCT00906373
A Study of IMC-A12 in Combination With Sorafenib in Participants With Advanced Cancer of the Liver treatment 2 completed NCT02643173
Hepatocellular Carcinoma Recurrence and Anesthesia No drug interventions Not Available Not Available completed NCT05045573
Pathological Results of Aggressive Hepatocellular Carcinomas Treated Using SIRT No drug interventions Not Available Not Available completed NCT05416073
Effect of Esketamine on Abdominal Pain During TACE-HAIC in Patients With Hepatocellular Carcinoma treatment 4 unknown_status NCT02928627
Clinical Significance of Hepatic and Circulating microRNAs miR-221 and miR-222 in Hepatocellular Carcinoma No drug interventions Not Available Not Available unknown_status NCT04635527
A Study on the Safety and Effectiveness of IBI318 Combined With Conventional TACE (cTACE) as a Perioperative Treatment for Potentially Resected Hepatocellular Carcinoma No drug interventions treatment 1 terminated NCT06558227
Study of ZG005 Combined With Bevacizumab Versus Sintilimab Combined With Bevacizumab in Advanced Hepatocellular Carcinoma treatment 2 not_yet_recruiting NCT04479527
Evaluation Effectiveness and Safety of (cTACE or DEB-TACE + FOLFOX Regimen HAIC) Combined With Camrelizumab and Apatinib Mesylas in the Treatment of Advanced Hepatocellular Carcinoma treatment 2 unknown_status NCT06478927
Backline Treatment of Advanced Hepatocellular Carcinoma With Palbociclib treatment Not Available recruiting NCT04163627
Changing Trends in HCC Procedures No drug interventions Not Available Not Available unknown_status NCT05536427
Safety and Efficacy of IPM001 in Patients With Advanced Hepatocellular Carcinoma No drug interventions treatment 1 recruiting NCT04517227
The Combination Therapy of TACE and Ablation With Durvalumab in Hepatocellular Carcinoma at Intermediate Stage (TAD) treatment Not Available not_yet_recruiting NCT03916627
Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC in Adult Patients treatment 2 recruiting NCT05594927
Icaritin Soft Capsule Versus Huachansu Tablet in the First-line Treatment of Unresectable Hepatocellular Carcinoma With Poor Conditions and Biomarker Enrichment (Biomarker Enrichment Study of Poor Prognosis HCC Patients, BESTPOP) treatment 3 recruiting NCT04802876
Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients With PD1-high mRNA Expressing Tumors treatment 2 recruiting NCT00441376
A Study of ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver treatment 1 completed NCT03463876
A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Apatinib in Patients With Advanced HCC(RESCUE) treatment 2 completed NCT03222076
Nivolumab With or Without Ipilimumab in Treating Patients With Resectable Liver Cancer treatment 2 completed NCT03969576
Drug-eluting Bead Transarterial Chemoembolisation (DEB-TACE) Versus (VS) Conventional Transarterial Chemoembolisation (cTACE) for Unresectable Hepatocellualr Carcinoma (HCC) No drug interventions treatment Not Available unknown_status NCT04035876
Combination Camrelizumab (SHR-1210) and Apatinib for Downstaging/Bridging of HCC Before Liver Transplant treatment 1 / 2 unknown_status NCT05068076
Role of Perfluorobutane in Lesion Detection, Targeting and Response Assessment for Ablation of HCC diagnostic Not Available completed NCT06061276
bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC treatment Not Available recruiting NCT03233360
Hepatocellular Carcinoma Registry in Asia: The INSIGHT Registry No drug interventions Not Available Not Available completed NCT05397860
Radiofrequency Ablation With Gradual Radiofrequency Energy Increment for Hepatocellular Carcinoma Treatment No drug interventions treatment Not Available unknown_status NCT06331260
Assessment of AFP and PIVKA-II as Prognostic Indicators in Liver Transplantation for Hepatocellular Carcinoma No drug interventions Not Available Not Available not_yet_recruiting NCT00990860
Study in Asia of the Combination of TACE With Sorafenib in HCC Patients Not Available 2 unknown_status NCT01798160
Selective Internal Radiation Therapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Hepatocellular Carcinoma (HCC). No drug interventions treatment 4 completed NCT06400160
Clinical Trial of TB511 in Advanced Solid Tumors treatment 1 / 2 not_yet_recruiting NCT05449860
Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma With Twin Cooled-wet Electrodes No drug interventions treatment Not Available unknown_status NCT04976660
TT-4 as a Single Agent in Subjects With Advanced Selected Solid Tumors No drug interventions treatment 1 / 2 unknown_status NCT00828594
Global Study Looking at the Combination of RAD001 and Sorafenib to Treat Patients With Advanced Hepatocellular Carcinoma treatment 1 terminated NCT04490694
TACE Combined With Lenvatinib for Unresectable Hepatocellular Carcinoma treatment 2 unknown_status NCT04803994
The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma treatment 3 recruiting NCT01351194
Radiofrequency Ablation Versus Hepatic Resection for the Treatment of Hepatocellular Carcinomas Smaller Than 2 cm No drug interventions treatment 4 unknown_status NCT05257694
Clinical Decision Biological Biomarker and Prognosis Prediction of Hepatocellular Carcinoma by Deep Learning No drug interventions Not Available Not Available recruiting NCT04954794
TACE Combined With Sintilimab Plus Bevacizumab Biosimilar in Patients With Advanced Hepatocellular Carcinoma (TASK-02) treatment 2 recruiting NCT04560894
SCT-I10A Plus SCT510 Versus Sorafenib as First-Line Therapy for Advanced Hepatocellular Carcinoma treatment 2 / 3 active_not_recruiting NCT06217094
Study of NP-101 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Undergoing Y-90 Treatment treatment 1 not_yet_recruiting NCT04521491
A Trial of Adjuvant Therapy After Hepatocarcinoma Resection Based on Folate Receptor-positive Circulating Tumor Cells treatment Not Available unknown_status NCT00822991
Sonazoid Enhanced Liver Cancer Trial for Early Detection No drug interventions diagnostic Not Available unknown_status NCT02301091
Combine TACE and RFA Versus TACE Alone for HCC With PVTT treatment 3 unknown_status NCT04209491
Interest of the Intervention of a Nurse Coordinator in Complex Care Pathway No drug interventions Not Available Not Available unknown_status NCT05643391
Safety and Feasibility of Radioembolization Using Ho-166 in Patients With Unresectable Hepatocellular Carcinoma No drug interventions treatment Not Available completed NCT00455091
A Phase III Study in Post-operative HBV-related Hepatocellular Carcinoma Not Available Not Available terminated NCT05458791
Intra-arterial Perfusion in Interventional Radiology No drug interventions Not Available Not Available unknown_status NCT02082691
Continued Administration of G-202 for One Patient With Advanced Hepatocellular Carcinoma Not Available Not Available no_longer_available NCT01092091
Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002) treatment 1 / 2 completed NCT04143191
Sorafenib Plus TACE Versus Sorafenib Alone as Postoperative Adjuvant Treatment for Resectable Primary Advanced HCC prevention 3 unknown_status NCT03338062
A Pilot Study to Assess Theragnostically Planned Liver Radiation to Optimize Radiation Therapy No drug interventions diagnostic Not Available completed NCT05675462
Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib as Second-line or Later Therapy in Patients With Advanced Hepatocellular Carcinoma treatment 1 recruiting NCT03318562
A PD Study of Oral eFT508 in Subjects With Advanced TNBC and HCC treatment 2 terminated NCT05451862
Holmium-166 Transarterial Radioembolization in Unresectable, Early Stage Hepatocellular Carcinoma. No drug interventions treatment Not Available recruiting NCT03812562
Nivolumab and Yttrium-90 in Treating Patients With Liver Cancer Undergoing Surgical Resection treatment 0 terminated NCT06337162
Pre-Transplant INCBB099280 for Hepatocellular Carcinoma (HCC) No drug interventions treatment 1 withdrawn NCT04523662
Study on the Effectiveness and Safety of Carrelizumab Combined With Apatinib Mesylate and Radiotherapy in the Treatment of Advanced Liver Cancer treatment 2 unknown_status NCT02026362
Multiple Antigen Specific Cell Therapy (MASCT) for Hepatocellular Carcinoma(HCC) Patients After Radical Resection or Radio Frequency Ablation(RFA). No drug interventions treatment 1 / 2 suspended NCT01273662
Axitinib as Second-line Treatment for Advanced Hepatocellular Carcinoma treatment 2 completed NCT04264962
Yang Yin Fu Zheng Jie Du Therapy in Recurrence of Hepatocellular Carcinoma Less Than 3 cm in Diameter No drug interventions treatment 0 completed NCT06464380
Anti-cancer Potentiality of Saffron Against Hepatocellular Carcinoma No drug interventions treatment 4 not_yet_recruiting NCT01686880
Y90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic Liver No drug interventions treatment 2 terminated NCT02548780
LifePearl-Doxo Pharmacokinetic (PK) Study No drug interventions treatment Not Available completed NCT04297280
TACE Combined With Anti-PD-1 Antibody in Patients With Advanced Hepatocellular Carcinoma treatment 2 recruiting NCT01775280
Response of Hepatic Tumors to Radioembolization No drug interventions treatment 2 withdrawn NCT04913480
SBRT and Durvalumab for Inoperable/Unresectable Hepatocellular Carcinoma treatment 2 recruiting NCT02867280
Sorafenib Treatment in Patients With Hepatocellular Carcinoma With Microvascular Invasion After Radical Resection treatment 3 terminated NCT05738980
Prevention of Postoperative Recurrence of Hepatocellular Carcinoma by Blocking RAK Cells With Anti-TIM-3 No drug interventions treatment Not Available recruiting NCT02834780
Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma treatment 1 completed NCT01521780
Characterization of Baseline Biomarker Variability in Participants With Hepatocellular Carcinoma (MK-0000-215) No drug interventions diagnostic 1 terminated NCT06546280
A Study of Camrelizumab Plus Apatinib as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Radical Resection or Ablation treatment 2 not_yet_recruiting NCT00426829
Proton Therapy and Bevacizumab for Primary Liver Tumors treatment 1 terminated NCT04476329
Optimization for Regorafenib in HCC treatment 2 terminated NCT01934829
Urea Cream Treatment Sorafenib-Associated HSFR in HCC prevention 2 completed NCT05205629
A Real-world Study of Donafenib Combined With TACE-based Treatment in Patients With Unresectable HCC Not Available Not Available unknown_status NCT01968629
24hr Imaging Of HCC After EOVIST diagnostic 0 withdrawn NCT05967429
Predictors of Sorafenib Response in HCC No drug interventions Not Available Not Available not_yet_recruiting NCT02587689
Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor No drug interventions treatment 1 / 2 unknown_status NCT05155189
A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular Carcinoma treatment 1 recruiting NCT02315989
Early-Phase Safety of Proton Therapy Equipment No drug interventions treatment Not Available completed NCT01131689
Trial of S-1 in Combination With Sorafenib for Patients With Advanced Hepatocellular Carcinoma treatment 1 completed NCT04780789
Volumetric Analysis of Hepatocellular Carcinoma After Transarterial Chemoembolization No drug interventions Not Available Not Available completed NCT04434989
SBRT Versus Ablation for Perivascular Hepatocellular Carcinoma No drug interventions treatment Not Available recruiting NCT03812289
Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer No drug interventions treatment Not Available terminated NCT05406089
Effects of Antiviral Therapy on Patients With HBV-related HCC No drug interventions Not Available Not Available completed NCT05935189
Establishment of a Tissue Registry for Hepatocellular Carcinoma Specimens No drug interventions Not Available Not Available recruiting NCT01901692
Sorafenib vs.TransArterial Chemoembolization Plus RadioTherapy in Hepatocellular Carcinoma With Macrovascular Invasion treatment 2 / 3 completed NCT05432492
A Study of AK112 in Patients With Unresectable Hepatocellular Carcinoma (HCC) treatment 2 unknown_status NCT02867592
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors treatment 2 active_not_recruiting NCT05718492
A Study of the Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents treatment Not Available recruiting NCT03163992
Pembrolizumab in Advanced Hepatocellular Carcinoma as Second-line Treatment After Failure of Sorafenib treatment 2 completed NCT05320692
A Study of TACE Combined With Camrelizumab Plus Rivoceranib (Apatinib) in Patients With Incurable Hepatocellular Carcinoma treatment 3 recruiting NCT05704192
CT-based HVPG Assessment for Predicting the Prognosis of HCC With TACE (CHANCE-CHESS 2302) No drug interventions Not Available Not Available recruiting NCT06349044
A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies. treatment Not Available recruiting NCT03138044
Combined Ipsilateral Liver Lobe Devascularization and Alcohol Treatment of the Large Hepatocellular Carcinoma No drug interventions treatment Not Available unknown_status NCT03379844
HEPAR Primary: Holmium-166-radioembolization in Hepatocellular Carcinoma Patients No drug interventions treatment 2 completed NCT02988440
Study of Safety and Tolerability of PDR001 in Combination With Sorafenib and to Identify the Maximum Tolerated Dose and/or Phase 2 Dose for This Combination in Advanced Hepatocellular Patients treatment 1 completed NCT04237740
Relenvatinib in the Tatment of Recurrence of Hepatocellular Carcinoma After Liver Transplantation No drug interventions treatment 3 unknown_status NCT01806740
DCE-MRI Using Dotarem® in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCC diagnostic 4 terminated NCT03794440
A Study to Evaluate the Efficacy and Safety of Sintilimab in Combination With IBI305 (Anti-VEGF Monoclonal Antibody) Compared to Sorafenib as the First-Line Treatment for Advanced Hepatocellular Carcinoma. treatment 2 / 3 unknown_status NCT03235167
Cytidine-phosphate-guanosine (CpG) DNA in Hepatocellular Carcinoma Combination Therapy No drug interventions treatment 1 unknown_status NCT01850667
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma No drug interventions treatment 2 completed NCT04415567
Adjuvant Lenvatinib Prevents Recurrence of High-risk Patients With HBV-related HCC After Liver Transplantation Not Available Not Available completed NCT00059267
Prevention of Recurrent Hepatitis B After Liver Transplantation Not Available Not Available completed NCT06001567
Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAIC treatment 2 recruiting NCT00142467
Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma treatment 2 completed NCT06512467
Donafenib Combine With Sintilimab and HAIC in Neoadjuvant of Resectable Hepatocellular Carcinoma treatment 2 not_yet_recruiting NCT04472767
Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma treatment 2 recruiting NCT05729867
Efficacy and Safety of a Fully Covered Self-Expandable Metal Stent for Unresectable HCC No drug interventions treatment Not Available recruiting NCT04025567
Vancomycin in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLC) Oral treatment 2 withdrawn NCT04106167
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy No drug interventions Not Available Not Available terminated NCT05323201
Study Of B7H3 CAR-T Cells in Treating Advanced Liver Cancer treatment 1 / 2 recruiting NCT05433701
Stereotactic Body Radiotherapy Versus Radiofrequency Ablation for Unresectable, Small (≤ 3 cm) HCC No drug interventions treatment Not Available active_not_recruiting NCT04653701
Safety and Efficacy of DEB-TACE Performed With a Novel Reflux-control Microcatheter in Patients With HCC No drug interventions Not Available Not Available unknown_status NCT05229601
A Study of HFB301001 in Adult Patients With Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT02759601
Dose Escalation Trial of Tefinostat for Cancer Associated Inflamation in Hepatocellular Carcinoma (HCC) treatment 1 / 2 unknown_status NCT01964001
The Effects of Vitamin B-6 and Coenzyme Q10 Status on Oxidative Stress, Antioxidant Capacities, and Inflammatory Responses in Patients With Liver Cancer No drug interventions prevention 2 / 3 completed NCT01759901
Effect of Vascular Inflow Occlusion in Open Liver Resection for Hepatocellular Carcinoma No drug interventions treatment Not Available completed NCT06358001
EchoTip AcuCore Post-Market Clinical Study No drug interventions Not Available Not Available recruiting NCT01170104
Trial of Transcatheter Arterial Chemoembolization (TACE) With Sorafenib for Locally Advanced Hepatocellular Carcinoma (HCC) treatment 2 unknown_status NCT05201404
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis treatment 3 recruiting NCT01198704
Study of Factors Predicting Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma (HCC) No drug interventions Not Available Not Available completed NCT03203304
Stereotactic Body Radiotherapy (SBRT) Followed by Immunotherapy in Liver Cancer treatment 1 terminated NCT01733004
A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors treatment 1 completed NCT03113604
Analysis of the Role of Hepatocyte SLAMF3 Receptor and Drug Resistance Proteins (MDR) in Resistance to Treatment With Sorafenib in CHC Patients No drug interventions Not Available Not Available withdrawn NCT05240404
Adjuvant Immunotherapy With Toripalimab Following Curative-intent Ablation for Recurrent Hepatocarcinoma treatment 2 unknown_status NCT04386772
Portal Vein Embolization Using Coils Plus TAGM vs Multiple Coils for Patients With Perihilar Cholangiocarcinoma or Hepatocellular Carcinoma No drug interventions treatment Not Available unknown_status NCT00910572
Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular Carcinoma No drug interventions treatment 2 completed NCT04077372
Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers No drug interventions supportive_care Not Available terminated NCT04576572
Comparison of Criteria for Liver Transplantation in Hepatocellular Carcinoma No drug interventions Not Available Not Available completed NCT05563272
89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors diagnostic 2 recruiting NCT05738772
Diagnostic Accuracy of APAC, ASAP and GALAD Scores in Hepatocellular Carcinoma Among Cirrhotic Patients No drug interventions Not Available Not Available not_yet_recruiting NCT00155272
Radiotherapy Plus Thalidomide in Locally Advanced Hepatocellular Carcinoma treatment 1 / 2 unknown_status NCT02527772
Liposomal Doxorubicin Plus Gemcitabine Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma treatment 2 / 3 withdrawn NCT04053972
The Impact on Recurrence Risk of Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial. treatment 3 unknown_status NCT02686372
A Study of TCR-Redirected T Cell Infusion to Prevent Hepatocellular Carcinoma Recurrence Post Liver Transplantation No drug interventions prevention 1 completed NCT00629668
Genetic Polymorphisms of TNF-α Promoter and HBV Genotype on Outcome of HBV-Related Chronic Liver Disease No drug interventions basic_science Not Available unknown_status NCT00720668
The Risk of Exacerbation of Chronic Hepatitis B After Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma No drug interventions Not Available Not Available unknown_status NCT03734068
Chemoembolization Using LifePearl Polyethylene Glycol Drug Eluting Microspheres With Doxorubicin in HCC Not Available Not Available unknown_status NCT03110068
Preoperative Estimation of Microvascular Invasion in Hepatocellular Carcinoma No drug interventions Not Available Not Available unknown_status NCT05976568
A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma treatment 2 / 3 not_yet_recruiting NCT04069468
Non-Interventional Registry Study to Evaluate the Effectiveness of TheraSphere® in the Treatment of Hepatocellular Carcinoma (HCC) No drug interventions Not Available Not Available active_not_recruiting NCT00838968
The Efficiency of Postoperative Interferon-alpha Treatment in p48 Positive Patients With Hepatocellular Carcinoma prevention Not Available withdrawn NCT04313868
GEN2 Directed Cancer Immunotherapy Trial other 1 active_not_recruiting NCT05897268
Cryoablation Combined With Tislelizumab Plus Lenvatinib in 1L Treatment of Advanced HCC (CASTLE-10) treatment 2 recruiting NCT06362369
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy treatment 1 / 2 recruiting NCT02238769
18F-FluoroethylCholine Positron Emission Tomography: a Promising Diagnostic Tool for Hepatocellular Carcinoma No drug interventions Not Available Not Available unknown_status NCT06089369
Postoperative Adjuvant Sintilimab in Hepatocellular Carcinoma With Microvascular Invasion treatment 3 not_yet_recruiting NCT03849469
A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors treatment 1 completed NCT00825669
Treatment of Portal Vein Tumor Thrombus After Hepatocellular Carcinoma Resection No drug interventions treatment Not Available completed NCT01894269
Chemoembolization With or Without Antiviral Therapy for Unresectable HBV-related HCC With Low HBV DNA Replication treatment 4 unknown_status NCT01375569
TRC105 for Liver Cancer That Has Not Responded to Sorafenib treatment 2 completed NCT03515369
Effect of Babaodan on Tumor Recurrence After Curative Resection of Hepatocellular Carcinoma No drug interventions treatment 4 unknown_status NCT04773769
Study of Guanábana Leaves for The Treatment of Patients With Gastric, Gastroesophageal Junction, Pancreatic and Colorectal Adenocarcinomas; Hepatocellular Carcinoma, and Low Grade Lymphomas No drug interventions treatment Not Available unknown_status NCT01332669
Drug-eluting Bead in Hepatocellular Carcinoma No drug interventions treatment 4 completed NCT06007846
A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer treatment 2 / 3 recruiting NCT01165346
Stereotaxic Irradiation of Hepatocellular Carcinoma No drug interventions treatment 2 completed NCT02757846
Radiomics of Hepatocellular Carcinoma No drug interventions Not Available Not Available unknown_status NCT05844046
Sequential or Up-front Triple Treatment With Durvalumab, Tremelimumab and Bevacizumab for Non-resectable Hepatocellular Carcinoma (HCC) Patients treatment 2 recruiting NCT06503146
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection No drug interventions diagnostic 2 not_yet_recruiting NCT05352646
NewishT Cell Therapy for HCC With High Risk of Recurrence After Radical Resection No drug interventions treatment 1 recruiting NCT05047146
The Clinicopathological and Prognostic Factors of Hepatocellular Carcinoma; 10 Years' Tertiary Center Experience in Egypt No drug interventions Not Available Not Available completed NCT03973112
A Clinical Study Evaluating the Use of HLX10 in Combination With HLX04 for the Treatment of Advanced Hepatocellular Carcinoma (HCC) Patients treatment 2 unknown_status NCT02539212
Comparison of Microwave and Radiofrequency Ablation for Liver No drug interventions treatment Not Available completed NCT02626312
Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function No drug interventions treatment 1 active_not_recruiting NCT01686412
Determination of Autonomic Responses to Exposure to Electromagnetic Fields With Low Energy Modulated Frequency No drug interventions health_services_research Not Available completed NCT04844112
CT/MR-US Automatic Fusion System in Pre-procedure Planning for Radiofrequency Ablation No drug interventions treatment Not Available completed NCT05739110
HCC Staging Modified by Tumor Micronecrosis No drug interventions Not Available Not Available completed NCT01489410
Comparing Lipiodol/Ethanol With Drug-eluting Beads (DEB) for Hepatocellular Carcinoma treatment Not Available withdrawn NCT04892810
Immunomonitoring of Interventional Radiology Procedures in the Management of Hepatocellular Carcinoma No drug interventions Not Available Not Available unknown_status NCT03841110
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors treatment 1 completed NCT03731910
Short-term MRI for Treatment Response Evaluation/Prediction of HCC Treated With TARE No drug interventions other Not Available unknown_status NCT02968810
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis prevention 2 active_not_recruiting NCT03259581
Safety of Transarterial Chemoembolization (TACE) in the Setting of an Elevated Bilirubin No drug interventions treatment 1 completed NCT04550481
Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study prevention 2 recruiting NCT04573881
The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy (#HOPE4LIVER EU/UK) No drug interventions treatment Not Available active_not_recruiting NCT05304481
Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma No drug interventions treatment 2 recruiting NCT01088581
Adjuvant Hepatic Arterial Infusional Chemotherapy After Curative Resection of Hepatocellular Carcinoma No drug interventions treatment 3 completed NCT00460681
Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular Carcinoma prevention 3 unknown_status NCT01837381
Transarterial Ethanol Ablation(TEA) for Unresectable Hepatocellular Carcinoma(HCC) No drug interventions treatment Not Available completed NCT06233981
Phase II Study of Moderate-dose Hypofractionated RT Combined With Tislelizumab for HCC With Diffuse Tumor Thrombosis treatment 2 recruiting NCT04798781
Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma treatment 2 active_not_recruiting NCT03375281
Radiofrequency Ablation Using Octopus Electrodes for Small Hepatocellular Carcinoma With No-touch Technique No drug interventions treatment Not Available completed NCT01668381
Enumeration and Function Analysis of Treg Cells in Peripheral Blood of HCC Patients Before and After Ablation Therapy No drug interventions Not Available Not Available unknown_status NCT01018381
Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C Infection treatment Not Available completed NCT05250895
BOLD MRI and FMISO PET for the Assessment of Hypoxic Tumor Microenvironment in Patients With Oligometastatic Liver Cancer Undergoing Yttirum-90 Selective Internal Radiation Therapy No drug interventions diagnostic 0 recruiting NCT06527495
Clinical Pharmacogenetic Study of Sorafenib in Egyptian Patients With Hepatocellular Carcinoma treatment 1 / 2 recruiting NCT05278195
Assessing the Prognosis of TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for HCC by Using Clinical and Imaging Biomarkers No drug interventions Not Available Not Available unknown_status NCT01657695
Hepatocellular Carcinoma Growth and Molecular Aggressiveness No drug interventions Not Available Not Available completed NCT00390195
Randomized Phase I/II of RAD001 in Advanced Hepatocellular Carcinoma (HCC) treatment 1 / 2 unknown_status NCT00351195
Etoposide, Oxaliplatin and Capecitabine in Advanced Hepatocellular Carcinoma (HCC) treatment 2 terminated NCT02269995
Post-marketing Surveillance of DC Bead in Patients With Hepatocellular Carcinoma No drug interventions Not Available Not Available completed NCT05435014
T-ACE Oil by TAE/TACE in Patients With Hepatocellular Carcinoma treatment 1 / 2 recruiting NCT04118114
Phase II Study of PRL3-ZUMAB in Advanced Solid Tumors No drug interventions treatment 2 recruiting NCT05987514
Multimodal Ultrasound and Hepatocellular Response to Local Treatments No drug interventions diagnostic Not Available recruiting NCT06342414
An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer No drug interventions Not Available Not Available recruiting NCT01432314
Efficacy of Radiation Therapy and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma (HCC) No drug interventions treatment 2 withdrawn NCT05111314
Comparison of Hepatic Intraarterial Versus Systemic Intravenous 68Ga-PSMA PET/CT for Detection of Hepatocellular Carcinoma No drug interventions diagnostic 0 withdrawn NCT01259414
Comparison of Two Solvents Used With Chemotherapy Agent for Transarterial Chemoembolization of Hepatocellular Carcinoma No drug interventions treatment 3 completed NCT00746655
SBRT + TACE for Primary Hepatocellular Carcinoma No drug interventions treatment Not Available withdrawn NCT00892255
Microwave Ablation of Resectable Liver Tumors No drug interventions Not Available Not Available withdrawn NCT06148155
A Study of [68Ga]Ga-NOTA-RG2 PET Imaging in the Diagnosis of Hepatocellular Carcinoma No drug interventions diagnostic Not Available recruiting NCT03349255
Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular Carcinoma No drug interventions treatment 1 terminated NCT06239155
A Phase I/II Study of AST-3424 in Subjects With Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT01387555
A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib treatment 2 completed NCT02549755
11C-acetate for Treatment Response After Radiotherapy for HCC basic_science 2 terminated NCT02426450
RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCC treatment 2 unknown_status NCT04767750
Role of LncRNA H19 in The Regulation of IGF-1R Expression No drug interventions Not Available Not Available completed NCT01438450
Oral Chemotherapy Versus Supportive Therapy In The Treatment Of Unresectable Hepatocellular Carcinoma No drug interventions treatment 2 / 3 unknown_status NCT02395250
Anti-GPC3 CAR T for Treating Patients With Advanced HCC No drug interventions treatment 1 completed NCT03839550
Combine Apatinib Mesylate With PD-1 Antibody SHR-1210 for HCC With High Risk of Recurrence After Radical Resection treatment 2 unknown_status NCT00819650
A Trial of Licartin for Preventing Tumor Recurrence After Liver Resection No drug interventions treatment 2 completed NCT05962450
Adoptive Autologous iNKT Cells for the Treatment of Progressed Hepatocellular Carcinoma Continuing on PD-1 Inhibitor Therapy treatment 2 recruiting NCT00605150
HDE Use Protocol of TheraSphere for Treatment of Unresectable HCC No drug interventions Not Available Not Available completed NCT05623150
CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome No drug interventions Not Available Not Available not_yet_recruiting NCT00479050
Combination Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Greater Than 3 cm No drug interventions treatment 1 completed NCT06265350
Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases treatment Not Available recruiting NCT04204850
Cabozantinib to Treat Recurrent Liver Cancer Post Transplant treatment 2 recruiting NCT03586050
Study to Evaluate the Safety and Effectiveness of Microwave Ablation in Patients With Hepatocellular Carcinoma in Korea No drug interventions treatment Not Available completed NCT03048123
HAIC Versus TACE for Large and Unresectable Hepatocellular Carcinoma Staged BCLC A/B No drug interventions treatment 2 completed NCT03776123
Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients No drug interventions Not Available Not Available completed NCT05711823
Aprepitant Plus Granisetron and Dexamethasone for the Prevention of Vomiting in Patients With HAIC Therapy for HCC prevention 3 not_yet_recruiting NCT02702323
Treatment Patients With Pulmonary Metastasis of Liver Cancer With Apatinib Combination With TACE: a Clinical Study treatment 2 / 3 unknown_status NCT01328223
Study of Combined Sorafenib With Radiotherapy in Patients With Advanced Hepatocellular Carcinoma No drug interventions Not Available Not Available unknown_status NCT03731923
Abbreviated MRI for HCC Surveillance No drug interventions other Not Available active_not_recruiting NCT01290523
Yttrium-90 Radioembolization With Glass Microspheres (TheraSphere) for Patients With Hepatocellular Carcinoma No drug interventions treatment Not Available terminated NCT06070623
Follow up After TACE by Elastography and Color Doppler. No drug interventions Not Available Not Available not_yet_recruiting NCT04202523
Combined Radiotherapy and Radiofrequency Ablation for Hepatocellular Carcinoma No drug interventions treatment 3 unknown_status NCT02967523
Surefire Precision Infusion System Registry No drug interventions Not Available Not Available terminated NCT06540508
Application of Integrated Proteomic and Serum Metabolomic Analysis in Assessing the Efficacy and Prognosis of TACE Combined With Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma No drug interventions Not Available Not Available enrolling_by_invitation NCT05440708
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma treatment 1 / 2 recruiting NCT03307408
Hepatocellular Carcinoma in Patients With a Cirrhosis Due to an Alcoholic or a Non Alcoholic Fatty Liver Disease No drug interventions Not Available Not Available unknown_status NCT01402908
A Phase III PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related HCC After Surgical Resection treatment 3 terminated NCT05484908
Efficacy and Safety of ALSS Treatment for ICIs-LF in Patients With HCC No drug interventions treatment Not Available recruiting NCT05971108
Real-world Elecsys® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCC No drug interventions diagnostic Not Available recruiting NCT02946138
Phase II Trial of Carbon-ion Radiotherapy Combined With GM-CSF for the Treatment of Hepatocellular Carcinoma No drug interventions treatment 2 withdrawn NCT03852238
Risk Factors of Hepatocellular Carcinomas Developed on Non-fibrotic Liver: Case-control Study (NoFlic Study) No drug interventions Not Available Not Available completed NCT01215838
MRI of the Liver With Eovist No drug interventions Not Available Not Available terminated NCT02683538
Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies No drug interventions treatment 2 completed NCT06261138
Survival Analysis: TACE vs. Combination Therapy in HCC No drug interventions Not Available Not Available completed NCT05557838
Study of Durvalumab Plus Tremelimumab as First-line Treatment in Chinese Patients With Unresectable Hepatocellular Carinoma treatment 3 recruiting NCT05564338
Efficacy and Safety of Sitravatinib Plus Tislelizumab or Placebo Plus Tislelizumab Versus Placebo as Adjuvant Treatment in Participants With Hepatocellular Carcinoma treatment 3 withdrawn NCT06526338
Adjuvant IP-001 Treatment for HCC Patients Following Surgical Resection and Ablation or Ablation Alone No drug interventions treatment 2 recruiting NCT05897138
A Study to Evaluate Lenvatinib Plus Tislelizumab for Locally Advanced Unresectable or Metastatic Hepatocellular Carcinoma With Hepatitis B Virus Infection and Biomarker Analyses treatment 2 not_yet_recruiting NCT04712643
A Study of TACE Combined With Atezolizumab Plus Bevacizumab or TACE Alone in Patients With Untreated Heaptocellular Carcionma treatment 3 active_not_recruiting NCT04806243
Carelizumab Combined With Regorafenib in the Treatment of HCC（CARE-2020） treatment 2 unknown_status NCT01595243
Effects of Telephone Consultations on Discharged Liver Cancer No drug interventions supportive_care Not Available completed NCT05161143
Donafenib Combined With TACE as Adjuvant Therapy of Patients With Hepatocellular Carcinoma treatment 2 not_yet_recruiting NCT04424043
Neo-TACE-HAIC for BCLC B Stage HCC No drug interventions treatment Not Available recruiting NCT02526043
Laparoscopic Versus Open Liver Resection for Hepatocellular Carcinoma No drug interventions treatment Not Available unknown_status NCT01300143
Association of Conformational High-dose Radiotherapy and of Hyperselective Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma No drug interventions treatment 2 completed NCT04843943
Sintilimab Combined With Bevacizumab Biosimilar for Potentially Resectable Intermediate HCC treatment 1 / 2 unknown_status NCT01348503
Lenalidomide in Combination With a Fixed Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma treatment 1 terminated NCT03416803
A Study of Individualized Radiotherapy Based on a Prediction Model of Lymph Node Metastasis in Hepatocellular Carcinoma No drug interventions prevention Not Available unknown_status NCT03511703
The Study of The Treatment of Postoperative Adjuvant Apatinib vs. TACE in Hepatocellular Carcinoma Patients treatment 2 unknown_status NCT03047603
Evaluation of Diagnostic Efficiency of PIVKA-II and Other Tumor Markers in HCC No drug interventions Not Available Not Available completed NCT01639703
Hepatic Xenetix-CT Perfusion diagnostic 4 completed NCT01128803
Immunotherapy of Hepatocellular Carcinoma by Induction of Anti-alpha Fetoprotein Response No drug interventions treatment 1 / 2 terminated NCT05772403
Contrast Enhanced Ultrasound (CEUS) in Atypical Liver Nodules in Patients With Chronic Liver Disease No drug interventions Not Available Not Available completed NCT03302403
Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors treatment Not Available unknown_status NCT00746590
Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular Carcinoma treatment 2 terminated NCT02232490
Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-L treatment 3 unknown_status NCT05616390
Sintilimab Combined With Bevacizumab and Liver Protective Support Therapy in Unresectable Hepatocellular Carcinoma treatment 2 recruiting NCT06313190
Combination of SBRT and Immunotherapy in Small Hepatocellular Carcinoma (HSBRT2402) treatment 2 not_yet_recruiting NCT05429190
Validation of SMS Protocol for HCC Screening in High-risk Patients No drug interventions Not Available Not Available enrolling_by_invitation NCT05113290
Effect and Safety of Recombinant Human Adenovirus Type 5 in Advanced HCC With Stable Disease After Sorafenib Treatment treatment 4 unknown_status NCT05257590
CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular Carcinoma treatment 2 recruiting NCT03516890
Management of Spontaneous Ruptured Hepatocellular Carcinoma No drug interventions Not Available Not Available completed NCT05752890
A Novel Biomarker for Response and Prognosis of HBV-related Hepatocellular Carcinoma No drug interventions Not Available Not Available not_yet_recruiting NCT00712790
Study of SIR-Spheres Plus Sorafenib as 1st Line Treatment for Non-resectable Primary Hepatocellular Carcinoma (HCC) treatment 1 / 2 completed NCT01465464
Orantinib In Combination With Transcatheter Arterial Chemoembolization In Patients With Unresectable Hepatocellular Carcinoma treatment 3 terminated NCT02436564
In Vitro Models of Liver and Pancreatic Cancer No drug interventions Not Available Not Available unknown_status NCT03739164
Tampa Associating Microwave Liver Ablation With Portal Vein Ligation for Staged Hepatectomy (TAMLAPS) No drug interventions Not Available Not Available enrolling_by_invitation NCT01956864
Study of High-Dose Oral Vitamin D for the Prevention of Liver Cancer other 1 withdrawn NCT03086564
A Basic-clinical Translational Research in Hepatitis B Virus (HBV)-Specific Antigen Peptides and HepG2 Cell Lysate Co-activated Dendritic Cells Combined With Transarterial Chemoembolization (TACE) in HBV-related HCC Treatment (BTRHBVAPHCLCDCCTCHBVHCCT) No drug interventions treatment 1 / 2 completed NCT02202564
Preliminary Results for the Double-dose Adenovirus-mediated Adjuvant Therapy Improving Outcome of Liver Transplantation in Patients With Advanced Hepatocellular Carcinoma treatment 2 completed NCT02151864
LDE225 in Patients With Advanced or Metastatic Hepatocellular Carcinoma and Child-Pugh A/B7 Cirrhosis treatment 1 completed NCT06405321
Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma No drug interventions Not Available Not Available recruiting NCT06519721
Safety and Efficacy Study of Lenvatinib Combined With VIC-1911 for the Treatment of Advanced HCC treatment Not Available recruiting NCT05339321
Autologous HBV-specific T Cell Receptor Engineered T Cells (TCR-T) in Patients With HBV-related Advanced HCC No drug interventions treatment 1 unknown_status NCT05200221
A Single Center Real-world Study of Donafenib in the Treatment of Hepatocellular Carcinoma in Routine Clinical Practice No drug interventions Not Available Not Available unknown_status NCT00629421
Early Screening of Hepatocellular Carcinoma in Cirrhotic Patients: a Prospective Study No drug interventions Not Available Not Available completed NCT00300521
Liver Transplantation With ADV-TK Gene Therapy Improves Survival in Patients With Advanced Hepatocellular Carcinoma No drug interventions treatment 2 completed NCT04715321
CT Perfusion Parameters Predict Vascular Pattern in Hepatocellular Carcinoma No drug interventions Not Available Not Available unknown_status NCT01379521
Safety and Efficacy of RAD001 + TACE in Localized Unresectable HCC treatment 2 terminated NCT05431621
Establishment of Molecular Classification Models for Early Diagnosis of Digestive System Cancers No drug interventions Not Available Not Available completed NCT05302921
Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors treatment 2 active_not_recruiting NCT05613621
Dissection of the Molecular and Immunological Interaction in Patients With HCC of Viral and Non-viral Etiologies No drug interventions Not Available Not Available enrolling_by_invitation NCT05332821
TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Advanced HCC Not Available Not Available recruiting NCT02329821
Change of Lactate Concentration During Hartmann Solution Infusion for Hepatic Resection No drug interventions Not Available Not Available completed NCT03518502
Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With Metastasis treatment 4 unknown_status NCT04297202
SHR-1210 Combined With Apatinib Mesylate in the Perioperative Treatment of Hepatocellular Carcinoma treatment 2 unknown_status NCT00902902
A Clinical Study of GP73 as a Hepatocellular Carcinoma (HCC) Tumor Mark No drug interventions Not Available Not Available unknown_status NCT00242502
Efficacy and Safety Study of Bevacizumab and Erlotinib to Treat Primary Liver Cancer That Cannot be Removed By Surgery treatment 2 completed NCT04260802
A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers treatment 1 / 2 recruiting NCT00906984
TheraSphere® for Treatment of Unresectable Hepatocellular Carcinoma No drug interventions Not Available Not Available approved_for_marketing NCT05992584
Lenvatinib, Sintilimab Plus SIRT for Unresectable HCC treatment 2 recruiting NCT03116984
A Study of Comparison of TACE Combination With and Without EBRT for Advanced HCC No drug interventions treatment 3 unknown_status NCT04797884
Electromagnetic Fields Versus Placebo For Child-Pugh A and B Patients With Advanced Hepatocellular Carcinoma No drug interventions treatment 2 / 3 recruiting NCT01137084
Liver Transplantation Results in Hepatocellular Carcinoma Patients With Immunosuppression Without Steroids treatment Not Available completed NCT00618384
TACE and Sorafenib for Advanced Hepatocellular Carcinoma (HCC) treatment 2 terminated NCT06084884
A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma No drug interventions treatment 1 / 2 recruiting NCT02851784
Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma No drug interventions treatment 2 / 3 completed NCT00826384
Transarterial Chemoembolization (TACE) Therapy of Hepatocellular Carcinoma (HCC) With Blocking Tumor Blood Temporarily and Enhancing Perfusion No drug interventions treatment 1 / 2 completed NCT02587884
Anti-recurrence Treatment of Postresection on HCC Patients With MVI Presence and Over-expression of ASPH No drug interventions treatment 1 unknown_status NCT05635279
Effect of Nutritional Indices on the Prognosis of HCC Patients No drug interventions Not Available Not Available recruiting NCT05498779
Ablation of Hepatocellular Carcinoma: a Nationwide Study No drug interventions Not Available Not Available completed NCT03422679
Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies treatment 1 / 2 terminated NCT05009979
18F-DCFPyL PET/CT in Hepatocellular Carcinoma diagnostic 2 recruiting NCT02412579
Genetic Profiling of Liver Cancer in Patients Undergoing Liver Transplantation No drug interventions Not Available Not Available completed NCT03175679
Adoptive Transfer of iNKT Cells for Treating Patients With Relapsed/Advanced HCC treatment 1 unknown_status NCT06096779
A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Patients With Unresectable Hepatocellular Carcinoma and Child-Pugh B7 and B8 Cirrhosis treatment 2 recruiting NCT01316679
An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423 No drug interventions Not Available Not Available completed NCT03046979
Study of Apatinib in Advanced Hepatocellular Carcinoma(HCC) treatment 2 unknown_status NCT03469479
Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria No drug interventions treatment 3 unknown_status NCT04266548
Arterial Base Fluorescence Segmental Positive Staining No drug interventions treatment Not Available completed NCT05007548
to Assess the Accuracy and Reliability of the Ga68-Dolacga Positron Emission Tomography Compared to Computer Tomography Volumetry and Indocyanine Green Retention Test for Measurement of Liver Reserve No drug interventions diagnostic 2 completed NCT01350726
Functional-three-dimensional Reconstruction of Liver by 99MTc-GSA-SPECT Scan No drug interventions Not Available Not Available unknown_status NCT00884520
An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037 Not Available 0 completed NCT03572582
Transarterial Chemoembolization in Combination With Nivolumab Performed for Intermediate Stage Hepatocellular Carcinoma treatment 2 completed NCT03164382
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma treatment 3 completed NCT01770431
Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma After Radical Hepatectomy No drug interventions treatment 4 completed NCT06085976
Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements. prevention 2 recruiting NCT03149523
Exhaustive Genetic and Immunological Characterization of Colon, Kidney and Liver Tumors No drug interventions Not Available Not Available unknown_status NCT04220944
Combined Locoregional Treatment With Immunotherapy for Unresectable HCC. treatment 1 active_not_recruiting NCT06311396
Development of a Neuronal Microscope No drug interventions prevention Not Available recruiting NCT06245798
Liver Resection for Patients With Hepatocellular Carcinoma and Clinically Significant Portal Hypertension No drug interventions Not Available Not Available completed NCT06182865
A Study of Ga-68 Dolacga to Evaluate Liver Reserve Function in Patients With HCC Before and After Proton Therapy No drug interventions diagnostic Not Available not_yet_recruiting NCT04246970
Prehabilitation and Posttransplant Training Program in Liver Transplantation No drug interventions treatment Not Available enrolling_by_invitation NCT05009550
ESP Block on Patient Outcomes in Patients With Liver Tumor Undergoing Radiofrequency Ablation No drug interventions treatment Not Available recruiting NCT04775056
A Study to Evaluate Vaccines Against COVID-19 in the Real World No drug interventions Not Available Not Available withdrawn NCT04538313
A Clinical Study in Patients With High-risk Recurrent Primary Hepatocellular Carcinoma Using Autologous TILs No drug interventions treatment 1 / 2 unknown_status NCT03307811
Endoscopic Ultrasound Guided Liver Biopsy No drug interventions diagnostic Not Available completed NCT03253250
The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by Resection treatment 4 unknown_status NCT03163186
Transradial Versus Transfemoral Arterial Access in Liver Cancer Embolization: Randomized Trial to Assess Patient Outcomes and Satisfaction (BEST ACCESS Trial). No drug interventions Not Available Not Available completed NCT03132740
Impact of Three-dimensional Visualization on Operation Strategy and Complications for Complex Hepatic Carcinoma No drug interventions Not Available Not Available unknown_status NCT03013712
A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer No drug interventions treatment 1 / 2 unknown_status NCT02352935
Percutaneous Irreversible Electroporation for Unresectable Hepatic Carcinoma in Poor Liver Function No drug interventions treatment Not Available completed NCT02332551
Percutaneous Irreversible Electroporation to Treat Liver Cancer Close to the Gallbladder No drug interventions treatment Not Available completed NCT01760616
Huaier Granule for Prevention of Disease Progression of Hepatocarcinoma After Non-radical Hepatectomy No drug interventions prevention 4 terminated NCT00858871
First Line Hepato Cellular Carcinoma (HCC) treatment 3 completed NCT01008657
Multipolar Radiofrequency Ablation for Hepatocellular Carcinoma Using Extra Nodular Versus Intranodular Technique No drug interventions treatment Not Available completed NCT01641276
Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular Carcinoma No drug interventions diagnostic Not Available completed NCT01126463
188RE-SSS Lipiodol to Treat HepatoCellular Carcinomas treatment 1 completed NCT05580835
PET / MR With PSMA for Diagnosis and Staging of Hepatocellular Carcinoma No drug interventions diagnostic Not Available recruiting NCT04732286
A Study of Atezolizumab in Combination With Bevacizumab in Spanish Patients With Unresectable or Unsuitable for Locoregional Treatments Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy treatment 3 completed NCT02366286
Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants No drug interventions Not Available Not Available completed NCT06178939
Effects of Cognitive Intervention Therapy on Postoperative Delirium No drug interventions other Not Available not_yet_recruiting NCT01908322
Investigating Patient Characteristics of Intermediate Stage Hepatocellular Carcinoma Patients Treated With Nexavar and Their Distribution to Different Treatment Groups as Well as Determining Effectiveness and Safety Not Available Not Available completed NCT02070822
3T MRI to Predict TACE Response of HCC No drug interventions Not Available Not Available unknown_status NCT01839630
Sorafenib Concomitantly Used With TACE (Transarterial Chemoembolization) in uHCC (Unresectable Hepatocellular Carcinoma) Patients in China Not Available Not Available completed NCT06156748
CT Imaging for Guiding PA-TACE for HCC No drug interventions Not Available Not Available recruiting NCT00913757
A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area No drug interventions Not Available Not Available completed NCT02018757
Safety and Efficacy of Arsenic Trioxide Contained in TACE in the Treatment of HCC No drug interventions treatment 2 unknown_status NCT03389126
Phase II Study of Avelumab in Patients With Advanced Hepatocellular Carcinoma After Prior Sorafenib Treatment treatment 2 completed NCT02788526
Adjuvant TACE to Reduce the HCC Recurrence After Resection No drug interventions treatment 3 completed NCT02716766
Study of SECOX Versus Sorafenib as First-Line Treatment in Patients With Advanced Hepatocellular Carcinoma (HCC) treatment 2 completed NCT02779465
Oral Vitamin D Treatment for the Prevention of Hepatocellular Carcinoma prevention 4 not_yet_recruiting NCT00699374
Study Of Sunitinib Malate Versus Sorafenib In Patients With Inoperable Liver Cancer treatment 3 terminated NCT01171482
Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma treatment 2 terminated NCT00082082
A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma treatment 2 completed NCT01177631
Proteomic Analysis of Human Hepatocellular Carcinoma No drug interventions basic_science Not Available completed NCT03941873
A Study to Investigate Sitravatinib as Monotherapy and in Combination With Tislelizumab in Participants With Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) or Gastric/Gastroesophageal Junction Cancer (GC/GEJC) treatment 1 / 2 completed NCT02115373
c-Met Second-Line Hepatocellular Carcinoma treatment 1 / 2 completed NCT01911273
A Study To Evaluate The Efficacy And Safety of The Investigational Drug PF-03446962 (A Monoclonal Antibody With Antiangiogenic Features) In Combination With Best Supportive Care Versus Placebo Plus Best Supportive Care In Patients Affected By Recurrent Liver Cancer treatment 2 terminated NCT05653427
A Study of Amivantamab Monotherapy in Participants With Previously Treated Advanced Hepatocellular Carcinoma treatment 2 terminated NCT02806076
RFA for Small HCC With No-touch Technique and Dual Cooled-Wet Electrode No drug interventions treatment Not Available unknown_status NCT04172194
Endoarterial Treatment in Combination With Percutaneous Thermoablation for Medium-sized and Oligonodular Hepatocellular Carcinomas No drug interventions Not Available Not Available completed NCT02148562
Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker Diversity No drug interventions Not Available Not Available unknown_status NCT06349980
A Study to Explore the Reasonable Dosage and Evaluate the Efficacy, Safety and Tolerability of HLX10 and HLX04 With or Without HLX53 in Untreated, Locally Advanced or Metastatic Hepatocellular Carcinoma Patients. treatment 2 not_yet_recruiting NCT02580929
Clinical Study of Effectiveness of Radiotherapy Before Surgery in High-risk Relapse Hepatocellular Cancer Patients No drug interventions treatment Not Available unknown_status NCT01915589
Refametinib(BAY86-9766) in RAS Mutant Hepatocellular Carcinoma (HCC) treatment 2 completed NCT00936689
Traditional (Traditional Chemoembolization) TACE Versus Microsphere TACE No drug interventions treatment 4 completed NCT03253289
Meclizine for Hepatocellular Carcinoma treatment 1 active_not_recruiting NCT00610389
Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors No drug interventions treatment 2 unknown_status NCT00920192
Safety Study of Foretinib (GSK1363089) in Adults With Liver Cancer treatment 1 completed NCT03347292
Regorafenib Plus Pembrolizumab in First Line Systemic Treatment of HCC treatment 1 completed NCT01774344
Study of Regorafenib After Sorafenib in Patients With Hepatocellular Carcinoma treatment 3 completed NCT02403544
Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular Carcinoma treatment 1 unknown_status NCT00397540
The Effect of Viral Load on Intrahepatic Recurrence in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC) No drug interventions treatment Not Available completed NCT04487067
A Study of Atezolizumab (Tecentriq) in Combination With Bevacizumab to Investigate Safety and Efficacy in Patients With Unresectable Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy-Amethista treatment 3 completed NCT02847767
Dynamic Contrast Enhanced HCC SABR Liver Study No drug interventions diagnostic Not Available unknown_status NCT00503867
SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma No drug interventions treatment Not Available terminated NCT00178867
A National Registry of Patients With Hepatocellular Carcinoma No drug interventions Not Available Not Available completed NCT00508001
Phase II Study of Best Support Care (BSC) Plus ZD6474(Vandetanib) in Patients With Inoperable Hepatocellular Carcinoma (HCC) treatment 2 completed NCT02973204
Circulating Tumor Cells and Tumor DNA in HCC and NET Not Available Not Available completed NCT04471272
RFA Using Gradual RF Energy Delivery Mode With Octopus Electrodes No drug interventions treatment Not Available unknown_status NCT02847468
Multimetabolic 18F-Fluorodeoxyglucose (FDG) and 18F-Fluorocholine (FCH) Positron Emission Tomography (PET) as an Early Predictive Factor of Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib No drug interventions diagnostic Not Available terminated NCT00701168
Therasphere® for Treatment of Unresectable Primary Liver Cancer and Metastatic Liver Cancer No drug interventions Not Available Not Available no_longer_available NCT01507168
A Study of GC33 (RO5137382) in Patients With Advanced or Metastatic Hepatocellular Carcinoma treatment 2 completed NCT01669668
Radiofrequency Ablation in Treating Patients With Liver Cancer (Hepatocellular Carcinoma) No drug interventions treatment 2 withdrawn NCT00662246
Dose Escalation Study Using Proton Beam Radiotherapy for Hepatocellular Carcinoma No drug interventions treatment 1 completed NCT03008512
A Phase II Study of Weekly Genexol-PM in Patients With Hepatocelluar Carcinoma After Failure of Sorafenib treatment 2 terminated NCT04970212
Safety and Effectiveness of BioTraceIO Lite for Tissue Damage Assessment Following Liver Tissue Ablation Procedures No drug interventions Not Available Not Available completed NCT00355212
Comparison Between Radiofrequency Versus Ethanol Injection for the Treatment of Hepatocellular Carcinoma No drug interventions treatment 3 terminated NCT00563095
A Comparative Study of the Efficacy of Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Pegylated Interferon Embolization (TAIE) for Liver Cancer No drug interventions treatment Not Available unknown_status NCT03663114
A Post-marketing Observational Study on Risk Factors for Hepatic Encephalopathy in Participants With Unresectable Hepatocellular Carcinoma Not Available Not Available completed NCT00355355
A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC) treatment 3 completed NCT01201655
Study of the Impact of Hypersplenism and Splenectomy on Hepatocarcinogenesis in Patients With Posthepatitic Cirrhosis No drug interventions Not Available Not Available unknown_status NCT03766555
Microwave Ablation Versus Liver Resection For Early Hepatocellular Carcinoma in Patients With Borderline Liver Function No drug interventions treatment Not Available recruiting NCT00792350
INSIGHT - Post Marketing Surveillance Not Available Not Available completed NCT06384950
Evaluating the Role of ChatGPT in Educating Patients With Early-stage Hepatocellular Carcinoma No drug interventions health_services_research Not Available recruiting NCT03878550
Case-Control Study of the Glycotest™ HCC Panel vs AFP for the Detection of Early-stage Hepatocellular Carcinoma No drug interventions Not Available Not Available active_not_recruiting NCT00635323
Safety And Efficacy Of Irinotecan Plus Capecitabine As First-Line Treatment In Asian Subjects With Hepatocellular Carcinoma treatment 2 completed NCT00844623
TK-based Suicide Gene Therapy for Hepatocellular Carcinoma No drug interventions treatment 1 completed NCT01308723
A Dose-Finding and Exploratory Study of RO5323441 in Combination With Sorafenib in Patients With Hepatocellular Carcinoma treatment 1 completed NCT03191123
Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma With Solitary Huge Tumor No drug interventions treatment Not Available unknown_status NCT03088423
HCC Response Assessment by MRI After SBRT No drug interventions Not Available Not Available completed NCT01258608
Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma treatment 1 / 2 completed NCT04763408
A Study to Evaluate the Safety and Tolerability of Lenvatinib in Participants With Advanced or Unresectable Hepatocellular Carcinoma Not Available Not Available completed NCT02630108
TACE Combined With Synchronous Radiofrequency /Microwave Ablation to Treat Large and Huge Hepatocellular Carcinoma treatment 3 unknown_status NCT02848638
Pair Production PET Imaging to Detect Particle Distribution in Patients Undergoing Yttrium-90 Radioembolization No drug interventions Not Available Not Available completed NCT01897038
A Safety, Tolerability, and Pharmacokinetics Study of Onartuzumab as Single Agent or in Combination With Sorafenib in Participants With Advanced Hepatocellular Carcinoma treatment 1 completed NCT00105443
A Phase III Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma treatment 3 completed NCT04066543
TACE Combined With Anlotinib Treatment of Middle-advanced Hepatocellular Carcinoma (HCC) Patients treatment 2 unknown_status NCT01214343
Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC treatment 3 unknown_status NCT02644603
Effect of Enhanced Recovery After Surgery(ERAS) After Liver Resection for Primary Liver Cancer No drug interventions treatment Not Available unknown_status NCT01387503
Expansion of Conventional Criteria for Liver Transplantation in Hepatocellular Carcinoma Through Downstaging No drug interventions treatment Not Available completed NCT00225290
Phase III Trial of Oral Thalidomide in Advanced Hepatocellular Carcinoma With Poor Liver Reserve treatment 3 terminated NCT02576964
A Study of Capecitabine (Xeloda) and Peginterferon Alfa-2a (Pegasys) in Treatment-Naive Participants With Advanced Liver Cancer treatment 2 completed NCT03083002
Risk of Hepatocellular Carcinoma in Patient With Liver Cirrhosis No drug interventions Not Available Not Available unknown_status NCT06530784
Cryoablation Combined With PD-1 Antibody and Bevacizumab for Hepatocellular Carcinoma treatment 2 not_yet_recruiting NCT00386984
Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma treatment 3 completed NCT03434379
A Study of Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma treatment 3 completed